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The signalling cascade induced by the binding of neurotrophins (NGF, 
BDNF, NT3 and NT4) to their high-affinity tyrosine kinase receptors 
(TrkA, B and C) is well documented to be important for neuronal cell 
survival, proliferation and differentiation.  Evidence has accumulated 
demonstrating the importance of these signalling pathways in non-
neuronal tissues, including the ovary where all neurotrophins and their 
receptors are expressed.  In the mouse, effects on ovulation have been 
demonstrated but the role of Trk signalling in neonatal ovary 
development is less clear.  Previous work had found that TrkB 
expression is upregulated at the time of follicle formation in the mouse 
and transgenic mice null for the TrkB receptor demonstrate significant 
loss of oocytes neonatally (TrkB knockouts, KO, die shortly after birth).  
This thesis examines the phenotype of the TrkB KO using 
morphological, histological and surgical techniques with the aim being 
to further investigate the role of TrkB signalling in oocyte survival, and 
to contribute to our understanding of neonatal ovary development.  The 
main questions addressed are: 1) what developmental defects are 
occurring on a morphological level that result in the phenotype of the 
TrkB KO; 2) can these defects be quantified; and 3) what are the long-
term survival prospects for TrkB KO oocytes.  Morphological assessment 
revealed that TrkB KO ovaries exhibit poorer follicle health than their 
Controls and this was confirmed by assessment of basement membrane 
(BM) composition.  TrkB KO brain and kidney were also assessed and 
found to have similarly affected BM.  It is well known that cells require 
contact with the BM to maintain survival, thus it is postulated that TrkB 
signalling contributes to oocyte survival through regulation of the BM.  
Due to the postnatal lethality of the mutation, TrkB KO ovaries were 
transplanted to ascertain long-term oocyte survival.  Unexpectedly it 
was found that TrkB KO oocytes are able to survive and follicles grow as 
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well as they do in the Control transplants.  Consequently, the in vivo 
effect has to be indirect.  It is known that oocytes in the neonatal ovary 
undergo an increased rate of cell death but it is not known how the cell 
debris is removed.  A novel observation of a neonatal ovarian immune 
response has been made in this thesis and is postulated to be a 
physiological mechanism for cell debris clearance.  In conclusion, this 
thesis has demonstrated that signalling through TrkB has an effect on 
regulating BM in the ovary and other organs, but that surprisingly it has 
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 During the 17th century it was postulated that babies grew 
from a miniature man (or homunculus) found inside the head of 
sperm.  In the 350 years or so that have since passed, our knowledge 
and understanding of reproduction has increased greatly, yet there is 
still much to be learnt and dogmas to be challenged.  Early forays 
into speculating on mechanisms of reproduction fixated on sperm as 
the crucial component.  This is probably understandable, given that 
ovulation is not externally visible, but production of semen is quite 
apparent.  Research has revealed that in fact sperm are not as 
essential as an oocyte which can support embryo development.  This 
was demonstrated when the first viable parthenogenetic mouse from 
two maternal genomes was produced (Kono et al., 2004). 
Research has also unveiled aspects of female reproductive 
physiology that our knowledge of is now taken for granted.  Some of 
these include uncovering: the cyclical changes that occur in ovarian 
tissue; the influence of gonadotrophin hormones upon these cycles; 
and the follicles containing the oocyte and somatic cells that are the 
linchpin of this endocrine system.  These discoveries and more, have 
contributed greatly to understanding how a mature, fertilizable oocyte 
is produced and, where possible, how fertility disorders may be 
treated.  However, the nature of science has taught us that there are 
usually more questions than answers.  Currently, there are groups 
focusing their research on the early development of the ovary.  Of 
particular interest is how and what factors regulate formation of the 
finite complement of primordial follicles, how are sufficient numbers 
preserved to maintain fertility, how are some activated to the growth 
phase and of these, why are some supported and some die.  The 
focus of this thesis is neonatal mouse ovary development and the role 
of TrkB signalling in it.    
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1.2. Embryonic ovary  
The vertebrate gonad forms as part of the genitourinary tract.  
This comprises the organs responsible for the production, storage 
and release of urine, and the internal and external reproductive 
organs.  The genitourinary tract forms from mesoderm and 
endoderm, although it is known that the internal reproductive organs 
form from intermediate mesoderm (Little et al., 2007).  The tract is 
sexually undifferentiated until week 8 of pregnancy in the human 
and 11.5 days post coitum (commonly referred to as embryonic age 
E11.5) in the mouse.  Thus, the tract follows an identical process of 
formation in both sexes until the sex is phenotypically determined by 
genetic factors.  The developing gonads are attached to the 
mesonephros (early evolutionary kidney) and consist of the coelomic 
epithelium, covering the gonad, and an underlying ridge of 
mesenchyme which will accommodate the primordial germ cells 
(PGCs).  There are also ducts associated with the gonads which will 
go on to form the reproductive tracts (Wolffian in male, Müllerian in 
female). 
 
1.2.1. Primordial germ cells to oogonia  
 The male and female gametes (sperm and oocyte respectively) 
are products of a series of differentiation events that can be charted 
from E6.25 in mouse development.  This is the earliest observable 
point of segregation of the precursor primordial germ cells (PGCs) 
from the extraembryonic mesoderm (Ohinata et al., 2005).  The 
precursor cells differentiate to form a population of lineage-restricted 
PGCs.  The PGCs then migrate from the allantois of the embryo 
towards the developing gonadal ridges, using amoeboid-like 
locomotion (Blandau et al., 1963) and are guided by responding to 
paracrine signalling molecules (Hoyer et al., 2005).  The PGCs rapidly 
proliferate as they migrate and continue to do so once the gonad is 
reached.  The gonad is colonized by PGCs at E10.5-E11.5 before they 
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lose their motile behaviour.  Many genes are important in PGC 
specification, proliferation and migration have been characterised 
through transgenic manipulation of the mouse (Rodrigues et al., 
2008).   
 Male differentiation begins with the expression of the male-
specific Sry gene (located on the Y chromosome).  Sry upregulates 
expression of anti-Müllerian hormone (AMH; also referred to as 
Müllerian inhibiting substance, MIS) from the testis, causing 
regression of the female Müllerian duct.  Sry also upregulates 
expression of testosterone, which is then secreted by the testis.  
Testosterone supports the survival and development of the Wolffian 
duct into the epididymis and vas deferens.  Sry is absent in females, 
thus AMH is not produced.  Müllerian ducts are not regressed and 
can instead form the oviduct and uterus, the lack of testosterone 
results in regression of the Wolffian duct.    
 It was assumed that formation of the female tract was a default 
pathway, and would only form without active expression of male-
specific genes.  However, the proposal that formation of the female 
tract is also under positive genetic regulation is gaining more 
credence.  For example, in the mouse, Wnt4 is a signalling molecule 
produced by ovarian somatic cells at the time of sex determination 
(Vainio et al., 1999).  Newborn males null for this gene do not exhibit 
any deformities in reproductive tract development, but newborn 
females are distinctly masculinised (Vainio et al., 1999).  Thus, 
female-specific gene expression is required to ensure a female ovarian 
phenotype.   
Once the sex of the gonad is determined, PGCs located in the 
developing ovary are then referred to as oogonia.  The ovary is 
initially a collection of interspersed oogonia, epithelial and 
mesenchymal cells (Byskov, 1986).  The proliferating oogonia 
eventually form clusters which longitudinally, are revealed to be 
cords extending from medulla to cortex.  These cords are separated 
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1.2.2. Oogonia to oocytes  
The oogonia continue to undergo mitosis until they replicate 
DNA one last time and then enter the first phase of meiosis, prophase 
1.  Once an oogonium enters meiosis it is called an oocyte. It is the 
specific process of an oogonium entering meiosis and becoming an 
oocyte that I shall refer to as oogenesis (although the term is 
sometimes applied more loosely by others).  
An intercellular connection (or “bridge”) is left connecting the 
oogonia to each other resulting from incomplete cell division during 
mitosis (Gondos and Zamboni, 1969).  Through these connections 
organelles, cytoplasm and signalling molecules can be passed 
(Pepling and Spradling, 1998).  The onset of meiosis can be observed 
to begin in distinct clusters of oogonia in the ovary, while there may 
still be other clusters continuing to undergo mitosis.  Within 
individual clusters the oocytes are at the same stage of meiosis as 
each other, thereby suggesting that the “bridges” facilitate 
synchronised germ cell development (Gondos and Zamboni, 1969; 
Pepling and Spradling, 1998).  They are, though, not required for 
fertility in female mice as Tex14 null mice lack “bridges” between 
oocytes at birth but are fertile (Greenbaum et al., 2009).   
To reach the quiescent dictyate stage associated with oocytes in 
follicles, oocytes must progress through leptotone, zygotene, 
pachytene and diplotene stages before reaching the dictyate stage of 
prophase I.  In the mouse the majority of oocytes have achieved this 
by the time of, or shortly after, birth.  Entry into meiosis occurs cell-
autonomously at ~E13.5 in the mouse (McLaren, 1984; Ohkubo et 
al., 1996; McLaren and Southee, 1997).  In contrast, oogonia also 
enter meiosis when exposed to the high levels of retinoic acid (RA) 
produced by the mesonephros and associated tubules in the female 
gonad (Bowles et al., 2006).  This latter finding fits in with the 
observation that a cortico-medullary boundary (see Figure 1.1) is 
formed in the ovary at the time oocytes enter meiosis, indicating that 
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this region and its gene expression potentially play a role in 
regulating entry to meiosis (Byskov, 1986; Byskov et al., 1997). 
Other examples of locally produced factors contributing to the 
regulation of meiosis exist.  For example prior to entering meiosis the 
tyrosine kinase receptor (KIT) is expressed by mouse and human 
oocytes and its ligand (Kit ligand; KL, also called stem cell factor) is 
expressed by supporting somatic cells.  Expression of both 
components is downregulated at meiosis and both are upregulated 
once the diplotene stage of prophase I has been reached (Driancourt 
et al., 2000; Hoyer et al., 2005).     
The KIT/KL signalling loop is an example of paracrine 
signalling and evidence of how its expression may be regulated at 
meiosis is found in the human fetal ovary.  Prior to follicle formation, 
activin (a member of the transforming growth factor-β family; TGF-β) 
is expressed in oocytes but the downstream signaling components 
(Smad2) are expressed in somatic cells (Coutts et al., 2008).  Thus, 
activin must exert its effects on somatic cells and, indeed, was found 
to reduce the amount of KL produced by human fetal somatic cells in 
culture.  Coutts et al., (2008) also used immunohistochemistry to 
reveal that KIT is downregulated in oocytes when activin is elevated.  
This allowed speculation that activin, secreted by oocytes, reduces KL 
production by granulosa cells which in turn reduces KIT expression 
by the oocyte.  Oogonia are then able to progress through prophase I 
of meiosis and form primordial follicles, which do not express activin, 
therefore allowing the expression of KIT to return (Coutts et al., 
2008).    
 The period of oogenesis in the developing mouse ovary 
continues until approximately E16.5, by which point nearly, if not all, 
oogonia have at least entered meiosis (Peters, 1970).  Progression to 
the diplotene stage is required for oocytes to form follicles as 
demonstrated by interfering with the meiotic machinery involved.  
Synaptonemal complex protein-1 (SCP-1) is a protein which 
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maintains the close association of paired chromosomes recombining 
during the pachytene stage of prophase I.  SCP1 expression 
disappears at entry to the diplotene stage and this disappearance 
precedes follicle formation.  It was demonstrated that prematurely 
and artificially downregulating SCP-1 by using antisense RNA results 
in precocious entry to the diplotene stage and early follicle formation 
(Paredes et al., 2005).  Expression of the RNA binding protein deleted 
in azoospermia-like (Dazl) is also implicated in this process.  The 
ovaries of mice null (knockout; KO) for Dazl appear normal at E15 
and enter meiosis, but arrest so that by E19 only a few oocytes 
remain, with the rest dying (Ruggiu et al., 1997).  Follicles are 
completely absent by adulthood although the remaining somatic cells 
maintain normal steroidogenic activity (McNeilly et al., 2000).  This 
result, along with the expression of Dazl protein in wild-type oocytes 
throughout oocyte and follicle development (Ruggiu et al., 1997), 
indicates a direct requirement for Dazl expression in oocytes to reach 
the dictyate stage of meiosis: if oocytes cannot reach this stage, they 
cannot direct folliculogenesis and die.   
Oocytes arrested in dictyate state maintain it throughout the 
rest of follicle growth and development.  If growing follicles are not 
lost to atresia, which most are, meiosis is resumed upon ovulation, 
the oocyte undergoes a second arrest and meiosis is only actually 











1.3. Perinatal ovary development 
 The next defined stage of ovarian development in the rodent is 
the process of folliculogenesis which occurs around the time of birth.  
As the term folliculogenesis is also another term used differently by 
different authors (often to describe the growth of follicles) I shall 
define folliculogenesis specifically to be the formation of primordial 
follicles, and not to refer to any later stages of follicle development.  
Folliculogenesis is reported in the literature to occur within either the 
last days of embryogenesis immediately prior to birth (mouse) or 
within the first two to three postnatal days (rat).  However, there is 
enough variation in the observed timing of folliculogenesis in 
published material to make it difficult to determine whether or not 
such strict boundaries can be defined.   
 
1.3.1. Primordial follicle formation 
 The precise molecular and cellular mechanisms by which 
formation of primordial follicles occurs are not fully understood.  It is 
known, however, that the purpose of this process is to ensure oocyte 
survival and this is achieved by the oocyte gaining somatic cell 
support through formation of a primordial follicle.  A primordial 
follicle is an oocyte surrounded by a single layer of flattened, non-
proliferating somatic pregranulosa cells.   
Although the formation of primordial follicles is not fully 
understood for all mammals, there are some basic observations that 
hold true for this process across species: oocyte number is 
dramatically reduced; oocyte clusters fragment and form closer 
associations with pregranulosa cells; follicles first form at the 
boundary of the ovarian cortex and medulla; and a BM is laid down 
around the follicle to separate it from the surrounding stroma (see 





































It has been proposed that primordial follicles in the rat ovary 
do not lay down a BM until the pregranulosa cells are opposed by a 
layer of mesenchymal prethecal cells, only then are they truly a 
primordial follicle (Rajah et al., 1992).  Similarly, in the fetal sheep 
ovary it is also postulated that colonisation of the ovary by streams of 
mesenchymal cells from the mesonephros contribute to follicle 
formation (McNatty et al., 2000).     
The initial mixing of cell-types (epithelial and mesenchymal) in 
the ovary has complicated which lineages could contribute to the 
supporting somatic granulosa cells.  Extremely detailed histological 
studies of the ovary at follicle formation in the rat (Rajah et al., 1992) 
and the sheep (Sawyer et al., 2002) demonstrate that pregranulosa 
cells are found alongside the oogonia within the cords and these are 
likely to be the source of supporting granulosa cells in the primordial 
follicles.  As both rat and sheep cords are open and continuous with 
the ovarian surface epithelium (OSE) but enclosed by BM at the 
medulla, it is possible to speculate that the source of these cells 
within the cords could include the OSE.  
 Sawyer et al. (2002) propose that one way primordial follicles 
could form is by oocyte and pregranulosa cells “budding off” from 
cords at the medulla.  An alternative mechanism whereby oocytes 
within clusters undergo apoptosis has been suggested (Pepling and 
Spradling, 2001).  This facilitates fragmentation of the cluster by 
allowing easier access of somatic cells to the surviving oocytes.  It has 
also been postulated that surviving oocytes benefit from the deaths of 
others by gaining nutrients and there is also the aspect of reduced 
competition for growth factors. 
Evidence demonstrating that apoptosis of oocytes within 
clusters contributes to follicle formation has been shown by the 
influence of hormones.  Treatment of neonatal female mice with 
genistein, a synthetic estrogen (Jefferson et al., 2006), results in 
reduced primordial follicle formation.  As does estradiol, progesterone 
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and genistein treatment of neonatal mouse ovaries in culture (Chen 
et al., 2007).  These studies reveal a reduced rate of apoptosis and 
increased oocyte survival; consequently there is reduced oocyte 
cluster breakdown and increased numbers of multi-oocyte follicles in 
response to hormone treatment.  This led to the hypothesis that in 
utero exposure to maternal estrogen prevents precocious follicle 
formation but at birth the sharp decrease in hormones triggers oocyte 
cell death in the clusters, allowing follicle formation.  Prenatal 
formation of primordial follicles (as occurs in humans and baboons, 
for example) takes place in the presence of maternal estrogens, thus, 
the effects of hormone signalling on this process cannot be the same 
across species.  In fact, reducing estrogen levels during pregnancy in 
baboons reduces primordial follicle formation in the fetus (Zachos et 
al., 2002; Pepe et al., 2006).  This information, combined with the 
finding that estrogen receptors are synthesised in human fetal 
ovaries at the time of follicle formation (Fowler et al., 2009) implies 
that maternal/fetal estrogens are actually required for primordial 
follicle formation in these species.  In addition, it has been 
demonstrated that effects of estrogen are mediated through a G-
protein coupled receptor (GPCR) in hamster ovary to promote 
primordial follicle formation (Wang et al., 2008).  Interfering with the 
receptor by siRNA prevented this promotion of follicle formation.  It, 
therefore, may be possible to speculate that mice are unique in 
forming follicles in response to a decrease in estrogen levels as other 
species demonstrate a requirement for it.   
 Whichever way it is achieved, it is of paramount importance to 
oocytes that they acquire associations with pregranulosa cells; once 
they do, the support provided is sufficient to maintain the follicle in a 
quiescent state throughout the female’s reproductive life, which can 




1.3.2. Gonadotrophin independent follicle growth   
 Instead of remaining quiescent some follicles immediately enter 
the growth phase upon formation.  This usually occurs at the 
medulla of the ovary and across species it is the norm to see a 
gradient of follicle development, with clusters of quiescent primordial 
follicles in the cortex and growing follicles in the medulla (Rajah et 
al., 1992; Sawyer et al., 2002).  The factors regulating entry of 
follicles to the growth phase are not yet completely understood.  
However, it is clear that there are a panoply of factors at work, on 
morphological and genetic levels. 
 In the mouse ovary, regulation of growth initiation can be 
partially attributed to the boundary between the cortex and the 
medulla (Byskov et al., 1997; see Figure 1.1).  In vitro culture of 
embryonic mouse ovaries revealed that failure to form a cortico-
medullary boundary resulted in all follicles commencing growth, 
however, if the boundary is formed then only a specific number of 
follicles will activate growth at the boundary (Byskov et al., 1997).  
Ultimately this was found to be dependant on a sufficient population 
of oocytes in the ovary, leading Byskov et al. (1997) to propose that 
the growing follicles in the medulla require contact with non-growing 
follicles in the cortex to regulate the size of the cohort recruited and 
prevent premature follicle activation. 
 The physical features of each stage of growth have been 
described thoroughly; initially one or two of the flattened granulosa 
cells become cuboidal in shape, indicating differentiation has 
occurred (a transitionary follicle).  The change in appearance is used 
as the hallmark of granulosa cell proliferation and activation of 
follicle growth.  This first phase of follicle growth is considered slow 
compared to the later gonadotrophin dependent stages.  It can take 
rodents weeks and larger species months for follicles to progress to 
the primary (one complete layer of cuboidal granulosa cells), 
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secondary (two layers) and preantral stages (multiple layers; see 
Figure 1.2).  
 The follicles prepare themselves for entry to the gonadotrophin 
dependant stage by becoming semi-responsive to available hormones 
but there is compelling evidence that follicle growth does not require 
gonadotrophins up until antrum formation.  Follicle stimulating 
hormone (FSH) and luteinising hormone (LH) are released from the 
anterior pituitary under the action of the gonadotrophin-releasing 
hormone (GnRH).  Mutation of the gene encoding GnRH in the 
hypogonadal (hpg) mouse prevents release of GnRH from the 
hypothalamus which in turn, ablates FSH and LH levels (Halpin et 
al., 1986) resulting in hpg mice lacking antral follicles.  Prevention of 
FSHβ subunit expression (Kumar et al., 1997) or of FSH receptors in 
the mouse by mutation (Abel et al., 2000) also stops follicles from 
progressing beyond the preantral stage.   
 Independence of these systemic hormones indicates that other 
factors must be involved in initiating and supporting early follicle 
growth.  One such factor is the ability of the cells to communicate 
with each other.  Gap junctions are cell-to-cell points of contact 
forming channels which allow second messengers, small metabolites 
and inorganic ions to pass.  The junctions are formed by each cell 
presenting one half on the channel (a connexon).  Each connexon is 
made up of six protein subunits from the connexin family, of which 
there are fifteen members.  Connexin43 (encoded for by the gene 
Gja1) is important in follicle growth although mutation in mice (Gja1 
KO) is neonatal lethal.  Heterotopic transplantation of the ovaries for 
three weeks revealed that the follicles block at the primary follicle 
stage of growth, or secondary stage depending on strain background 
(Ackert et al., 2001).  Connexin43 protein is expressed between the 
pregranulosa cells of primordial follicles from P1 (Juneja et al., 1999) 
allowing Ackert et al. (2001) to hypothesise that its expression is 
required in gap junctions for granulosa cell proliferation in early 
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follicles.  However, it was also demonstrated that the germ cell 
population of the Gja1 KO is reduced in the E11.5 and E17.5 gonads 
(Juneja et al., 1999).  Although the evidence is compelling that 
subsequent growth of surviving follicles is affected in Gja1 KOs, the 
possibility that the already depleted population of oocytes 
transplanted may have altered the intraovarian signalling, and 
therefore the outcome of the transplants, was not addressed.   
The factors considered most likely to be activators of follicle 
growth are those that stimulate, promote and maintain granulosa cell 
proliferation. 
The TGF-β superfamily receives much attention as many of its 
members facilitate roles in ovarian function (Shimasaki et al., 2004; 
Drummond, 2005; Knight and Glister, 2006).  One such member is 
growth differentiation factor-9 (GDF-9) which is normally expressed 
in the oocyte from primary follicle stage onwards.  Expression of this 
growth factor is required for follicle growth past the primary stage as 
ovaries from mice unable to express the protein are blocked at this 
point due to granulosa cells unable to proliferate (Dong et al., 1996).  
Other oocyte expressed TGF-β superfamily members shown to be 
involved are members of the bone morphogenetic protein family 
(BMP-15 and BMP-7).  A natural mutation occurring in the sheep 
homologue of Bmp-15 (FecXI) results in blocked follicle growth at the 
primary stage (Galloway et al., 2000).  In addition, although mice null 
for Bmp-15 did not show an effect on fertility (Yan et al., 2001) rat 
granulosa cells co-cultured with oocytes and BMP-15 did show an 
increase in mitosis (Otsuka and Shimasaki, 2002).  BMP-7 stimulates 
rat granulosa cell proliferation and promotes the primordial to 
primary follicle transition in vivo (Lee et al., 2001b).   
 In contrast to the positive regulation by these oocyte-expressed 
TGF-β superfamily members described so far, it has been found that 
the member, AMH, has a role as a repressor of primordial follicle 
recruitment.  AMH protein is expressed in the granulosa cells of 
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secondary follicles onwards (Durlinger et al., 2002) and mice null for 
the factor exhibited precocious follicle activation such that at four 
months significantly more preantral follicles were found with a 
concomitant reduction in the number of primordial follicles retained 
(Durlinger et al., 1999).  Thus, it is proposed that AMH functions as a 
way for already growing follicles to prevent premature activation of 
quiescent follicles.   
The KIT/KL pathway (already known to be important for PGC 
migration, oogonia survival, and entry to meiosis as discussed above), 
also seems to be a central mediator of primordial follicle activation 
through paracrine signalling (Driancourt et al., 2000).  The pattern of 
expression indicates that this would occur between the granulosa 
cells and the oocyte, and between the granulosa cells and the thecal 
layer.  This is because mRNA and protein for the receptor KIT is 
found in oocytes from the diplotene stage onwards and mRNA in the 
thecal layer (Manova et al., 1990).  However, mRNA for the ligand, KL, 
is contrastingly expressed in granulosa cells from the primary stage 
onwards (Manova et al., 1993).  Evidence for a role in follicle 
activation can be found: KL stimulates oocyte growth (Reynaud et al., 
2000), added to ovarian culture it promotes follicle activation (Nilsson 
and Skinner, 2004), it has a mitogenic effects on rat granulosa cells 
in culture (Otsuka and Shimasaki, 2002); and if the murine KL gene 
is mutated or if signalling is blocked (either by injecting pups with 
neutralising antibody or by adding it to mouse ovary culture) 
primordial follicle activation is reduced (Yoshida et al., 1997; 
Driancourt et al., 2000). 
The KIT/KL pathway can also regulate and be responsive to the 
expression of other factors.  KL mRNA is increased in the granulosa 
cells of Gdf-9 KO mouse ovaries (Elvin et al., 1999), possibly 
explaining the continuation of oocyte growth observed in the null 
ovaries even though the granulosa cells do not proliferate. 
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BMP-15 stimulates KL mRNA expression in granulosa cells co-
cultured with oocytes (Otsuka and Shimasaki, 2002).  However, KL 
added to the co-culture results in a dose-dependent reduction in 
Bmp-15 mRNA oocyte expression.  This suggests that there is a 
negative feedback loop between the two.  In addition, although BMP-
15 stimulates granulosa cell proliferation in vitro, blocking the KIT 
receptor on the oocyte with an antibody, prevents the mitotic effect of 
BMP-15 on granulosa cells, leading Otsuka and Shimasaki (2002) to 
speculate that the effect on mitosis seems to be mediated by the KIT 
receptor. 
As well as members of the TGF-β superfamily, the KIT/KL 
pathway also interacts with other growth factors implicated in the 
primordial to primary activation.  Basic fibroblast growth factor 
(bFGF) is detected in the oocytes of primordial follicles, the granulosa 
cells of growing follicles and upregulates primordial follicle activation 
(Nilsson et al., 2001).  The interactions of bFGF and the KIT/KL 
pathway were tested using a P4 rat ovary culture system.  Addition of 
a bFGF neutralising antibody abrogated the KL induced activation, 
and addition of a KIT receptor blocking antibody prevented the bFGF 
induced activation (Nilsson and Skinner, 2004) demonstrating that 
both pathways contribute to follicle activation.  While KL had no 
effect on bFGF mRNA levels in cultured ovaries, bFGF did increase KL 
mRNA.   
In a similar manner the role of the cytokine leukaemia 
inhibitory factor (LIF) on follicle activation was assessed (Nilsson et 
al., 2002).  Normally expressed in the somatic cells of quiescent and 
primary follicles, LIF promotes the levels of primordial follicle 
activation in P4 cultured rat ovaries and a LIF neutralising antibody 
abrogates the effect.  LIF can also increase the amount of KL mRNA 
granulosa cells can produce in vitro, therefore Nilsson et al. (2002) 
hypothesise that LIF may promote activation through regulation of KL 
expression.          
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 Thus, hormones and growth factors produced by granulosa 
cells exert effects on follicle assembly and growth, but the oocyte is 
considered to be the master organiser of these effects (Eppig, 2001).  
There is now strong evidence that oocyte-specific transcription factors 
(TFs) regulate expression of some of the genes just discussed and 
their mutation results in oocyte loss through improperly regulated 
primordial follicle formation, follicle activation and oocyte survival 
(Suh et al., 2002; Skinner, 2005; Pangas and Rajkovic, 2006; Pepling, 
2006; Rodrigues et al., 2008).   
 Null mutation of a gene encoding murine newborn ovary 
homeobox TF (Nobox) results in oocyte loss by P14 (Rajkovic et al., 
2004).  Wild-type and null mice have comparable numbers of oocytes 
and primordial follicles on the day of birth, although by P7 it is 
apparent that complete follicle formation, activation and subsequent 
growth is affected with more oocyte clusters found in the KO than in 
the wild-type ovary.  Downregulation of the TGF superfamily 
members, Gdf-9 and Bmp-15, in Nobox null mice indicates how the 
mutation may cause the phenotype.  
 As well as the BM deposited around the follicle another form of 
extracellular matrix (ECM) is formed around the oocyte.  This is 
referred to as the zona pellucida (ZP) and it is instrumental in 
mediating fertilisation and preventing polyspermy from occurring.  ZP 
mRNA is expressed in newborn mouse ovaries (Soyal et al., 2000) and 
in human ovaries the protein is expressed in primordial follicles 
onwards (Gook et al., 2008).  Rajkovic et al. (2004) demonstrated that 
expression of ZP proteins is not affected in the Nobox null mutant 
although it is when another TF (murine factor in the germ line, alpha; 
Figlα) is mutated (Soyal et al., 2000).  Figlα, a helix-loop-helix TF, is 
specifically expressed in oogonia and oocytes in the neonatal ovary 
peaking around the time of birth in the mouse.  Figlα mutation 
results in almost complete loss of oocytes by P1 as oocytes are unable 
to form primordial follicles (Soyal et al., 2000).  It is proposed by 
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Soyal et al. (2000) that this effect on primordial follicle formation is 
attributable to oocyte inability to recruit supporting somatic cells, 
resulting in oocyte apoptosis, rather than lack of ZP. 
 Recent studies have revealed that these TFs are under the 
control of another oocyte-specific TF important for ovary development 
(spermatogenesis and oogenesis helix-loop-helix1; Sohlh1).  Pangas et 
al. (2006) examined the ovaries from Sohlh1 null mice; in addition to 
reduced primordial follicle activation and subsequent oocyte loss, 
mRNA transcripts for Nobox and Figlα are both reduced, as are the 
genes they regulate (Gdf-9, Bmp-15 and ZP).  However, NOBOX did 
not co-immunoprecipitate with Sohlh1 indicating that it is not a 
direct target of Sohlh1.  Transcripts of another TF (LIM-homeobox 
protein 8; Lhx8) were significantly reduced in the Sohlh1 KO at the 
time of birth (Pangas et al., 2006).  Lhx8 is expressed in a similar 
pattern to Sohlh1 and KO mice have a similar phenotype culminating 
in oocyte loss (Choi et al., 2008).  The newborn Lhx8 KO is shown to 
have reduced mRNA for Figlα (and consequently the ZP genes), Nobox 
(and consequently Gdf-9) and both Kit and KL (Choi et al., 2008).  
Thus, it is demonstrated that Sohlh1 can exert transcriptional 
regulation over Lhx8 but it is Lhx8 which can regulate the expression 
of growth factors important in follicle formation and activation 
through regulating Figlα and Nobox expression and by stimulating 
Kit/KL expression. 
  These examples demonstrate the myriad of factors within the 
ovary that are acting in concert to repress and promote follicle 
activation.  Follicles that have commenced growth begin to prepare 
themselves for entering the gonadotrophin dependent stage, although 
this will not be possible until puberty.  Only then will sufficient levels 
of gonadotrophins be released from the anterior pituitary (FSH and 
LH) which support full follicle growth and ovulation.  Preparation for 
gonadotrophin dependence, and entry to the fast phase of growth, 
commences with FSH receptor (FSHR) synthesis by the granulosa 
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cells of secondary follicles.  In addition, formation of the prethecal 
layer occurs at this time by cells derived from the mesenchyme 
orientating themselves against the follicular BM.  LH receptor (Lhr) 
mRNA is found in the thecal layers of immature follicles (Camp et al., 
1991) but subsequent growth to the preantral follicle stage is 
considered to be responsive, but not dependant on gonadotrophins, 
as discussed above.  Once the follicles become gonadotrophin 
dependent, the majority of follicles die as they do not receive 
sufficient support.  The surviving follicles progress through 
subsequent stages of growth to the ovulatory stage as part of the 
reproductive cycle.  The end of the preantral stage is characterised by 
formation of a fluid-filled cavity in the granulosa cells (antral follicle; 
see Figure 1.2).  This leads to differentiation of mural granulosa cells 
(those found in the follicle wall) and the cumulus granulosa cells, 
found next to the oocyte.   
The preovulatory (or Graffian) follicle is associated with final 
stages of growth.  Up until this point, gonadotrophin support is 
utilised by the follicles in a two-cell model between the granulosa and 
thecal cells.  The thecal layer expresses LHR, and under the effects of 
LH provides increasing amounts of aromatisable androgens in the 
form of testosterone to the granulosa cells of growing follicles where it 
is converted into estrogens.  Granulosa cells of antral follicles also 
express LHR (Camp et al., 1991).  The follicles grow due to the 
proliferative action of FSH on granulosa cells and, thus, produce 
increasing concentrations of oestrogen and inhibin, the TGF-β 
superfamily member.  These hormones negatively act on the 
hypothalamic-pituitary axis to reduce FSH release thereby 
suppressing the growth of smaller follicles, but by this stage the 
larger follicles are able to withstand this reduction in FSH.  
Eventually in the cycle, oestrogen levels reach a point where it 
actually causes a surge in the release of gonadotrophins (a small FSH 
surge precedes a large LH peak mid-cycle).  The surge in LH ruptures 
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the follicle wall and the oocyte is released.  The remaining granulosa 
cells of the ovulated follicle luteinise and form a corpus luteum.  This 
structure secretes progesterone, which supports pregnancy, should it 
occur.  Each cycle a cohort of follicles is taken through the stages of 
antral and preovulatory development.  How the primordial follicles 
are initially recruited from the pool is unclear, although it is 
eventually depleted resulting in senescence (see Figure 1.3).  The 
steroidal control and the intraovarian factors regulating this process, 
and their interactions with each other, have been extensively 
reviewed (Baker and Spears, 1999; McGee and Hsueh, 2000; Hillier, 
2001; Suh et al., 2002; Gilchrist et al., 2004; Barnett et al., 2006; 
















































1.4. Cell death in the developing mammalian ovary 
 The factors regulating cell death of oogonia and oocytes in the 
developing mammalian ovary are not fully understood, although it 
has long been recognised to occur in rodents and human ovaries on a 
large scale (Beaumont and Mandl, 1962; Baker, 1963).  Across 
mammals, cell death in the ovary during oogenesis is a key factor in 
regulating the ovarian reserve and ultimately the reproductive life-
span of the female since the remaining germ cells have by then exited 
mitosis and entered meiosis.   
Beaumont and Mandl (1962) characterized the embryonic and 
neonatal rat ovary in terms of germ cell number and morphology.  
Their observations suggest that morphologically distinct cell death 
events take place in waves at different points in ovary development.  
They also observed that the dying cells are removed within 24 hours, 
making this a rapid process, which is consequently difficult to 
observe.  Phagocytosis of apoptotic oocytes by somatic cells is one 
possible way to remove the debris, and this has been observed in 
immature human ovaries (Baker and Franchi, 1967). 
  Morphologically, the cells dying bear the hallmarks of classic 
programmed cell death (PCD) referred to as apoptosis.  These include 
condensed chromatin and cytoplasm, a wrinkled nuclear envelope, 
cell shrinkage and eventually the membrane of the cell breaks down 
so that smaller apoptotic bodies (blebbing) are formed but retained 
within a membrane.  The controlled destruction of the cell, in 
particular the retention of the debris within a membrane, is thought 
to contribute to the anti-inflammatory nature characteristic of 
apoptosis.  This is in contrast with another form of PCD, necrosis, 
which results in the loss of the plasma membrane inducing an 
inflammatory response.   
The first wave of cell death occurs in the oogonia prior to 
meiosis, during meiosis and another as the oocytes reach the 
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diplotene stage (coincident with the formation of the primordial 
follicles; Beaumont and Mandl, 1962).  These peaks have also been 
observed in mice (Coucouvanis et al., 1993; Ghafari et al., 2007) and 
a peak has been observed in human fetal ovary at the time of 
folliculogenesis (Fulton et al., 2005).  Although it has been proposed 
that there is a basal level of loss of oogonia and oocytes during 
embryogenesis with a peak during meiosis and at follicle formation 
(McClellan et al., 2003).  The loss of oocytes continues into the 
neonatal period in rodents, with oocyte number only stabilising from 
P6/7 (Kerr et al., 2006; Rodrigues et al., 2009). 
   The occurrence of a peak in apoptosis at entry to meiosis is 
open to speculation although there is evidence that apoptosis is 
occurring in PGCs/oogonia prior to entry to meiosis.  One mechanism 
postulated to account for cell death is the failure of germ cells to 
obtain sufficient amounts of growth factors from supporting somatic 
cells.  This would be a useful mechanism, allowing regulation of 
surviving cell number within a structure, such as the ovary, and 
could promote the apoptosis of any cells that have migrated 
incorrectly to an area without trophic support.  For example, when 
murine PGCs from E12.5 embryos are cultured in vitro for 4-5 hours 
almost half of them exhibited signs of apoptosis.  Addition of the 
oocyte growth promoting cytokine KL, significantly reduced the 
percentage of PGCs exhibiting an apoptotic marker (Pesce et al., 
1993) although this effect was not found over longer culture periods.  
In addition, mice heterozygous for Kit exhibited increased oocyte 
apoptosis in E15.5 mouse embryos (Driancourt et al., 2000). 
The aryl-hydrocarbon receptor (AhR) is a basic helix-loop-helix 
TF proposed to be a mediator of prenatal germ cell apoptosis.  In vitro 
culture of embryonic ovaries without the support of serum normally 
results in elevated levels of apoptosis.  E13.5 Ahr KO ovaries, 
however, exhibit more non-apoptotic germ cells when cultured 
without support than wild-type ovaries, demonstrating that its 
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expression would normally contribute to germ cell death under those 
conditions (Robles et al., 2000).  The next peak of apoptosis is 
proposed to occur during meiosis (at the pachytene stage in 
particular); it may be that this is a way of removing oocytes with 
abnormal chromosomes.  The Bcl2-associated X protein (BAX) is a 
component of the pro-apoptotic pathway.  The function of BAX has 
been investigated in relation to apoptosis occurring during meiosis.  
Consistent with BAX’s apoptotic properties, mice null for the Bax 
gene contain approximately twice as many oogonia as wild-type 
ovaries at E14.5 (Alton and Taketo, 2007).  However, upon entering 
meiosis, and up to its completion, the proportion of oocytes lost in 
Bax KO mice was comparable with the proportion lost in wild-type 
ovaries, thus oocyte apoptosis occurring during meiosis is not 
regulated by BAX. 
The prevention of prenatal oocyte apoptosis (as demonstrated 
by the Ahr and Bax KO mice) results in increased numbers of oocytes 
which are maintained during folliculogenesis.  Ahr KO ovaries contain 
significantly more primordial follicles than wild-types at P4 (Robles et 
al., 2000) and Bax KO ovaries contained significantly more cells 
stained for an oocyte marker (mouse vasa homologue, MVH) than Bax 
heterozygotes at P5 (Alton and Taketo, 2007).   
Likewise disruption of pro-survival genes such as Bcl2 (B-cell 
lymphoma/leukemia 2) have an effect on oocyte and follicle number.  
Null expression of Bcl2 in the mouse results in a reduced primordial 
follicle pool, demonstrating that oocytes do require protection from 
apoptosis, although the mice are still fertile reiterating that apoptosis 
is not the only mediator of neonatal oocyte loss (Ratts et al., 1995).  
The opposite could also be induced in mice by overexpressing Bcl2, 
the ovaries contain increased numbers of primordial follicles, 
indicating that more oocytes than normal are saved from an apoptotic 
fate (Flaws et al., 2001).    
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 There are studies, though, that are beginning to emerge to 
suggest that apoptosis is not the only mechanism of oocyte loss, in 
fact some actively proclaim that it is not associated with the loss of 
primordial follicles (Tingen et al., 2009).  As discussed in Section 
1.2.2, loss of oocytes can be associated with failure to reach the 
diplotene stage of meiotic prophase I.  Observations made in wild-
type mice have provided additional support for this hypothesis.  
Oocytes that had not reached the diplotene stage (as demonstrated by 
continued germ cell nuclear antigen expression; GCNA) were 
observed to be extruded through the OSE of neonatal mouse ovaries 
(Kerr et al., 2006).  Thus, it is postulated to be a mechanism which 
actively contributes to reduction in oocyte number in the ovary 
during the neonatal period (Wordinger et al., 1990).   
 Other forms of PCD are active during oocyte cell death in vivo 
and in vitro, such as caspase-independent pathways (Lobascio et al., 
2007) and autophagy (Lobascio et al., 2007; De Felici et al., 2008; 
Rodrigues et al., 2009). 
 Thus, it can be concluded from the literature that although 
apoptosis was considered to be the main mechanism of cell death in 
the developing ovary, it is not the only way to remove oocytes and its 
blockade is not the only way to save them.  Therefore, there are 
multiple pathways which can regulate oocyte death in the developing 
ovary.  However, it would seem manifest that fate of the germ cell 
depends on the stage of differentiation it is in and the stimulus 
received.  Cell death in the developing ovary and subsequent cell 
death associated with atresia of growing follicles has been extensively 
reviewed (Tilly, 1996; McGee et al., 1998; Morita and Tilly, 1999; 






1.5. Neurotrophins and Trk receptors  
 The neurotrophins are a family of polypeptide growth factor 
molecules which bind to a family of tyrosine kinase receptors (TrkA, B 
and C).  The ligands are named for their characteristic role in the 
development and nourishment (troph) of the nervous system (neuro; 
neuron).  They are released from neuronal targets in the developing 
nervous system to promote growth of the innervating neurons.  In 
some instances there is competition for these neurotrophins, and 
without sufficient levels the neurons competing for them may 
succumb to apoptosis.  Hence they are best known for their roles in 
neuronal growth and survival.  There is a very large field of literature 
available on neurotrophin and Trk research (the number of available 
publications through pubmed returning hits for “neurotrophins” is 
34,567, for “TrkB” alone it is 2,136 hits).  Considering this, I have 
decided to focus the majority of the introduction on Trk signalling to 
TrkB and its ligands.    
 
1.5.1. Neurotrophins: the ligands  
 The neurotrophin nerve growth factor (NGF) was first 
discovered by Stanley Cohen and Rita Levi-Montalcini in the 1950’s.  
They were awarded the 1986 Nobel Prize in Physiology or Medicine, 
and the discovery of NGF was followed by that of other members of 
the same family.  These include brain derived neurotrophic factor 
(BDNF) and neurotrophins 3 and 4 (NT3 and NT4).  More recently 
NGF-like neurotrophins 6 and 7 have been discovered but it is not yet 
apparent if they have significant signalling roles in mammalian 
development and they are, therefore, not discussed further here (Gotz 
et al., 1994; Lai et al., 1998).   
 Neurotrophins are initially synthesised in an immature form 
called proneurotrophins.  Once considered to be inactive, these 
precursors are actually capable of signalling via the p75 receptor 
which they bind to with high affinity (Lee et al., 2001a).  The mature 
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neurotrophins are formed by the action of convertases (enzymes 
responsible for the cleavage of proteins) including members of the 
furin serine proteinase family (Seidah et al., 1996).  Mature ligands 
form homodimers which then bind to the p75 receptor with low 
affinity and the Trk receptors with high affinity (Lewin and Barde, 
1996; Lu et al., 2005).   
 
1.5.2. Trks: the receptors 
 Although the first ligand (NGF) was discovered several decades 
ago, it wasn’t until much later that the receptor for this family of 
growth factors was identified.  The Trk locus encoding the receptors 
was first recognised in humans when it transformed into an active 
oncogene in a colon carcinoma through fusion with tropomyosin 
(Martin-Zanca et al., 1986).  This allowed identification of three 
tropomyosin-related tyrosine kinase receptors: TrkA, TrkB and TrkC.  
These receptors are comprised of an extracellular binding domain, a 
transmembrane domain and an intracellular region containing the 
tyrosine kinase domain.  The extracellular sequences are distinct 
between the receptors allowing them to bind, with high specificity, 
their respective ligands.  NGF binds to and activates TrkA, BDNF and 
NT4 to TrkB and NT3 to TrkC (Dechant, 2001).  It has been found in 
some in vitro models that NT3 can activate TrkA and TrkB, although 
with less affinity than for TrkC (Ip et al., 1993; Barbacid, 1994; 
Davies et al., 1995).   
 Each Trk receptor exists in a full-length form which expresses 
the intracellular tyrosine kinase domain responsible for triggering the 
downstream signalling cascade.  Some additionally express truncated 
receptors, which do have an intracellular domain although it does not 
contain the tyrosine kinase domain (see Figure 1.4). 
 Neurotrophin homodimers bind to the Trk receptor, causing it 
to dimerise (Jing et al., 1992) resulting in phosphorylation of 
cytoplasmic tyrosine residues and activation of the kinase domain 
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(Klein et al., 1991).  The signalling cascades are initiated by adaptor 
molecules and/or enzymes attaching to the phosphorylated tyrosine 
residues (Schlessinger and Ullrich, 1992).  Due to the sequence 
homology of the intracellular sequences across the Trk receptor 
family, the downstream signalling cascades initiated can be the same, 
although activated by different ligands, see Figure 1.5 (Patapoutian 
and Reichardt, 2001; Huang and Reichardt, 2003; Segal, 2003; 
Reichardt, 2006).     



























































































 1.5.2.1. Truncated Trk receptors 
 The truncated Trk receptors are able to bind neurotrophins, as 
they express the extracellular binding domains, however, they lack 
the intracellular tyrosine kinase activity required to transduce 
intracellular signals (see Figure 1.4).  Thus, truncated receptors were 
considered to be incapable of downstream tyrosine kinase signalling.  
At odds with this seeming lack of function considerable upregulation 
of truncated receptor isoform expression was observed in chicken and 
mouse neuronal and non-neuronal tissues during embryogenesis 
(Escandon et al., 1994).  The reasons for this remain unclear, 
although possible functions for these truncated receptors have since 
been postulated.  It was suggested that where ligand is of limited 
availability the truncated receptors could compete with the full-length 
receptors for their respective ligands.  Unable to transduce a signal 
effectively makes them negative regulators of the activity of the 
pathway (Biffo et al., 1995).  A more subtle effect was also considered 
plausible as truncated receptors could theoretically act as “mops” to 
bind excess signal without over-stimulating the signalling pathway.  
In addition the ability of full-length TrkB and its truncated isoforms 
to dimerise together was postulated to result in inhibition of 
downstream signalling (Eide et al., 1996).  However, it has actually 
been demonstrated that these truncated receptors are capable of 
some forms of immediate cell signalling.        
Rose et al. (2003) assessed the action of BDNF on cultured 
astrocytes and neurons through full-length and truncated TrkB 
receptors (T1 and T2).  Expression pattern analysis revealed the 
detection of full-length receptors to be high in neurons and low in 
astrocytes but the reverse was true for truncated (T1) receptors.  
Application of BDNF results in Ca2+ release from astrocytes and 
neurons but when a Trk inhibitor (K252a) is applied it only blocks 
BDNF-induced Ca2+ release in neurons, not in astrocytes.  K252a 
inhibits tyrosine kinase activity of Trk receptors by prevention of 
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autophosphorylation of intracellular tyrosine residues (Ohmichi et al., 
1992; Tapley et al., 1992).  Thus, BDNF must be inducing Ca2+ 
release in the astrocytes by activation of truncated receptors.  The 
evidence for truncated TrkB signalling is strengthened by the finding 
that astrocytes from mice mutant for the full-length receptor release 
Ca2+ in response to BDNF as well as astrocytes from mice expressing 
the full-length receptor (Rose et al., 2003).      
These results indicate two separate signalling pathways 
activated by BDNF binding.  The known signalling pathway in 
neurons consists of BDNF binding to full-length TrkB receptor, 
opening Nav1.9 Na+ channels depolarising the cell.  This causes 
voltage-gated Ca2+ channels to open resulting in Ca2+ influx (Blum et 
al., 2002).  Blocking Na+ channels prevents BDNF-induced Ca2+ signal 
in neurons but not astrocytes. The alternative mechanism was shown 
to involve the Ins(1,4,5)P3 pathway that activation of (through ligand 
binding) results in Ca2+ release from intracellular stores. Inhibition of 
this pathway significantly reduces BDNF-induced Ca2+ signal in 
astrocytes.  What has not been answered is how truncated receptors 
initiate the signalling cascade required to activate the Ins(1,4,5)P3 
pathway when they lack the tyrosine kinase domain.    
 
1.5.3. p75: the receptor 
Widely considered to be a receptor that signals death to the cell 
p75 is a member of the tumour necrosis factor receptor superfamily 
(TNFRS).  Each mature neurotrophin has a similar affinity for p75 as 
the recognition domain is highly conserved across neurotrophins (He 
and Garcia, 2004).  The affinity mature forms of neurotrophins have 
for p75 is low; in contrast, immature forms of neurotrophins 
(proneurotrophins) bind to and activate p75 receptors with high 
affinity, see Figure 1.5 (Lee et al., 2001a; Woo et al., 2005).  
Transduction of proneurotrophin signals are dependant on 
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interactions of p75 with co-receptor sortilin, a type I transmembrane 
protein (Bronfman and Fainzilber, 2004; Teng et al., 2005).  
In addition to neurotrophin-p75 interactions there are also 
different receptor-receptor associations which can alter neurotrophin 
affinity (identified by co-immunoprecipitation techniques).  Trk and 
p75 receptors can interact directly to form a complex able to increase 
ligand specificity; in particular TrkB was demonstrated to have an 
increased specificity for BDNF when the TrkB-p75 complex was 
formed (Bibel et al., 1999).  Truncated TrkB receptors are also able to 
interact with p75 (Hartmann et al., 2004).  Structural analysis of 
crystalline NGF homodimers showed that they have the potential to 
recruit both p75 and TrkA receptors into trimolecular multiplexes (He 
and Garcia, 2004).  With evidence for the existence of p75 isoforms 
(Schor, 2005), these findings combined reveal how difficult it may be 
to predict the outcome of neurotrophin signalling.   
Overall it appears that the end effect on the cell is dependent 
on the type(s) of receptor present, the form of the neurotrophin, and 
ultimately the cell type receiving the signal.  Clearly the dogma that 
Trk receptors solely mediate cell survival and p75 receptors solely 
mediate cell death should be considered redundant. 
 
1.5.4. Detecting TrkB mRNA and protein 
 There is a lack of precise molecular data available relating to 
the nature of TrkB and its receptor isoforms, with complete 
nucleotide sequence data for full-length TrkB only available on NCBI 
Entrez Gene database towards the end of the course of this PhD and 
TrkB T2 expression is still not confirmed, except in the rat.  This 
impacted considerably on determining reliably which receptor 
isoforms are expressed in which tissues, when and at what level.  It 
also meant that it is not possible to be entirely sure what is generated 
by the transgenic mouse null for full-length TrkB, TrkBFL (Klein et al., 
1993) either in terms of truncated isoforms or other splice variants 
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induced by the mutation, although Klein et al. (1993) did 
demonstrate by Western blot that truncated receptor protein was 
unchanged in the brains of TrkBFL KO newborn mice. 
 Protein detection has also been greatly hampered due to the 
lack of information available, and although many papers have been 
published on expression patterns of TrkB receptors in many tissues, 
the supposed expression pattern has differed depending on: the 
tissue; the antibody; and the protocol used.  Considering the size of 
the field of Trk signalling research it seems amazing that there is a 
paucity of reliable antibodies for TrkB.  This, however, is what we 
believe to be the case (and others have come to the same conclusion, 
personal communication with Dr Minichiello, EMBL, Italy).  For 
example, the commercially available antibody for full-length TrkB was 
purchased from Santa-Cruz and tested with wild-type brain, yet mass 
spectrometry on bands from 2D gels revealed that full-length TrkB 
was not detected by the antibody.  A separate antibody considered to 
be specific for full-length TrkB (a gift from Professor Kaplan, Hospital 
for Sick Children, University of Toronto, Canada) actually reacted 
with TrkBFL KO tissue.  Given that it is possible for some antibodies 
to work under only very strict conditions it remains feasible that 
further refinement of the protocols may need to be carried out to 
ensure optimisation but they could not be considered robust 
antibodies.  
Thus, bearing in mind the issues described here the discussion 
of mRNA detection and protein expression patterns should not be 
considered absolute.  Future research in this field may be able to 
make use of transgenic mice which can express a reporter gene under 
the control of TrkB promoters to establish expression patterns.  For 
example the TrkB allele has been floxed and a tau-lacZ gene attached 
allowing the targeted removal of the gene from neurons (Xu et al., 
2000).  The transgenic mice were used to assess the role of TrkB in 
the hippocampus and to visualise where TrkB expression is replaced 
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by lacz (Xu et al., 2000).  Use of heterozygotes expressing the lacz 
transgene may provide more reliable detection of TrkB expression in 
neuronal tissues.   
 
1.6. Roles of Trk receptors in the development of t he nervous 
system 
 A large amount of the information available on the roles of Trk 
signalling has been generated from research using transgenic mice 
null for the ligand or receptor of choice.  These mice tend to either 
show no apparent phenotype due to compensatory roles or are lethal 
in early postnatal development.  It may be possible to assume that 
mutations arising in humans would follow the same pattern and 
therefore would not be apparent, however, the activity of Trk 
signalling contributes to many conditions.  For TrkB these include: 
metastisisation of cancer; epileptogenesis; schizophrenia; and 
obesity. 
 As mentioned at the start of this section Trk signalling is best 
characterised for its roles in neuronal growth and survival, although 
it is also involved in neuronal differentiation and synaptic function: 
as cell survival is particularly pertinent to the development of the 
ovary it will be focused on here.   
 
1.6.1. Cell survival 
 The roles of Trk signalling in cell survival in the developing 
peripheral and central nervous systems have been exemplified by 
studies using mutant mice null for TrkA, TrkB, Ngf and Bdnf.  It  has 
been well reviewed that across differing neuronal populations all KOs 
suffer some degree of neuronal cell loss (Barbacid, 1994; Klein, 1994; 
Snider, 1994; Conover and Yancopoulos, 1997; Tessarollo, 1998) and 
almost all exhibit neonatal lethality.  These effects are found mainly 
in the sympathetic and sensory neurons of the peripheral nervous 
 53 
system (PNS) where the ligand is secreted in limited amounts to 
control the number of innervating neurons according to the size of 
the target tissue.  Generally TrkA KOs exhibit loss of sympathetic 
neurons, in particular the superior cervical ganglia, SCG (Fagan et 
al., 1996); TrkB KOs lose nodose ganglion neurons; and TrkC KOs 
lose parvalbumin (PV)-postitive dorsal root ganglion (DRG) neurons 
(Ernfors et al., 1994).  Klein et al. (1993) assessed in detail the 
phenotype of mice null for TrkB.  Homozygous mutant pups do not 
survive past the first postnatal week due to an inability to feed.  
Neuronal counts found significantly less ganglion and facial motor 
neurons, both involved in feeding.   
 It seems in the central nervous system (CNS) that there is 
greater redundancy in Trk signalling, for example in the 
hippocampus survival roles of growth factors can overlap such as is 
found for neurotrophins and insulin-like growth factor-1, IGF-1 
(Lindholm et al., 1996).  However, it has also been demonstrated in 
the mouse embryo that BDNF (produced by the cerebral cortex) 
regulates the survival of dorsal thalamic neurons as they innervate 
the cerebral cortex (Lotto et al., 2001).  Artificially increasing cortical 
levels of BDNF in vivo resulted in a reduced level of thalamic neuronal 
cell death and blocking BDNF increased the levels of cell death.  
 Another way this has been demonstrated is through 
pharmacological inhibition of Trk signalling (Chen et al., 2005).  
Transgenic mice were generated for each Trk receptor by the insertion 
of alleles into the kinase domain which render the receptor 
susceptible to specific pharmacological inhibition by the molecule 
PP1.  Effects of PP1 administration during pregnancy on cell 
populations already known to be reliant on Trk signalling for survival 
were assessed by cell count at P0.5.  TrkA inhibited mice exhibited a 
50% loss in SCG neurons; TrkB inhibited mice a 60% loss in nodose 
ganglion neurons; TrkC inhibited mice a significant decrease in the 
number of PV-positive DRG neurons.  Thus, these pharmacologically 
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controlled Trk KO mice exhibit the same phenotype as the other 
transgenic KO mice generated when exposed to PP1.  The intended 
use of these mice is ultimately to allow research into the role of Trk 
receptors in adult neuronal cell survival (which cannot be done in the 
other KOs generated due to their postnatal lethality).     
The potential administrative routes for PP1 (oral and/or 
intraperitoneal) and the fact that it can cross the placenta to the 
embryo means that it would allow highly specific points of 
development to be assessed for their requirement for the kinase 
activity of each Trk receptor; as such, they could be extremely 
informative in studies on fertility. 
     
1.7. Roles in the development of non-neuronal tissu es 
 In spite of extensive characterisation of the roles of 
neurotrophins and their receptors in the nervous system, through the 
use of transgenic mice, it wasn’t until relatively recently that 
functions were also identified in non-neuronal tissues (for review see 
Tessarollo, 1998).   
Mice null for Nt3 exhibit heart defects that are attributed to 
defective survival and/or migration of neural crest cells (Donovan et 
al., 1996).  A similar phenotype is observed when expression of TrkC 
is ablated by mutation (Tessarollo et al., 1997).  Thus, it appears that 
the NT3-TrkC signalling pathway is critical in regulating development 
of the heart and it has not yet been demonstrated to be under the 
control of other neurotrophins or their receptors.  A variant of the 
p75 receptor has, however, been implicated in vasculature 
development.  In addition to exhibiting nervous system defects, mice 
null for the p75 variant also had dilated blood vessels with thinner 
walls (von Schack et al., 2001).  Blood vessels consequently rupture 
and blood loss causes death of the pup by late gestation. 
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The immune system can be considered to be another area of 
major non-neuronal Trk signalling with expression of the Trk 
receptors in many immune tissues and subsets of cells (Vega et al., 
2003).  Lymphocytes in particular are strongly regulated by Trk 
signalling, as is one of the tissues they develop in, the thymus.  NGF 
can regulate proliferation of lymphocytes in vitro (Thorpe and Perez-
Polo, 1987; Otten et al., 1989) and mutation of TrkA results in 
abnormal development of the murine thymus (Garcia-Suarez et al., 
2000).  Similarly TrkB KO mice demonstrated significant loss of 
thymocytes (lymphocyte precursors) in the thymus (Garcia-Suarez et 
al., 2002) and Bdnf null mice exhibit a decrease in circulating and 
stored (spleen or bone marrow) lymphocytes (Schuhmann et al., 
2005).  In addition to regulating the physiologically normal immune 
system, Trk signalling is also implicated in pathological immune 
conditions such as chronic inflammation in lung disease (Nockher 
and Renz, 2003).  Thus, there is considerable potential for Trk 
signalling in the development and regulation of the immune system. 
 
1.8. Neurotrophins, Trks and the developing mammali an 
ovary  
The subject of mature ovary development and Trk signalling 
has been covered much more extensively than roles in neonatal ovary 
development.  To maintain brevity I will limit the breadth of this 
Chapter to reviewing the available literature on early ovary 
development and the roles of Trk signalling in relation to this.   
The developing and mature ovary is now a recognised site of 
functional neurotrophin-Trk signalling (Dissen et al., 2002; Dissen et 
al., 2009).  mRNA and protein detection has revealed neurotrophins 
and receptors to be expressed in the ovary across many species: 
human (Anderson et al., 2002); primate (Dees et al., 1995); rodent 
(Dissen et al., 1995; Spears et al., 2003); and hen (Jensen and 
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Johnson, 2001).  The majority of the literature available relates to 
their effects on follicular growth and ovulation (postnatal events), 
although there is also a growing body of evidence demonstrating roles 
for the neurotrophin-Trk signalling pathway in the developing 
mammalian ovary.   
 
1.8.1. Ovarian innervation 
 A principal factor one would consider to be important when 
contemplating the phenotypes of ovaries where neurotrophin 
signalling has been altered is assessing any effect on neuronal 
innervation of the ovary.   
Ovaries receive innervation from the PNS through sympathetic 
and sensory neurons and in the rhesus macaque ovary, p75 
expressing neuron-like cells extend into the vasculature, the 
interstitium, and primordial and growing follicles (Dees et al., 1995; 
Dees et al., 2006).  Originally it was thought that the sole site of 
neurotrophin action in the ovary was on the nerves innervating the 
gland.  Disrupting innervation of the ovary can be achieved by 
administering antibodies directed against the ligand or receptor.  For 
example administration of an antibody raised against NGF resulted in 
loss of the sympathetic innervation of neonatal rat ovary (Lara et al., 
1990).  This in turn caused abnormal ovary function with a reduction 
in preantral follicle development and abnormal estrous cyclicity.  
Thus, an assumption is made that neural defects in the ovary can be 
considered unlikely to be responsible for neonatal ovarian phenotypes 








1.8.2. TrkA, TrkC and p75 
 The majority of the information available in relation to Trk 
signalling and neonatal ovary development focuses on TrkB, however, 
some information is available pertaining to the other neurotrophin 
receptors which shall be summarised first. 
 
 1.8.2.1. TrkA 
The role of NGF-TrkA signalling in neonatal rodent ovary 
development has recently been concluded to contribute to the 
regulation of primordial follicle formation and early follicle growth 
through stimulation of somatic cell proliferation and FSHR 
expression (Dissen et al., 2009 review).  Assessment of P7 Ngf KO 
mouse ovaries revealed an apparent reduction in mesenchymal cell 
proliferation (Dissen et al., 2001).  This is proposed to cause a 
reduction in primordial follicle formation in the Ngf KO at P2 and P4 
through structural reorganisation problems (unpublished findings 
referred to in Dissen et al., 2009).  Subsequent differentiation and 
proliferation defects result in significantly less primary and secondary 
follicles at P7, although by that point no difference in primordial 
follicle number is found (Dissen et al., 2001).  TrkA protein is found 
at high levels in the oocyte and granulosa cell layer of primordial and 
primary follicles, with a reduction in intensity from the secondary 
stage (Dissen et al., 2001).  The same group only identified low levels 
of TrkA in the interstitium of P7 mouse ovaries.  Thus, it is unclear if 
it is an autocrine pathway (for example, NGF-TrkA is expressed by 
and acting only on granulosa cells), paracrine pathway (mesenchymal 
cells to granulosa cells/oocyte), or both in effect regulating these 
processes.   
 It is also proposed by the same group that NGF-TrkA signalling 
contributes to follicles attaining gonadotrophin support.  This is 
based on the observation that Fshr mRNA was decreased in P7 Ngf 
KO ovaries (Romero et al., 2002). In the same study, pre-treatment of 
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cultured P2 rat ovaries with NGF then treatment with FSH resulted in 
increased numbers of multi-layered follicles.  This result was only 
induced by FSH following NGF treatment and not by FSH or NGF 
treatment alone, demonstrating that NGF treatment does induce Fshr 
mRNA transcription which results in functional protein synthesis.  
However, Romero et al. (2002) do not seem to consider that the 
reduced mRNA of Fshr in the P7 Ngf KO ovaries may simply be 
caused by the reduction in secondary follicles (which they also did 
not count in the ovaries cultured with NGF).  Therefore, it seems 
plausible to me that the reduction of early growing follicles in the P7 
Ngf KO may actually be a primary effect of reduced granulosa cell 
proliferation and the reduced Fshr mRNA is a secondary effect caused 
by reduced secondary follicles present.  In conclusion, there is strong 
evidence to suggest that NGF-TrkA signalling is not required for 
oocyte survival but is for getting the process of follicle formation and 
early follicle growth underway. 
 
 1.8.2.2. TrkC 
Less evidence exists for the role of the NT3-TrkC pathway in 
neonatal ovary development, as illustrated by its exclusion from a 
recent review on the roles of neurotrophin signalling (Dissen et al., 
2009).  Dissen et al. (1995) found that mRNA levels of rat Nt3 and 
TrkC remain unchanged during follicle formation, which may indicate 
their non-requirement.  In addition, as well as examining the ovaries 
of TrkB KO mice, Spears et al. (2003) assessed those of a TrkC KO 
strain.  TrkC receptors appear not to be required for oocyte survival 
as no difference in oocyte number was found between the neonatal 
wild-type and TrkC KO ovaries.    
 
 1.8.2.3. p75 
Examination of the protein distribution of the p75 receptor has 
revealed that in the developing rat, mouse and human ovary, it is 
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strongly localised to the mesenchyme and ovarian stroma (Dissen et 
al., 1995; Dissen et al., 2001; Anderson et al., 2002).  As the 
expression of neurotrophins and receptors which exert functional 
roles (NGF-TrkA and BDNF/NT4-TrkB) are expressed in granulosa 
cells, the oocyte, or both, it raises the possibility that p75 serves no 
role in follicle formation or oocyte survival.  Or at least this would be 
unlikely to occur through the receptor multiplexes (discussed in 
Section 1.5.3) as the Trk and p75 receptors are simply not localised 
in the same areas of the ovary.  However, specific and consistent 
localisation of p75 to the stroma may suggest it serves a function 
there. 
 
1.8.3. TrkB   
Through RT-PCR, Nt4 and Bdnf mRNA have been detected in 
human and rodent ovaries during follicle formation (Anderson et al., 
2002; Spears et al., 2003; Harel et al., 2006).  Transcription of Nt4 
mRNA increases at the time of follicle formation in the rat (Dissen et 
al., 1995). As well as variations in the amount of transcription there 
are changes in where it and translation occur during folliculogenesis.  
Using in situ hybridisation (ISH), Nt4 mRNA is detected mainly in the 
oogonia of human fetal ovaries prior to follicle formation, though once 
incorporated into a primordial follicle NT4 protein is mainly localised 
to the flattened granulosa cells, with lower levels in the oocyte 
(Anderson et al., 2002).  There is also a switch in expression of the 
protein in the mouse, non-growing follicles exhibit NT4 and BDNF 
protein mainly in the oocytes, but they are found at a greater 
intensity in the granulosa cells of growing follicles (Paredes et al., 
2004).  
 The expression of full-length and truncated TrkB receptor 
isoform mRNA is confirmed in the ovaries of mice (Spears et al., 2003) 
and humans (Anderson et al., 2002; Harel et al., 2006) at the time of 
folliculogenesis.  In addition, detection of full-length TrkB mRNA 
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increases in the neonatal rat ovary at the time of follicle formation 
(Dissen et al., 1995).  Immunohistochemistry for full-length TrkB 
receptor protein reveals consistent localisation in mouse and human 
oocytes prior to and during follicle formation (Anderson et al., 2002; 
Spears et al., 2003; Paredes et al., 2004; Harel et al., 2006).  It has 
also been detected in pregranulosa and primordial follicle granulosa 
cells in human fetal ovaries (Anderson et al., 2002; Harel et al., 
2006).    
 Intriguingly, the full-length receptors capable of signalling are 
expressed at much lower levels than truncated receptors.  This has 
been demonstrated in mouse ovary at the level of RNA (RT-PCR; 
Spears et al., 2003) and protein (Western blot; Paredes et al., 2004). 
Paredes et al. (2004) also used antibodies able to distinguish the 
expression pattern of the T1 truncated TrkB receptor protein from 
that of the full-length isoform on P7 mouse ovary sections.  The 
intensity of the immunofluorescent signal generated was used to 
interpret expression levels.  Comparatively, the level of full-length 
TrkB receptor expression in oocytes from primordial to secondary 
follicles was low against expression of the TrkB T1 isoform.  The 
expression of the truncated receptor in primordial follicle oocytes is 
low but plentiful and localised to the oocyte cell membrane of growing 
primary and secondary follicles.  Recent unpublished work from this 
lab (Murray and Spears) found extremely low levels of TrkB T1 in 
newborn mouse ovaries.  This is consistent with the findings of 
Paredes et al. (2004) as newborn mouse ovaries consist mainly of 
primordial follicles.  In contrast with the localisation studies, 
unpublished findings were recently reported to show that denuded 
oocytes from infantile mouse ovaries only express TrkB T1 (RT-PCR; 
Garcia-Rudaz et al. discussed in a recent review on the role of 
neurotrophins in the ovary; Dissen et al., 2009). 
  Thus, in the mammalian neonatal ovary, localisation of the 
different TrkB signalling components indicates strong potential for 
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different combinations of autocrine and paracrine signalling to occur 
between the granulosa cells and the oocytes.  It seems that these 
relationships change dynamically by alteration of expression levels 
depending on the stage of follicle development and the compartment 
of the follicle examined.  
As discussed in Section 1.6.2. mice null for Trk receptors or 
their ligands have been generated and their phenotypes described 
with particular emphasis on the effects on neuronal cell populations.  
Assessment of mice null for the ligand Nt4 has revealed that as well 
as not suffering from developmental abnormalities Nt4 KO mice have 
normal fertility (Conover et al., 1995) and a normal complement of 
secondary follicles at P10 (Paredes et al., 2004).  In contrast, Bdnf KO 
mice die shortly after birth (Conover et al., 1995) and although their 
fertility has not been assessed, mice null for both Bdnf and Nt4 
exhibit significantly reduced numbers of secondary follicles (Paredes 
et al., 2004).  This compensatory effect by the ligands has also been 
demonstrated in vitro.  Addition of either anti-BDNF or anti-NT4 
antibodies to P0 wild-type ovary cultures had no effect on healthy 
oocyte density, but in combination the antibodies resulted in a 
significant decrease in healthy oocyte density (Spears et al., 2003).   
 Spears et al. (2003) also assessed ovary development of mice 
null for the full-length TrkB receptor (TrkBFL; Klein et al., 1993) on a 
congenic C57BL/6 background.  This mutation prevents downstream 
signalling from the tyrosine kinase domain but does not prevent 
expression of the truncated receptors.  TrkBFL KO pups die within the 
first postnatal week and assessment of the ovaries was only possible 
up to P4/5.  At this point the ovaries contained significantly less 
oocytes than wild-type ovaries with reduced numbers of follicles.  
Spears et al. (2003) replicated this effect in vitro by culturing P0 wild-
type mouse ovary with the pan-Trk inhibitor (K252a, previously 
discussed in Section 1.5.2.1).  After a week in culture with the 
strongest dose of K252a tested, P0 mouse ovaries exhibited 
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significantly reduced follicle numbers and extensive cell death with 
more than 85% of oocytes lost.   
These observations led Spears et al. (2003) to hypothesise that 
limited neurotrophin availability creates competition amongst oocytes 
forming primordial follicles.  Oocytes with insufficient support do not 
survive and undergo apoptosis, should sufficient tyrosine kinase 
activity be generated then the oocyte can survive. 
 The presence of truncated TrkB receptors during 
folliculogenesis and their apparent upregulation in growing follicles 
(Paredes et al., 2004) imply a functional role.  The nature of the role 
is not clear although it does not appear to be in oocyte survival.  Trk 
activity inhibition by K252a causes significant oocyte loss (Spears et 
al., 2003) implying that any activity of non-catalytic Trk isoforms is 
not sufficient for oocyte survival.  Furthermore, a less severe effect on 
oocyte survival was found when expression of truncated receptors 
was also removed by mutation of all murine TrkB receptor isoforms 
(TrkBFLTr; Paredes et al., 2004).  Ovaries from P7 TrkBFLTr mice contain 
normal primordial and primary follicle numbers, although secondary 
follicles are significantly reduced.  Survival must eventually become 
an issue for these TrkBFLTr KO ovaries as transplantation for two 
weeks (necessary due to postnatal lethality) revealed that follicles 
were unable to sustain development and were found to be 
degenerating or missing altogether (Paredes et al. 2004).  
The TrkBFLTr mouse may be puzzling in its less severe response, 
but it may point towards the possibility that the truncated receptors 
exert a dominant negative effect in the TrkBFL KO.  The truncated 
receptor can bind ligand but cannot transduce a signal, thus it binds 
available ligand preventing it from activating another pathway.  In 
contrast, no isoforms are expressed in the TrkBFLTr KO leaving ligands 
free to potentially activate other survival pathways. 
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1.9. Aims of PhD 
The formation of the pool of primordial follicles is one of the 
most important processes that the mammalian ovary undergoes to 
ensure long-term fertility of the individual, yet it is relatively poorly 
understood.  The regulation of follicle growth and ovulation by the 
actions of gonadotrophins is a very well studied process and a 
consequence of this has been that infertility arising from difficulties 
in these latter (post-pubertal) stages can be treated in a variety of 
ways.  However, integral for this is the availability of primordial 
follicles.  Thus, without a supply of primordial follicles fertility 
treatments, for the most part, are redundant.  It is, therefore, crucial 
that the factors acting during this period of development to regulate: 
oocyte survival; successful incorporation into primordial follicles; and 
their initiation to the growth phase, are understood.   
The roles of many growth factors and their signalling pathways 
in facilitating these crucial, concomitant processes are beginning to 
be elucidated, however, by no means is there a complete picture.  
One signalling pathway has been demonstrated to exert a prominent 
role in neonatal murine oocyte survival, namely that of full-length 
TrkB signalling, yet the mechanisms of its action are not yet fully 
understood.  My thesis aimed to investigate this.   
       
Specifically my goals were to: 
 
1.  Decipher and investigate the chain of events occurring in 
the TrkBFL KO mouse that leads to the phenotype of severe oocyte 
loss seen shortly after birth. 
2. Extrapolate to determine how TrkB signalling contributes to 







































2.1. TrkBFL KO mice 
 Expression of murine full-length TrkB was disrupted by 
targeted gene mutation of the tyrosine kinase domain (Klein et al., 
1993) and subsequently placed on a C57BL/6 congenic background 
(Spears et al., 2003).  TrkBFL null offspring were generated by mating 
TrkBFL heterozygous breeding pairs.  Wild-type and TrkBFL 
heterozygous littermates acted as Controls for the TrkBFL KOs.  Mice 
were kept in accordance with UK legal requirements: housed under a 
temperature-controlled, 12 hour light: 12 hour dark regime with food 
and water ad libitum.         
 
2.2. Genotyping of mutant mice 
 
2.2.1. Collection of material 
 TrkBFL KO mice do not survive beyond the first postnatal week 
and as such, do not reach weaning age when ear clips would 
normally be obtained for genotyping.  Therefore, pups collected had a 
piece of tail tip taken after tissue collection for genotyping.  Tail tips 
and ear clips (to genotype breeding stock) were placed in 1.5ml 
eppendorf tubes and stored at -20oC until extraction. 
 
2.2.2. Extraction of DNA 
 DNA was extracted from the ear clip/tail tip using the hotSHOT 
method, see Appendix A (Truett et al., 2000).  Briefly, 75µl of alkaline 
lysis reagent was added to samples in 1.5ml eppendorfs followed by 
heating to 95oC on a thermal cycler (MJ Research) for 30 minutes.  
The eppendorfs were cooled to 4oC before 75µl of neutralising reagent 
was added.  The extracted DNA was stored at -20oC until genotyping. 
 
2.2.3. Genotyping of DNA by polymerase chain reacti on 
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Prior to genotyping by polymerase chain reaction (PCR) the 
DNA sample was further diluted: embryonic/neonatal DNA was 
diluted 1:5 in MilliQ autoclaved ddH2O and adult DNA was diluted 
1:10.  This initial dilution allowed 5µl of extracted DNA (from either 
adult or non-adult tissue) to be used with the same genotyping PCR 
bulk mix consisting of PCR buffer, primers and polymerase enzyme 
necessary to drive the reaction (see Appendix A).  Thin walled PCR 
tubes (0.5ml) were used for the reaction on a thermal cycler (MJ 
Research).  The PCR programme was specific to genotyping TrkB (see 
Appendix A).  In each reaction appropriate controls were used (DNA 
samples previously shown to be wild-type, heterozygous or null for 
TrkB) and in addition a water blank tested for contamination.      
 
2.2.4. Analysis of PCR products on agarose gel  
Agarose gels were prepared by adding agarose powder to TBE 
(see Appendix A) and heating in a microwave to dissolve the powder.  
Once the gel had cooled slightly SYBRsafe (Invitrogen) was added to 
allow eventual visualisation of the bands (see Appendix A).  The 
mixture was then poured into the chamber of a tank with a well comb 
inserted before being left to cool for approximately 30 minutes.  The 
well comb was then removed before sufficient TBE buffer was added 
to the tank to cover the gel.    
After the PCR reaction the tubes were centrifuged before 4µl of 
loading buffer was added to each sample.  This resulted in a final 
volume of 24µl per sample, 8-10µl of which was then pipetted into a 
well in the gel.  The tank was then connected to a power pack and 







2.2.5. Visualisation of DNA products  
The gel was visualised using a UV transilluminator linked to 
software (Syngene).  The PCR products were compared with molecular 
weight markers to confirm the genotype of the sample.     
 
2.3. Tissue collection 
 
2.3.1. Gross dissection   
Neonates were killed by decapitation and tail tips were collected 
for subsequent genotyping as described in Section 2.1.  Pups were 
pinned to a corkboard and a ventral incision was made to allow 
access to the gonads which were collected under magnification.  
Tissue was immediately immersed in fixative. 
 
2.4. Wax Histology 
 
2.4.1. Ovary fixation  
The ovaries were fixed in Bouins or 4% paraformaldehyde (PFA) 
for a minimum of an hour but not more than 24 hours.  Ovaries were 
washed in 70% ethanol to remove traces of fixative before storage in 
fresh 70% ethanol until processing.   
 
2.4.2. Wax embedding  
Processing consisted of ovaries being passed through a series of 
alcohol solutions increasing in strength (70%, 90%, 100% x 2) before 
immersion in a paraffin wax/xylene solution which allows 
penetration of the tissue by the molten paraffin wax.  Ovaries were 
then placed into a plastic mould before it was filled with wax and 
allowed to cool. 
 
2.4.3. Sectioning and mounting wax blocks 
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 Wax blocks were removed from plastic moulds and a heated 
chuck was fused with the base of each block.  Blocks were then 
carefully trimmed around the tissue and orientated on a microtome 
(Reichert-Jung) before sectioning at 5µm.  The wax ribbons were 
floated onto a waterbath (50oC), placed onto poly-L-lysine (PLL) 
coated slides and allowed to dry overnight in a 37oC oven.     
 
2.4.4. Haematoxylin and eosin staining wax sections  
Slides were dewaxed in xylene (10 minutes x2) before 
rehydration through decreasing ethanol concentrations (100%, 90%, 
70%, 5 minutes each) to tap water.  Freshly filtered haematoxylin (30 
seconds) was used to stain nuclei before the slides were returned to 
tap water.  The intensity of the stain was determined under a 
microscope without letting the sections dry out.  If the stain was too 
strong then the sections were dipped in acid alcohol before 
microscopically checking again.  Once the level of desired stain was 
achieved the slides were “blued up” in Scott’s tap water solution 
(STWS; 3 minutes) before a 3 minute wash in tap water.  To stain the 
cytoplasm of the cells the slides were immersed in eosin stain for 30 
seconds, briefly washed in tap water before placing in potassium 
alum to fix the stain (30 seconds).  The slides were given a final rinse 
in tap water before quick dehydration through the ethanol solutions 
(70%, 90%, 95%, 100% x2).  The sections were then cleared in xylene 
(6 minutes x2) before a xylene-based mountant (DPX) was used to 
apply coverslips.  Once slides were dry the sections were examined 
and photographed under brightfield microscopy (DMLB microscope, 






2.5. Plastic Histology 
 
2.5.1. Resin embedding 
In addition to wax-embedding ovaries two different types of 
resin were also used (Technovit and LR White purchased from TAAB). 
   
 
2.5.1.1. Technovit  
Ovaries stored in 70% ethanol were dehydrated by moving 
through increasing concentrations of ethanol (96% and 100%) before 
being pre-infiltrated with a 1:1 mixture of the polymer and ethanol (2 
hours in each solution).  The ovaries were then equilibrated overnight 
in the polymer alone before embedding in plastic moulds.  The 
embedding solution consists of polymer, hardener and softener.  It 
polymerises at room temperature in approximately 2-3 hours.  After 
polymerisation has taken place the chuck is adhered to the block 
using polymer plus hardener.  The blocks were then left to dry for at 
least 24 hours before removing from the mould and cutting.     
 
2.5.1.2. LR White  
Ovaries stored in 70% ethanol were dehydrated through 
increasing concentrations of ethanol (90%, 95%, 100% x2, 30 
minutes each).  The ovaries were equilibrated in LR White polymer 
overnight before embedding in fresh polymer in a gelatine capsule (LR 
White degrades plastic).  The reaction for LR White requires reduced 
exposure to air (the capsule has a lid), increased temperature (60oC 
oven) and takes longer to polymerise (overnight).  The gelatine 
capsule is removed by running in hot tap water for 1-2 hours.  The 
block is left to dry before supergluing to a wooden chuck.     
 
2.5.2. Sectioning and mounting resin blocks 
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Blocks were cut on a Reichart-Jung microtome using glass 
blades.  After orientation of the block, 5µm sections were cut and 
collected.  As a ribbon does not form in the same way as for wax 
blocks, each section was collected under magnification and floated on 
room temperature tap water.  Sections were then placed on PLL slides 
and air dried.  
 
 
2.5.3. Haematoxylin and eosin staining resin sectio ns 
Dry slides were immersed in freshly filtered haematoxylin (2 
minutes) to stain nuclei before being washed in tap water.  The 
intensity of the stain was microscopically determined and if it was too 
strong acid alcohol was used to reduce its intensity before 
microscopically checking the slides again.  Once the level of desired 
stain was reached the slides were “blued up” in STWS (2 minutes) 
before washing for 2 minutes in tap water.  One minute in eosin was 
sufficient to stain the cytoplasm of the cells.  The slides were then 
given another brief wash in tap water before immersion in potassium 
alum for one minute.  A final wash of tap water then the slides were 
left to air dry completely before coverslips were mounted using DPX.  
Once slides were dry the sections were examined and photographed 
under brightfield microscopy (as described in Section 2.4.4). 
 
2.6. Oocyte cell counts and follicle classification  
 
2.6.1. Cell counts 
 The beginning and end sections of each ovary were identified 
and every “n”th section in between was photographed under 
brightfield microscopy (as described in Section 2.4.4).  To obtain the 
P0 counts in Chapter 3 every 9th section was counted, to obtain the 
P0-P7 counts, every 18th section was counted, and in Chapter 5, 
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every 10th section was counted.  Each section was then reconstructed 
in Powerpoint before being merged and compressed into a GIF file 
(graphics interchange format) which reduces the file size but doesn’t 
reduce visual quality.  Cell counter tool in ImageJ allowed several cell 
types of interest to be counted simultaneously in each section.  The 
analysis carried out for this experiment (and all others) was done so 
blind to genotype.  
    
 2.6.1.1. Cell types counted 
 Oocytes were counted when the nucleus was visible in the 
section.  Apoptotic oocytes were recognised from their appearance of 
a shrunken cytoplasm and heavy eosin stain.  Apoptotic cells were 
identified by their lack of cytoplasm and their very heavy punctate 
haematoxylin stain.  
 
 2.6.1.2. Count correction  
 An estimated total number of cells can be obtained for each 
ovary by multiplying the total number of cells counted by “n”.  Where 
size of the object being counted exceeds section thickness the chance 
of the object being double counted is increased and the final number 
will be an overestimate.  To address this problem a methodology was 
devised whereby a correction factor is applied to the estimated total 
(Abercrombie, 1946).  It requires calculation of the mean diameter of 
the object being counted.  This can then be taken into account in 
relation to the thickness of the section and the estimated total of 
cells.  Mean diameter for each cell type was obtained by measuring 
and averaging the two widest perpendicular cross-sections of the 
object (in ImageJ).  Where possible, a minimum ten examples of each 
cell type were measured to obtain the mean.  The corrected estimated 
total for each cell type counted in each ovary was calculated by using 
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2.6.2. Follicle classification 
 To assess follicle development, oocytes counted were also 
categorised in terms of their somatic cell associations.  Oocytes yet to 
form primordial follicles were found in clusters with other oocytes 
and were referred to as pre-primordial oocytes.  Primordial follicles 
were considered to consist of an oocyte clearly associating with one or 
more flattened pre-granulosa cells.  The oocytes in follicles 
transitioning to the growth phase (primordial-primary follicles) were 
surrounded by only one layer of somatic cells but some had 
differentiated into cuboidal granulosa cells.  One complete layer of 
cuboidal granulosa cells identified the primary follicles and the 
beginnings of a second layer identified the primary-secondary 
follicles.  Two complete layers were used to identify secondary 
follicles.  Preantral follicles were considered to have three layers of 
granulosa cells and appearance of spaces in the granulosa 
compartment indicated development of an antrum (hence they were 
called early antral follicles). 
 
 2.6.2.1. Follicle measurements   
 As described in Section 2.6.1.2 oocyte nucleus was measured 
to allow correction of estimated total oocyte counts.  In addition to 
the nucleus, oocyte and follicle (up to the follicular BM) 







2.7. Immunohistochemistry and immunofluorescence 
 
2.7.1. Dewaxing and rehydration 
 Slides were dewaxed in xylene (5 minutes x2) before 
rehydration through decreasing ethanol concentrations (100% x2, 
95%, 90%, 70%, 5 minutes each) to MilliQ ddH2O (minimum 5 
minutes).    
 
2.7.2. Antigen retrieval 
 Fixation of tissue can prevent access of antibodies to epitopes, 
these sites can be re-exposed by high-temperature antigen retrieval 
(achieved by pressure cooking).  To 1600ml of MilliQ ddH2O, 15ml of 
Vector Antigen Unmasking Solution (citrate buffer; Vector H-3300) 
was added and the solution heated to boiling.  At that point the slides 
were added and the cooker closed, once steam was apparent the 
slides were left for 5 minutes.  The slides were then left to cool in the 
solution for 20 minutes before tap water was added to cool the slides 
further, a 5 minute wash in phosphate-buffered saline (PBS) on a 
shaker followed.  To ensure that the sections were always covered 
with solution during the subsequent stages a hydrophobic pen was 
then used (ImmEdge) to encircle the sections.  This also facilitated 
using lower volumes of more expensive reagents. 
 
2.7.3. Immunohistochemistry 
 Sections were prevented from drying out by carrying out blocks 
and antibody exposure in a hydrated tray.  In addition, the sections 
were covered with parafilm during overnight primary antibody 
exposure.      
 
2.7.3.1. Blocking 
 Prior to antigen retrieval endogenous peroxidases were blocked 
to prevent non-specific reactions occurring by immersing slides in 
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0.5% H2O2 in methanol at room temperature for 10 minutes.  To 
further reduce non-specific antibody binding and background 
staining, non-immunised animal serum solution (2ml serum, 8ml 
PBS and 0.5g BSA) with avidin (1ml of serum solution:4 drops avidin) 
was applied to the sections for one hour at room temperature.  The 
slides were washed in PBS/0.01% tween for 5 minutes with agitation.  
A biotin block (1ml serum solution:4 drops biotin) was applied 
overnight with the primary antibody.  Avidin-biotin block kit from 
Vector laboratories.        
 
2.7.3.2. Primary antibody 
Primary antibody for immunohistochemistry was diluted in the 
serum/biotin solution (see Section 2.7.3.1) and applied at 50µl per 
slide overnight at 4oC.  Control slides with primary antibody omitted 
were exposed to the serum/biotin solution only.   
 
2.7.3.3. Secondary antibody 
Parafilm was removed and the slides were washed (2 x 5 
minutes) in PBS/0.01% tween.  The secondary antibody (biotin 
conjugated) was diluted in the serum solution made on day one of the 
protocol and was applied at 100µl per slide for one hour at room 
temperature.  The slides were then washed (2 x 5 minutes) in 
PBS/0.01% tween.   
 
2.7.3.4. Antigen detection 
 Detection of the biotinylated secondary was facilitated by using 
the Vectastain ABC Elite kit (Vector laboratories).  The strong affinity 
and multiple binding sites that avidin has for biotin means that it can 
form a complex with a biotinylated peroxidase enzyme (ABC) and still 
bind the biotinylated secondary antibody.  The ABC kit was prepared 
30 minutes in advance and agitated until use to facilitate complex 
formation: 2 drops of solution A and 2 drops of solution B in 5ml of 
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PBS.  Three to four drops of ABC were applied per slide for 30 
minutes at room temperature.  The slides were then washed (2 x 5 
minutes) in PBS/0.01% tween.          
Detection of the ABC complex is achieved by application of 3,3'-
diaminobenzidine (DAB) which acts as the substrate for the 
peroxidase enzyme, depositing a dark-brown stain.  To 5ml of MilliQ 
ddH2O two drops of buffer stock are added, followed by four drops of 
DAB stock, two drops of H2O2 were only added immediately prior to 
use.  It was tested on excess ABC to ensure the reaction worked 
before the slides were exposed to DAB.  Reaction visualisation took 
between 30 seconds and 5 minutes depending on the antibody and 
tissue.  The reaction was ended by rinsing the slides with MilliQ 
ddH2O.  Slides were counterstained in haematoxylin before 




Sections were dewaxed, rehydrated and processed through 
antigen retrieval as described in Sections 2.6.1 and 2.6.2. 
 
2.7.4.1. Blocking 
Prior to antigen retrieval endogenous peroxidases were blocked 
to prevent non-specific reactions occurring using 3% H2O2 in 
methanol at room temperature for 30 minutes.  To reduce 
background staining non-immunised animal serum solution (2ml 
serum, 8ml PBS and 0.5g bovine serum albumin, BSA) was applied 
for one hour at room temperature before 2x 5 minute washes in PBS 
with agitation.  
 
2.7.4.2. Primary antibody 
 Primary antibody for immunofluorescence was diluted in the 
serum solution (see Section 2.7.4.1) and applied at 50µl per slide 
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overnight at 4oC.  Control slides were exposed to the serum solution 
only.  
 
2.7.4.3. Secondary antibody 
Parafilm was removed and the slides were washed (2 x 5 
minutes) in PBS.  The secondary antibody (horseradish peroxidase, 
HRP conjugated) was diluted in the serum solution made on day one 
of the protocol and was applied at 100µl per slide for 30 minutes at 
room temperature.  The slides were then washed (2 x 5 minutes) in 
PBS.  The subsequent steps were carried out with minimal light 
exposure to the fluorescent reagents or slides (once they had been 
exposed to fluorescent reagents).   
 
2.7.4.4. Fluorescence visualisation 
 Detection of the secondary antibody was amplified using the 
tyramide signal amplification kit (TSATM Plus Fluorescein; 
PerkinElmer).  TSA uses the HRP-conjugated secondary antibody to 
catalyse deposition of the fluorophore labelled tyramide onto tissue 
sections.  A 1:50 dilution of the tyramide was prepared in the kit 
diluent before 50µl per slide was applied for 10 minutes at room 
temperature.  The slides were then washed (2 x 5 minutes) in PBS.  
To counterstain the nuclei, 100µl of propidium iodide (PI; 1mg/ml in 
PBS) was applied to each slide for 15 minutes at room temperature.  
The slides were then washed (2 x 5 minutes) in PBS before mounting 
with Vectashield (Vector) and sealing coverslip with nailvarnish.   
Slides were stored in the dark at 4oC until they were visualised 
by confocal microscopy (Zeiss LSM510 attached to an upright 
Axioskop research microscope).  The green TSA was visualised by an 
argon/krypton laser at 488nm, the red PI counterstain was visualised 

















TrkBFL KO mouse ovary:  















Over many decades, morphological studies, and more recently 
genetic studies, have revealed the complex topology of the embryonic 
and neonatal ovary.  After initially forming, the ovarian anlagen is 
comprised of a heterogeneous population of cells seemingly without 
organisation, but within a short space of time (taking only days in the 
mouse) the fundamental units of the ovary (primordial follicles) are 
formed and commence growing (see Figure 1.2). 
As the follicles progress through each stage of development, the 
oocyte and supporting somatic cells respond to the effects of growth 
factors which can be endocrine, paracrine or autocrine, as discussed 
in Chapter 1.  It is not until the individual reaches sexual maturity 
that the effects of this orchestra of cell-to-cell communication on 
fecundity are usually revealed.  In extreme cases it may be possible to 
assess the effect of a mutation on fertility, even if it results in the 
death of the neonatal pup, as oocyte survival at the time of birth will 
have direct consequences on the fertility of the individual at maturity. 
Spears et al. (2003) established that the ovaries of mice lacking 
the full-length TrkB receptor (TrkBFL KO) on a congenic C57BL/6 
background contained significantly less oocytes than their wild-type 
Controls at P4/5.  Similarly, culturing wild-type newborn ovaries with 
pan-Trk receptor blocker K252a significantly reduced the number of 
oocytes surviving, as did adding antibodies directed against the 
specific TrkB ligands, BDNF and NT4.  K252a is a protein kinase 
inhibitor which prevents the phosphorylation of all Trk receptors, 
inhibiting downstream signalling (Tapley et al., 1992).  Human fetal 
ovary cultured with K252a for two days also exhibited a significant 
reduction in density of healthy germ cells (Spears et al., 2003).   
In an attempt to decipher the role of Trk signalling in the 
mouse ovary prior to folliculogenesis, Spears et al. (2003) cultured 
E16.5 wild-type mouse ovaries in the presence of K252a.  
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Unexpectedly, this showed that K252a does not affect oocyte survival 
or the growth of oocytes at this stage.  Instead, the experiments 
revealed that in contrast to the culture of newborn ovaries (which 
supports formation of primordial and early preantral follicles) 
culturing E16.5 ovaries bypasses the normal formation of primordial 
follicles, with follicles forming directly at the primary stage.  This 
observation critically provided the backbone for the interpretation 
that Trk signalling is essential specifically for primordial follicle 
survival in the mouse, as an effect was only found when primordial 
follicles were present.   
The role of the truncated TrkB receptors in neonatal ovary 
development was partially addressed by examination of the ovaries 
from mice null for all TrkB receptor isoforms (TrkBFLTr; Paredes et al., 
2004).  P7 TrkBFLTr KO ovaries exhibit a significant reduction in the 
number of secondary follicles but no difference in primordial or 
primary follicle numbers.  The block in follicle growth is attributed to 
a significant reduction in granulosa cell proliferation, thereby 
preventing the formation of secondary follicles.  This subsequently 
causes a significant reduction in Fshr mRNA synthesis, preventing 
follicle gonadotrophin dependence and possibly further growth 
(Paredes et al., 2004).    
Prior to commencement of this project, the role of the truncated 
TrkB receptors (T1 and T2) was difficult to determine as no KO was 
available for analysis.  This was due to the truncated receptors 
having an almost identical sequence to the full-length receptor apart 
from short intracellular tails that terminate before the tyrosine kinase 
domain.  Thus, it was easier to disrupt expression of all isoforms 
through mutation of the signal peptide motif, as was done to generate 
the TrkBFLTr KO (Rohrer et al., 1999).  A TrkB T1 KO has since been 
generated and in collaboration with Dr Lino Tessarollo’s research 
group (National Cancer Institute, Frederick, Maryland, USA) its 
phenotype has been assessed by the Spears group.  The mice appear 
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normal and fertile and examination of their neonatal ovaries does not 
reveal any abnormalities (Spears and Murray; unpublished findings, 
2008). 
Thus, at the start of this project it could be intimated that 
prevention of full-length TrkB signalling has a significant role in the 
survival of oocytes during folliculogenesis (Spears et al., 2003), 
whereas prevention of both full-length and truncated TrkB signalling 
prevents early follicle growth (Paredes et al., 2004).  
 
3.2. Aim 
The aim of this Chapter was to assess the neonatal 
development of the TrkBFL KO ovary.  
 
3.2.1. Limitations   
 During the course of any PhD many problems, small and large, 
are overcome; unfortunately during this project there were significant 
issues which need to be addressed before presentation of the results.  
These issues can be subdivided into three topics: TrkBFL KO survival; 
TrkB genotyping; and histology.    
        
 3.2.1.1. TrkBFL KO survival  
 Immediately prior to the start of this PhD, the on-site animal 
house where the TrkB colony had been maintained was closed down 
and all colonies were re-derived into a new facility for almost the 
entire duration of the project.  The TrkB colony was originally housed 
in the Hugh Robson Building (HRB; a conventional breeding unit with 
no barrier to pathogens); these mice were used for the research 
published by Spears et al. (2003).  The new unit at Little France (LF) 
was a much cleaner facility with individually ventilated cages, IVCs, 
and a pathogen-free status; these mice were used for this 
investigation. 
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As discussed in Chapter 1, the TrkBFL KO pups do not survive 
for more than a few days after birth, thus, it was expected that 
collection of postnatal material beyond P7 may be difficult.  However, 
it became apparent that even fewer pups than anticipated were 
surviving with many TrkBFL KOs now dying on the day of birth.  Pup 
weight was recorded at the point of collection and a significant 
reduction in the mean birth weight of the entire LF colony was found 
compared to the original HRB colony (see Figure 3.1).  This indicates 
that the colony as a whole was disadvantaged at birth in the LF unit 
when compared to the HRB unit.  Figure 3.1 reveals significant 
weight differences between Control and TrkBFL KO pups at P4 and P6, 
but at P0 there is no difference between the genotypes irrespective of 
which animal unit they were born in.  Thus, in utero the TrkBFL KOs 
do not suffer significant growth retardation compared to their 
littermates, it is only once the pups are dependent on suckling that 
the retarded growth of the TrkBFL KO pups becomes apparent.  There 
was, though, an effect taking place in utero which reduced the weight 
of all LF pups. 
 The small number of TrkBFL KOs generated by the LF colony 
meant that there were not enough samples collected of each age (for 
each experiment) to allow a thorough statistical analysis to be carried 
out.  To maximise the scope of the project in line with the available 







































 3.2.1.2. TrkB colony genotyping  
During the initial 10 months of the PhD, genotyping of the 
TrkB colony proved unreliable, often giving incorrect results.  This 
problem contributed to the reduction in TrkBFL KOs produced by the 
colony, as wild-type breeders were misidentified as heterozygous, 
resulting in breeding pairs unable to generate TrkBFL KOs.  A forward 
primer common to both genotypes and two separate reverse primers 
(one to detect the wild-type allele and the other to detect the mutant 
allele) were used to genotype the colony (Schimmang et al., 1995).  
The variable results were due to the TrkBFL KO reverse primer 
occasionally being detected by wild-type samples to give a 
heterozygous result.  This would not impact on the correct 
identification of TrkBFL KOs (such as those used for the research 
published in Spears et al., 2003) as only wild-type or heterozygotes 
would be misidentified.  A TrkBFL KO mouse would only give a 
genotyping result if the reaction worked (TrkBFL KO band) or a blank 
if it did not, in which case the sample would be repeated.  A 
significant portion of time was spent analysing the only sequence 
data available at that time: the putative TrkB sequence of a cDNA 
clone which lacks the intron/exon details (Klein et al., 1989).  As 
discussed in Chapter 2, expression of the full-length TrkB protein 
was disrupted by insertion of a neo cassette into exon K2 of the 
catalytic domain (Klein et al., 1993).  Once the location of exon K2 
was identified by basepair number in the cDNA clone sequence, 
primers were designed from within this coding sequence to genotype 
the TrkB colony reliably, as confirmed by BLAST.     
 
 3.2.1.3. Histology  
During this project the low rate of sample collection was 
compounded by histological problems which resulted in a number of 
samples unsuitable for particular analyses.  It was identified that the 
in-house made Bouins fixative caused poor preservation of the 
 84 
ovarian ultrastructure.  Consequently, poor morphology only allowed 
simple counts to be carried out and prevented further assessment of 
the ovaries.  Freshly purchased Bouins fixative and resin embedding 
the ovaries greatly enhanced morphological preservation and 
assessment, although, once embedded in resin the tissue could not 
be utilised for other protocols such as immunohistochemistry which 
require wax embedded or frozen tissue.  Thus, it was decided to fix 
one ovary in Bouins for resin embedding and the other in 
paraformaldehyde (PFA) for wax embedding.  Ideally, all suboptimally 
fixed material would have been discarded, but as TrkBFL KO tissue 
was so limited, it was used for some analysis.  It is essential to stress, 
though, that in all comparisons made between Control and TrkBFL 
KOs, like was only ever compared with like.  
 
3.2.1.4. Outcome  
Ultimately, the end result of these problems outlined above was 
extremely few TrkBFL KOs to analyse.  Therefore, taking into account 
the limitations of this project, the aim was completed by carrying out 
a detailed developmental analysis of a sample-limited time-course of 












3.3. Materials and Methods  
 
3.3.1. Animals  
Transgenic animals were generated and genotyped as described 
in Chapter 2.  Control (wild-type and TrkBFL heterozygote) and TrkBFL 
KO pups were collected from P0 through to P7.  Pups were weighed at 
collection.  The phenotype had previously been apparent at P4/5 but 
collecting TrkBFL KO ovaries closer to that age was rare due to 
neonatal TrkBFL KO lethality occurring earlier in the LF colony (see 
Section 3.2.1.1).  Therefore, it became protocol that if a pup seemed 
weak it was collected before it expired regardless of age, but where 
possible the pups were left as long as was feasible before being 
collected.  Hence there were some ovaries older than P4/5 collected, 
providing an almost complete P0-P7 time-course by the end of the 
study.  Imminent demise can be considered an unlikely contributing 
factor to abnormal ovarian phenotypes.  This assumption is based on 
the observation by Spears et al. (2003) that although TrkC KO mice 
exhibit the same postnatal lethality as TrkB KO mice (thus, would 
also have been collected close to death) they do not exhibit an ovarian 
phenotype such as the one observed in the TrkB KO mice.     
 
3.3.2. Histological assessment of mouse ovaries  
Initial P0 counts were carried out on ovaries with the bursa 
removed.  Ovaries were fixed, embedded in Technovit resin, sectioned 
at 5µm and stained for haematoxylin and eosin (H&E) as described in 
Chapter 2.5.3.  Upon embedding in the resin, the “cleaned up” 
ovaries moved to the base of each mould, resulting in loss of the start 
of each ovary when sectioning the block.  As each of these ovaries 
had been treated the same way, it is assumed that a similar portion 
of each ovary has been lost and, therefore, the counts are at least 
comparable with each other (although not with ovaries collected 
subsequently).  Ovaries subsequently collected were left intact within 
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the bursa providing a “buffer” region of tissue that could be safely 
discarded at the start of histological sectioning.  One pair of P0 
ovaries were treated in this way, hence they are included in the P0-P7 
counts.  Oocyte counts and follicle classifications were carried out as 
detailed in Chapter 2.6.  
 
3.3.4. Follicle health assessment  
Follicle health was assessed on a rating basis of 1 = poor 
health, 2 = medium health, 3 = good health, see Figure 3.2.  The poor 
follicle health rating of 1 was applied where the follicle lacked an 
obvious basement membrane (BM), exhibited poor somatic cell-to-
oocyte arrangement and contained an oocyte of poor quality.  Medium 
health rating of 2 was used where follicles exhibited a discontinuous 
BM and/or poor somatic cell-to-oocyte arrangement.  Good health 
rating of 3 was given where a continuous visible BM could be seen, 
the oocyte had somatic cell support and a healthy oocyte appearance.  
Each P0-P7 Control and TrkBFL KO ovary was assessed for each 
category of follicle (primordial, primordial-primary and primary).  The 
number of poor, medium and good follicles counted in each ovary was 
then calculated as a percentage of the total follicles in each category.    
To assess how the TrkBFL KOs compared to their Controls in 
terms of follicle health from primordial through to primary stages, the 
mean percentage of poor follicles was calculated for the P0-P7 Control 
ovaries and compared with the mean percentage of poor follicles in 
the P0-P7 TrkBFL KOs.  This was repeated for the mean percentages of 
good follicles. 
 
3.3.5. Statistical analysis  
As discussed previously, low sample sizes mostly prohibited 
statistical analysis, although in some instances it was feasible and 
appropriate to compare aspects of the sibling Control and TrkBFL KOs 





































3.4.1. The P0 TrkBFL KO ovary does not exhibit a reduction in health 
Total counts for healthy oocytes, apoptotic oocytes and 
apoptotic cells were obtained for Control (n=2) and sibling TrkBFL KO 
(n=6) P0 ovaries.  As expected the counts obtained for healthy oocyte 
number varied between Control ovaries (Rodrigues et al., 2009) and 
no clear difference was observed between those cells or any others 
assessed in the TrkBFL KO ovaries (see Figure 3.3).    
 
3.4.2. The P0-P7 TrkBFL KO ovary does not exhibit a reduction in health  
Ovaries were collected from P0-P7, where possible.  The 
following ages were not available: P1, P2 and P5.   One or two ovaries 
of each remaining age was assessed for healthy oocyte, apoptotic 
oocyte and apoptotic cell number (see Figure 3.4).  As expected the 
healthy oocyte counts revealed a sharp decline in number which 
plateaus by P7 in the Controls (Kerr et al., 2006; Rodrigues et al., 
2009) but no effect of TrkBFL KO was found.  The sharp decrease in 
oocyte number is reflected in the initially high numbers of apoptotic 
oocytes counted.  Again, no difference was apparent between Control 
and TrkBFL KO ovaries in counts obtained for apoptotic oocytes or 
other apoptotic cells.       
During the analysis it became apparent that some of the 
ovaries were infiltrated with an unknown cell-type similar in 
appearance to apoptotic cells.  For this reason these ovaries, and 
their corresponding Control or TrkBFL KO ovary, were omitted from 
the apoptotic cell results.  The infiltrate of unknown cell-type is the 








































































3.4.3. Follicle development in the P0-P7 TrkBFL KO ovaries 
The results show that up to P7, TrkBFL KO ovaries are capable 
of supporting oocyte survival.  Thus, the logical progression was to 
determine how the TrkBFL KO ovaries compared to their Controls in 
terms of follicle development.  This has been broken down into three 
stages: the incorporation of oocytes into primordial follicles; follicle 
growth initiation; and follicle growth progression. 
 
3.4.3.1. The P0-P7 TrkBFL KO ovary supports folliculogenesis 
Oocytes yet to form primordial follicles (pre-primordial oocytes) 
and those that had formed primordial follicles were calculated as a 
percentage of the total oocytes in these two categories.  These oocytes 
are the dormant, non-growing population of oocytes.  There is no 
obvious difference between Control and TrkBFL KO ovaries, although 
the results (Figures 3.5 A and B) demonstrate three interesting 
points: firstly, at P0 follicle formation is well underway in both 
groups; secondly, the percentage of primordial follicles formed in both 
genotypes gradually increases with age; so that thirdly, regardless of 
genotype >80% of dormant oocytes were found in primordial follicles 
by P7 with some pre-primordial oocytes remaining. 
 
3.4.3.2. The P0-P7 TrkBFL KO follicles initiate growth 
To determine how the TrkBFL KO ovaries compare to Control 
ovaries in terms of follicle growth initiation, the growing and non-
growing oocytes were calculated as a percentage of the total oocytes.  
Figures 3.6 A and B demonstrate that from P0 to P7, irrespective of 
genotype, the majority (>80%) of oocytes are found in a dormant 
state.  The remaining oocytes are found in growing follicles, revealing 
that at P0 there are already follicles which have activated growth and 






































































3.4.3.3. Early follicle growth is delayed in the TrkBFL KO ovary 
It has been demonstrated in the previous sections that the 
TrkBFL KO ovaries exhibit morphologically normal neonatal ovary 
development: primordial follicles are formed; a dormant pool of 
oocytes is maintained; and follicles initiate growth.  The analyses so 
far, however, do not determine to what stage these growing follicles 
progress in the TrkBFL KO ovaries.  Therefore, the follicles were 
characterised as stated in Chapter 2.6.2 and calculated as a 
percentage of the total growing follicles.   
Figures 3.7 A and B demonstrate that regardless of genotype 
the most common type of growing follicle observed in the neonatal 
ovary is the primordial-primary follicle with both genotypes 
containing ~80% primordial-primary follicles, even at P7.      
Figure 3.7 A reveals that primary follicles are first observed in 
Control ovaries at P4, with primary-secondary follicles appearing at 
P6.  In stark contrast the TrkBFL KO ovaries do not produce primary 
follicles until P6 and no primary-secondary follicles were observed 
even at P7 (Figure 3.7 B).  This clearly demonstrates that the TrkBFL 
KOs exhibit a delay in progression through the early stages of growth 
initiation (from primordial-primary to primary follicle stage).  
Statistical analysis using a two-tailed, paired Student’s t-test rejected 
the null hypothesis, thus from P4-P7 there is a significant reduction 
in the mean number of primary follicles produced by TrkBFL KO 












































































3.4.4. TrkBFL KO ovaries exhibit poorer follicular health than t heir 
Controls  
Some of the P2/3 TrkBFL KO follicles demonstrated poor 
follicular arrangement.  This was judged from abnormal granulosa 
cell-to-oocyte orientation and the absence of an intact follicular BM 
(see Figure 3.2).  It was decided that due to its excellent maintenance 
of morphology, in particular that of the BM, the resin embedded 
tissue would be ideal for quantifying this observation from P0-P7, as 
described in Section 3.3.4.  TrkBFL KOs exhibit a larger percentage of 
unhealthy follicles than Controls at each stage (see Figure 3.9 A).  A 
one-tailed, paired Student’s t-test was used to determine if this trend 
was significant.  The difference is significant at the primordial and 
primordial-primary follicle stages (P<0.05).  The same analysis was 
used to determine if Controls had a higher percentage of follicles in 
good health than the TrkBFL KO ovaries.  This was found to be true 
with Controls exhibiting significantly more healthy follicles at all 



















































 It was previously demonstrated that TrkBFL KO ovaries exhibit 
mass apoptosis and significant loss of oocytes and follicles by P4/5 
(Spears et al., 2003).  The main results of this Chapter in relation to 
the TrkBFL KO have revealed that the phenotype is not apparent in 
the re-derived colony, instead the TrkBFL KO ovaries assessed for this 
PhD present a phenotype of reduced early follicle growth and a 
measurable reduction in follicle health compared to their Controls.   
 
3.5.1. Early follicle growth  
 The aim of this project was to describe the TrkBFL KO ovary.  As 
previous assessment of the colony indicated a severe effect by P4/5 
(Spears et al., 2003) ovaries were examined here at an earlier stage of 
development.  P0 TrkBFL KO ovaries were examined from the re-
derived colony and it was found that these ovaries demonstrate no 
effect on oocyte number, the presence of dying oocytes or general 
apoptosis, as compared to their Controls, demonstrating that full-
length TrkB is not required for oocyte survival at the time of follicle 
formation.   
A time-course of P0-P7 ovaries from the re-derived colony was 
then subjected to a detailed analysis.  Again, genotype had no effect 
on oocyte number, oocyte death, or apoptosis in general.  From the in 
vivo material collected, the single TrkBFL KO P7 ovary assessed 
contained approximately half the number of oocytes of the Control 
ovary.  This is not out-with the realms of innate variability in terms of 
oocyte number, although the P0-6 TrkBFL KOs had exhibited similar 
numbers to the Controls.  It is possible that if further P7 TrkBFL KO 
ovaries were collected (which would simply take too long to be 
feasible) then an in vivo phenotype on oocyte survival may become 
apparent, although with a sample size of only one no conclusion can 
be drawn. 
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Thus, P0-P7 TrkBFL KOs for the most part appear normal, they 
do not display any defect in their ability to incorporate oocytes into 
primordial follicles, and they are able to maintain a proportion in a 
quiescent state as well as the Controls.  Growth initiation from the 
primordial to the primordial-primary stage of follicle development 
occurs normally, however, it is clear that completing this transition 
and reaching the primary stage is affected, as TrkBFL KOs exhibit 
significantly less primary follicles than their Controls. 
The maintenance of a quiescent pool of primordial follicles in 
the TrkBFL KO ovary potentially indicates that the pathways 
responsible for repression of follicle activation are intact.  One such 
pathway, discussed in Chapter 1.3.2, is regulated by anti-Müllerian 
hormone (AMH).  A known repressor of primordial follicle activation, 
it is expressed in murine granulosa cells from the primary follicle 
stage onwards (Durlinger et al., 2002).  Strongest expression is found 
in small and large preantral follicles, although it is also possible to 
observe staining in the granulosa cells of follicles that have activated 
growth (primordial-primary).  Thus, it is possible to propose that in 
spite of the reduction in primary follicle number in TrkBFL KO ovaries, 
the transitory follicles present may express sufficient AMH to 
suppress primordial follicle activation.   
Paredes et al. (2004) examined P7 ovaries from mice lacking all 
TrkB receptor isoforms (TrkBFLTr KO) and found a significant 
reduction in the formation of secondary follicles but none in the 
formation of primordial or primary follicles.  Therefore, the TrkBFL KO 
appears to exhibit a slightly different phenotype by demonstrating a 
block in follicles reaching the primary stage.   
It must be pointed out that the TrkBFL KO and the TrkBFLTr KO 
are mutations placed on different backgrounds.  The TrkBFL KO 
generated by Klein et al. (1993) was placed on the C57BL/6 
background, whereas the TrkBFLTr KO generated by Rohrer et al. 
(1999) was placed on an Institute for Cancer Research (ICR) strain.  
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The reasoning behind using the ICR strain was that both litter size 
and KO survival were improved on this background compared to 
C57BL/6.  It is feasible that strain differences may contribute to 
differences in observed follicle development but in spite of this, I 
propose that the phenotypes of the TrkBFL KO and the TrkBFLTr KO are 
actually more similar than they may first appear and in fact it is 
possible that the TrkBFL KO phenotype is a precursor of the TrkBFLTr 
KO phenotype.  The reasoning behind this is that Paredes et al. 
(2004) actually address that they would have expected there to be 
higher numbers of primary follicles found in their TrkBFLTr KOs if the 
block was solely in reaching secondary stage.  This increase would be 
created by follicles activating growth, reaching primary stage, but not 
progressing to secondary stage.  However, this is not the case, as 
TrkBFLTr KOs actually exhibit a slight (albeit insignificant) reduction in 
primary follicle number (Paredes et al., 2004).  I propose that the 
significant reduction in secondary follicle number in the TrkBFLTr KO 
is a consequence of follicles taking longer to reach the primary stage 
of growth as I have shown here occurs in TrkBFL KO mice.  
Examination of TrkBFLTr KO ovaries at an earlier age would be 
required to confirm if this is the case.  There is supporting evidence 
for my hypothesis, as mice null for the neurotrophin, Ngf, exhibit 
significantly less primary and secondary follicles but no difference in 
primordial follicle number at P7 (Dissen et al., 2001).  Subsequent 
examination of the Ngf null ovaries at P2 and P4 revealed a reduction 
in primordial follicle number which they propose to account for the 
reduction in primary and secondary follicles observed at P7 
(unpublished findings referred to in Dissen et al., 2009).  Thus, a 
reduction in formation of early follicle stages may subsequently cause 
a reduction in follicle growth; though by that point, the effect on the 
population of early follicles may no longer be so marked.   
Contrary to the Ngf KO study, TrkBFL KO ovaries do not exhibit 
a reduction in the ability to form primordial follicles, thus it is 
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proposed that both the TrkBFL and TrkBFLTr KO ovaries exhibit slower 
growth from the primordial-primary follicle stage onwards, reducing 
the number of primary follicles in the TrkBFL KO, and the number of 
secondary follicles in the TrkBFLTr KO. 
As discussed in Chapter 1, growth factors which exert 
mitogenic effects on granulosa cells are potential activators of follicle 
growth.  To determine if TrkB signalling exerts its effects on follicle 
growth by regulating expression of growth factors or their receptors, 
Paredes et al. (2004) examined two such paracrine signalling systems 
in the Control and TrkBFLTr KO ovaries at P7.  The first is oocyte-
expressed growth differentiation factor-9 (GDF-9) and its putative 
receptor, bone morphogenetic protein type II receptor (BMPRII), found 
on granulosa cells (Shimisaki et al., 2004).  The second is the oocyte-
expressed KIT receptor and the granulosa cell expressed ligand, KL.  
No difference was found between the genotypes in their transcription 
of Kit, KL or Gdf-9.  BmprII mRNA was significantly higher in the 
TrkBFLTr KO, although this is not thought to be of major importance 
as the BmprII and KL mRNA levels were corrected in the TrkBFLTr KO 
to account for the reduced numbers of granulosa cells in the TrkBFLTr 
KO.  Thus, in the P7 TrkBFLTr KO ovary, these growth factor signalling 
pathways are normal.  There is, though, a significant reduction in the 
expression of proliferation markers (bromodeoxyuridine, BrdU, and 
proliferating cell nuclear antigen, PCNA) in granulosa cells explaining 
the reduction in secondary follicles (Paredes et al., 2004).  It was also 
found in newborn Ngf KO ovary that somatic cell proliferation is 
reduced, contributing to the significant reduction in primary and 
secondary follicles (Dissen et al., 2001).   
The endocrine status of these mice was also examined and it 
was found that serum from TrkBFLTr heterozygous and KO pups 
contained significantly less FSH, compared to serum from Control 
mice.  TrkBFLTr heterozygotes, though, did not display an effect on 
follicle development, indicating that this is not the cause of the KO 
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phenotype (Paredes et al., 2004).  The lack of secondary follicles 
(which are characterised by granulosa cell Fshr expression) was 
confirmed by a significant reduction in TrkBFLTr KO Fshr mRNA.   
It is not possible to address here the capacity of TrkBFL KO 
primary follicles to continue growing in vivo in the KO.  Primary-
secondary stage follicles were not observed (although apparent in 
P6/7 Control ovaries) but, since follicle growth is delayed in TrkBFL 
KO mice, ovaries would need to be collected from mice older than P7 
to determine if these follicles could develop further.  It is unlikely that 
TrkBFL KO mice would survive for the required number of days to 
allow this to be undertaken. 
It is interesting to note that the rate of small preantral follicle 
growth that occurs normally in the C57BL/6 mouse ovary is known 
to be reduced significantly when compared to other strains at P4 
(Canning et al., 2003).  It may be possible that the opportunity to 
study the reduced rate of follicle development observed in the in vivo 
TrkBFL KO was impinged upon by this trait of the C57BL/6 mouse.  
  I propose that in addition to the TrkBFLTr and Ngf KOs, a 
granulosa cell proliferation defect is present in the phenotype of the 
TrkBFL KO.  Thus, neurotrophin signalling in the ovary contributes to 
the proliferative capacity of the somatic cells through unknown 
pathways parallel to and not associated with the GDF-9 or KL 
pathways.  The role of the truncated TrkB receptor isoforms in follicle 
growth initiation and its support is not clear, although as I have 
proposed that the phenotypes between the TrkBFLTr and the TrkBFL 
KO are actually quite similar, the conclusion could be drawn that 
additionally removing expression of the truncated receptors does not 
worsen the phenotype.  This is supported by the fact that the TrkB T1 
KO does not present an ovarian phenotype as discussed in the 
introduction.     
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3.5.2. Follicle health  
The arrangement of the follicle is very precise, with an oocyte at 
the centre, enclosed by layers of granulosa cells, and a BM separating 
it from the steroidogenic thecal cells.  Observations had previously 
been made that sections from TrkBFL KO ovaries often appeared fuzzy 
(Spears et al., 2003).  In addition, poor follicular organisation is 
apparent.  This abnormality is characterised by poor granulosa cell 
orientation around the oocyte and BM support of the follicle.  Clear 
disruption of follicles was first observed in P2/3 TrkBFL KOs and this 
effect was confirmed by blind assessment of the P0-P7 Control and 
TrkBFL KO ovaries.   
 The health of primordial, primordial-primary and primary 
follicles was assessed, and one of the parameters used was the 
integrity of the follicular BM.  In the majority of the follicle categories 
examined, TrkBFL KO ovaries exhibit significantly higher percentages 
of follicles with poor health and significantly lower percentages of 
follicles with good health, compared to Controls.  The fact that any 
“good” follicles are observed suggests that in the TrkBFL KO some 
follicles are maintained appropriately.  This is reinforced by Spears et 
al. (2003) who demonstrated that culturing P0 wild-type ovaries with 
K252a results in ~85% loss of oocytes, but those that survived had 
normal oocyte diameters, demonstrating normal growth.   
 It has also been observed in the TrkBFLTr KO that there is 
disruption of the BM (Paredes et al., 2004) and from the sections 
shown of the Ngf KO (Dissen et al., 2001) it is possible to see poor 
follicular BM.  Therefore, it is proposed that the poor follicular health 
exhibited by the TrkBFL KOs, in particular disruption of the BM, is of 
physiological significance and may contribute to the reduction in 
follicle growth.   
 The significance of reduced follicle health has been implicated 
through studies investigating the importance of the BM.  The BM can 
influence cell shape, cell behaviour, cell death and cell anchorage.  It 
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also provides support for the tissue and presents signalling molecules 
to granulosa cells, and can ultimately affect oocyte quality (Irving-
Rodgers and Rodgers, 2005).  If the structure of the follicle is 
disrupted then it is possible to hypothesise that so will the 
connections between the oocyte and its supporting somatic cells.  An 
important connection between the oocyte and granulosa cell is the 
transzonal projection (TZP).  Many of these granulosa cellular 
extensions cross the zona pellucida (ZP) to the oocyte (Albertini et al., 
2001).  Gap junctions are found at the ends of TZPs and as discussed 
in Chapter 1.3.2 gap junctions are composed of connexins.  The 
connexin found between oocyte and somatic cells is connexin37 and 
mice null for the gene (Gja4 KO) exhibit a block in follicle growth at 
the preantral stage (Carabatsos et al., 2000).  The segregated 
expression pattern of the connexins in ovarian follicles (connexin37 
between oocyte and somatic cell and connexin43 between somatic 
cells) implied separate functions, yet fertility could be restored in the  
Gja4 KOs through ectopic oocyte expression of Gja1 (Li et al., 2007).   
In summary, even though the severe phenotype is no longer 
apparent in the re-derived TrkBFL KO ovaries, there is a subtle 
phenotype exerted by the mutation on the health of the follicles, 
crucially indicated by the BM.  Thus, it is proposed that the abnormal 
follicular structure of the TrkBFL KO ovaries contributes to the 
proliferative defect in TrkBFL KOs.  Accordingly, the next Chapter will 
examine the BM of the TrkBFL KOs in detail.  
 
3.5.3. Re-derivation  
 There are two issues to be addressed in relation to the re-
derivation of the TrkBFL colony.  The first is the lower birth weight 
resulting in fewer TrkBFL KOs collected and the second is the change 
in phenotype of the TrkBFL KOs. 
 Comparing the mean birth weight of the LF and HRB colonies 
revealed that the LF colony was significantly smaller in weight on the 
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day of birth compared to the previous colony.  It has been 
demonstrated that housing in IVCs can affect pup survival and 
weanling weight, depending on air changes per hour and cage change 
intervals (Reeb-Whitaker et al., 2001).  Thus, re-derivation of the 
colony into IVCs is a credible cause of the reduction in TrkB colony 
weight at P0.  Given that TrkBFL KOs perish neonatally due to their 
inability to feed, it seems likely that postnatal survival may be 
influenced by birth weight (what reserves of body fat they manage to 
accumulate in utero may help them to survive longer postnatally).  A 
lower birth weight means a reduced fitness of newborn pups, 
resulting in increased loss of TrkBFL KOs.   
There is also evidence to indicate that animal housing may 
influence the variation in survival of mice with the same mutation on 
the same background.  The TrkBFL KO was generated by Klein et al. 
(1993) on a C57BL/6 background and the majority of mutants 
perished within the first 48 hours of birth.  The mice assessed by 
Spears et al. (2003) were descendants of the Klein TrkBFL KO 
maintained on the same background and it was found that these KO 
pups could survive to P4/5 in conventional caging.  However, upon 
re-derivation most TrkBFL KO pups did not survive that long, 
although a few did very occasionally.  Intriguingly, Dr Vega’s group at 
the University of Oviedo in Spain routinely published papers 
describing the same Klein TrkBFL KO on the same C57BL/6 
background surviving to P15 (Garcia-Suarez et al., 2006; Perez-
Pinera et al., 2008).  Through personal correspondence with Dr Silos-
Santiago (who provided these mice from Vertex Pharmaceuticals, San 
Diega, USA) it was established that these TrkBFL KOs were able to 
survive for up to a month and the colony was housed in a 
conventional breeding unit.  These observations strongly indicate that 
there is a potential role for unit sterility to act as a factor in the 
robustness of the TrkBFL KOs. 
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 How the re-derivation could have affected the phenotype of the 
colony is unclear.  It is has been proposed, in evolutionary theoretical 
scenarios, that phenotypes can alter depending on the environment, 
this is referred to as phenotypic plasticity (Pigliucci et al., 2006).  It 
has also been found through studying respiratory responses in mice, 
that a pathogen-free environment can result in loss of phenotype 
(Pinto et al., 2008).  This led the group to conclude that pathogens 
and environment can affect presentation of mutant allele phenotypes.  
It may be that the TrkBFL KOs were able to exhibit a robust phenotype 
when housed in the conventional caging of the HRB unit but re-
derivation into the sterile LF unit was a sufficient enough change in 
































Chapter 4  
 

















The extracellular matrix (ECM), although once considered of 
limited purpose, actually has incredibly diverse functions in normal 
and pathological conditions, from growth and wound healing to 
tumour formation.  The multicellular organism simply could not exist 
without it due to the structural support it provides in the form of 
connective tissue.  The ECM can generally be described as proteins 
and proteoglycans secreted by epithelial, stromal and fibroblast cells.  
The proteins self-assemble into macromolecular structures located in 
the extracellular spaces of the tissue (Bosman and Stamenkovic, 
2003; Gelse et al., 2003).   
The ECM has many functions including: the provision of 
support to cells and strength and elasticity to tissues; creation of 
microenvironments within tissue by separating functional regions 
from supportive structures (parenchyma and stroma respectively); a 
substrate for cells to move on, thereby facilitating cell migration; 
binding biologically active components which regulates availability of 
growth factors, nutrients and hormones.  Subsequently the latter can 
influence cell differentiation, proliferation, migration, survival and 
death.  The ECM orientates and polarises the cells into basal and 
apical regions, and can regulate tissue turgidity by controlling the 
movement of fluid (Tanzer, 2006).   
Part of the ECM is a thickened layer, referred to as the 
basement membrane (BM), which is found immediately adjacent to 
the epithelial cells it supports (see Figure 4.1).  The BM is in contact 
with and supported by ECM components found in the stroma (also 
referred to as the interstitial matrix).  The composition of both the BM 
and the interstitial matrix varies according to tissue and cell type and 
can be remodelled by the actions of proteases, allowing the ECM to be 
regulated in a dynamic, temporal and organ-specific fashion (Bosman 



































The ECM component found in greatest quantity in most 
animals is the glycoprotein collagen.  It forms a scaffold (which 
provides structural integrity) along with another glycoprotein, laminin 
(which provides biological activity).  This mesh of macromolecules is 
interconnected by accessory proteins, generally proteoglycans and 
nidogen (Hallmann et al., 2005; Tanzer, 2006).  Members of the 
collagen family are made up of three polypeptide chains (α-helices) 
which assemble into a triple helix.  They can be heterotrimeric 
(comprising two or more different chains) or homotrimeric (three 
identical chains).  With more than 20 collagens produced from 
distinct genes the possible ECM compositions are extensive, although 
mainly fibrillar collagens are synthesised including types I, II, III, V 
and XI (Bosman and Stamenkovic, 2003; Gelse et al., 2003).  Fibrillar 
collagens include those found in skin, bone, tendons and cartilage as 
they confer strength due to the rigidity of their triple helix.  They 
contribute mainly to stromal ECM but there is also evidence of 
collagen type V fibrils projecting from the stroma into the scaffold of 
the BM, increasing epithelial cell anchorage (Adachi and Hayashi, 
1994).      
The BM (also referred to as the lamina densa) is considered to 
be a specialised layer of ECM.  The proximity of its location, adjacent 
to the epithelial cells, allows biologically active components of the BM 
to regulate cell behaviour.  The BM is similar to the stromal ECM in 
that it is comprised of a network of collagen and laminin linked by 
accessory proteins, except that the collagen is the more flexible, non-
fibrillar collagen type IV  (Bosman and Stamenkovic, 2003; Gelse et 
al., 2003; Hallmann et al., 2005).  Laminin is composed of three 
chains (α, β, γ) and each type of chain has a subset of isoforms, 
facilitating tissue-specific expression of up to 15 different laminins 
(Colognato and Yurchenco, 2000; LeBleu et al., 2007; Miner, 2008).  
Laminin was first recognised as a non-collagenous component of 
ECM when it was isolated from large quantities of ECM produced by 
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a tumour cell line.  Characterisation subsequently revealed its 
presence in normal tissues (Timpl et al., 1979).  Laminin 1 
(composition α1β1γ1) is the major laminin expressed embryonically in 
several tissues, with laminin-α1 the chain best characterised 
(Colognato and Yurchenco, 2000).   
As well as deposition of ECM, maintenance of tissue form and 
function is regulated by the turnover of ECM which is achieved partly 
by the actions of proteases and their inhibitors.  Proteases include: 
the matrix-metalloproteinases (MMPs); plasminogen activators (PAs); 
the a disintegrin and metalloproteinase (ADAM) family and 
cathepsins.  Protease activity is subject to the tissue inhibitors of 
MMPs, TIMPs (Curry and Osteen, 2003; Mazaud et al., 2005).    
Laminin not only contributes to tissue structure and integrity 
but also confers biological activity upon the cells interacting with the 
BM by binding to cell surface receptors (integrins, see Figure 4.1).  
There are also adhesive connections that form laterally between the 
cells sitting on the BM (see Figure 4.1).  Cell-cell connections include 
tight junctions, adherens (the cadherins), desmosomes and gap 
junctions.  Other cell-ECM connections include dystroglycan and 
other proteoglycans.  These adhesive associations discussed form 
complexes with intracellular components including β-catenin, which 
in turn associates with actin attached to the mictotubules of the 
cytoskeleton.  This regulates the behaviour of the cell including its 
shape.  The complexes can also regulate the activation of cellular 
signalling cascades, which can control gene expression and cell 
function (Hagios et al., 1998; Bosman and Stamenkovic, 2003; Zahir 
and Weaver, 2004).   
  
4.1.1. Ovarian ECM 
 Proliferating PGCs migrate from the allantois to the 
undifferentiated gonad of the developing embryo.  There they are 
incorporated along with somatic cells (epithelial cells derived from the 
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mesonephros and ovarian surface epithelium, OSE) into the sex cords 
which are segregated from the mesenchymal and endothelial cells of 
the underlying stroma by a BM (Byskov et al., 1986; Rajah et al., 
1992; Luck, 1994; Rodgers et al., 2000; Rodgers et al., 2003).  It is 
during the perinatal period of rodent ovary development that the 
primordial follicles are formed.  Many oocytes undergo cell death at 
this time but those that survive are incorporated into follicles and are 
surrounded by a BM which separates them from the surrounding 
stroma.  The ovarian stroma has been implicated in primordial follicle 
formation due to the expression of growth factors and/or receptors 
expressed there, which may facilitate the co-ordinated breakdown of 
the nests to individual follicles.  It has also been proposed by Rajah et 
al. (1992) that primordial follicles are not truly formed in the rodent 
ovary until the epithelial pregranulosa cells are opposed by 
mesenchymal (stromal) cells to induce deposition of a BM.   
 The advent of the electron microscope has greatly facilitated 
studies of the ovarian ECM (Zamboni, 1974).  It was observed that 
the quiescent primordial follicles in the ovary of the rhesus monkey 
were separated from the surrounding tissue by a thin basal lamina 
(the follicular BM) and collagen fibrils.  The BM is essential in 
maintaining the avascular nature of the oocyte and granulosa cell 
compartment of the follicle as well as supporting its structure and 
facilitating growth.  It is also important in conferring signalling 
molecules to follicular cells which act on follicle development and 
ultimately are important in ensuring the goal of the ovary: to produce 
a mature fertilisable oocyte at ovulation, capable of supporting 
embryo development. 
Immunohistochemical techniques have begun to establish the 
spatiotemporal expression of ECM components in the ovary.  This is 
integral to understanding the requirements of healthy follicles at each 
stage of growth, and how an atretic follicle may be identified.  The 
research group of Professor Ray Rodgers (Research Centre for 
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Reproductive Health, Adelaide, Australia) is dedicated to 
understanding the role of ECM in mammalian ovarian development 
and function.  However, their model organism of choice is the bovine 
ovary (Rodgers et al., 2003).   
The component identified to be first laid down around the 
mouse primordial follicle by Berkholtz et al., (2006) is laminin.  This 
component is also present in the BM from primordial follicles 
onwards in rabbit and pig ovaries and was also found in the 
interstitium between oocyte cords prior to follicle formation (Lee et al., 
1996).  However, another study detected collagen type IV in the BM of 
the mouse primordial follicle (Nakano et al., 2007).  It has also been 
found in the primordial follicles of rat (Mazaud et al., 2005) and cow 
(Rodgers et al., 2000), thus not all studies are in agreement.   
Berkholtz et al. (2006) also described the BM components 
expressed in growing follicles of the mouse ovary.  Laminin and 
collagen type IV are found in the BM of primary follicles, aggregates of 
fibronectin (another cell adhesion glycoprotein) and diffuse fibrillar 
collagen type I is found in the granulosa cell layer.  In the secondary 
and larger multi-layered follicles laminin and collagen type IV are 
additionally observed in the thecal layer.  Fibronectin in these larger 
growing follicles is still found in aggregates in the granulosa cell layer 
as is diffuse collagen type I, both are also found in the thecal layer.  
Antral follicles maintain the same BM composition but also exhibit 
deposits of fibronectin and collagen type I in the follicular fluid 
(Berkholtz et al., 2006).  Collagen (types I and IV), laminin and 
fibronectin were all identified in the ovarian stroma, and all except for 
laminin were detected in the OSE.   
The aggregates of ECM that form in the granulosa layer of 
preantral and antral follicles were originally observed by two Austrian 
scientists (Call and Exner) in rabbit ovulatory follicles in the 19th 
century.  They described these aggregates as clumps of granulosa 
cells arranged around a cavity and named them Call-Exner bodies.  It 
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has since been shown that the cavity of these structures contains 
ECM components similar to those of the follicular BM (namely 
collagen type IV and laminin) and are actually located in the 
granulosa layer of preantral follicles onwards in mammals (van Wezel 
et al., 1999).  Thus, it is apparent that the regulation of the 
composition of the follicular BM, the thecal layer, and the ECM 
within the follicle itself varies in a species and follicle stage-
dependant fashion.   
Once puberty is reached, the ovary continually undergoes 
cycles of follicle growth, atresia, and ovulation.  This requires a great 
degree of ECM remodelling which must be carried out in a controlled 
fashion: too much degradation and not enough synthesis results in 
the follicle not being maintained, too little degradation and follicle 
growth is impaired.  As previously mentioned, it is the role of 
proteases to degrade the different components of the ECM, and this 
has been well documented for ovulation (Curry and Osteen, 2003).   
Prior to ovulation the proteases also play a role in ovary 
development.  The first stage in folliculogenesis is the degradation of 
the ECM which segregates the ovigerous cords from the surrounding 
stroma.  This allows the oocytes to forge somatic associations with 
the pregranulosa cells, ultimately resulting in the formation of 
primordial follicles.  Mazaud et al. (2005) revealed that in the rat this 
process is assisted by the actions of the MMP and PA families of 
proteases.  The importance of controlling BM remodelling has also 
been demonstrated in follicle growth in the mouse.  The protease, a 
disintegrin and metalloproteinase with thrombospondin type 1 
motifs-1 (ADAMTS-1) protein is found in the granulosa cells of 
follicles from the secondary stage onwards (Brown et al., 2006).  The 
mouse null for this gene (assessed by the same group) suffers from a 
defect in ovulation, again demonstrating that the ultimate role is in 
releasing the oocyte.  However, the Adamts-1 KO mouse also 
exhibited reduced numbers of antral follicles alongside increased 
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numbers of dysgenic follicles.  These defects in follicular ECM 
components were tracked back to earlier stages of follicle growth 
(Brown et al., 2006), demonstrating how defective protease regulation 
can affect normal fertility. 
 
4.1.1.2 Neurotrophin signalling and the ovarian ECM  
A role for neurotrophin signalling in relation to the ECM has 
been implicated in different in vitro and in in vivo disease systems.  It 
has been demonstrated in vitro that downstream signalling 
components of tyrosine kinase receptors (Akt/PKB) are implicated in 
the production of ECM components such as laminin and collagen 
type IV by embryoid bodies (Li et al., 2001).  Activation of the 
Akt/PKB pathway through TrkB is sufficient to prevent anoikis in a 
rat intestinal epithelial cell line (Douma et al., 2004): anoikis is when 
a cell loses contact with ECM and undergoes apoptosis.  In tumours, 
it is this ability of cells to suppress anoikis that allows the tumours to 
grow unchecked and eventually metastasise.  Human ovarian 
epithelial cancers overexpress Bdnf and TrkB mRNA, with particular 
overexpression of the full-length receptor in high-grade carcinomas 
revealing an in vivo role (Yu et al., 2008).  In conjunction with 
assessing samples of cancerous tissue, Trk signalling in cancer cell 
lines was assessed.  Cells which had survived anoikis (spheroid 
anchorage-independent cells) had increased levels of full-length TrkB 
mRNA and increased levels of phosphorylated phosphatidylinositol 
3’kinase (PI3K), demonstrating the role of TrkB signalling in cell 
survival pathways (Yu et al., 2008).  It was also found that silencing 
TrkB signalling by siRNA reduced the amount of phosphorylated Akt 
and increased the amount of anoikis induced in the cells (Yu et al., 
2008).  These observations demonstrate that TrkB overexpression 
protects cells from a fate of cell death (anoikis) by activating the 
PKB/Akt survival pathway, apparently through full-length TrkB.     
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Other evidence of involvement of Trk signalling in the ovary 
regulating follicular BM deposition includes observations of BM 
breaches in preantral follicles of the TrkBFLTr KO (Paredes et al., 
2004).  In addition, Dissen et al. (2001) examined the ovaries of P7 
mice null for Ngf; their figures reveal that the follicular BM of primary 
and secondary follicles appears abnormal (although they did not 
comment on this).  Thus there is evidence in the literature to support 
the hypothesis that Trk signalling may regulate ovarian ECM 
deposition, and signalling survival in response to a loss of contact 
with ECM. 
  
4.2. Aim  
Chapter 3 showed that TrkBFL KO ovaries contain follicles with 
a hazy BM.  This was assessed morphologically in Chapter 3 and a 
reduction in follicle health from the primordial through to the 
primary stage was shown, when compared to Control ovaries.  The 
aim of this Chapter was to investigate the role of TrkB signalling on 
BM formation by histologically comparing the follicular basement 














4.3. Materials and Methods  
 
4.3.1. Animals 
Transgenic animals were generated and genotyped as described 
in Chapter 2.1-2.2.  Control (wild-type and TrkBFL heterozygote) and 
TrkBFL KO pups were collected from P0 through to P7.   
 
4.3.2. Tissue collection  
Ovary, testis, kidney and brain were collected from P0 (ovary, 
testis, brain), P3 (ovary and kidney), P4 (ovary), P6 (ovary, kidney, 
brain) and P7 (ovary) Control and TrkBFL KOs as described in Chapter 
2.3.  In addition, non-experimental wild-type ovaries (P2) and kidney 
(P0) were collected to test stains.  The high content of BM in the 
tubules of kidney acts as an excellent positive control for ECM stains.       
 
4.3.3. Tissue preparation  
Ovaries were fixed in Bouins or PFA as described in Chapter 
2.4.1.  Testes were fixed in 4% PFA for approximately one hour, 
kidneys and brains were fixed in 4% PFA overnight.   
Post-fixation, all tissue types were treated the same way as 
detailed in Chapter 2.4.  Briefly, the tissue was embedded in wax 
(kidneys and brains were embedded coronally) before being sectioned 
at 5µm on a microtome. 
 
4.3.4. Histological assessment by general BM stains   
 Prior to specific assessment of the BM, adjacent sections from 
the ovaries, testes and kidneys were stained with H&E (as detailed in 
Chapter 2.4.4) to ensure morphology was adequate for assessment. 
   
4.3.4.1. Van Gieson stain  
 Van Gieson stain turns collagen fibres red and is used to stain 
connective tissue.  The protocol was tested on wild-type P0 kidney 
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and P2 Bouins and PFA fixed ovary to see if it would be appropriate 
for use on experimental material.   
The van Gieson stain was prepared a day in advance: 15ml of 
0.5% aqueous acid fuchsin, 75ml of saturated picric acid, 50ml of 
MilliQ ddH2O and 0.25ml of HCl.  Picric acid precipitate formed and 
was avoided when decanting the stain.  Slides were dewaxed and 
rehydrated to tap water as described in Chapter 2.4.4 before 
immersion in van Gieson stain for 2-10 minutes.  The slides were 
then washed in tap H2O before the level of stain was checked 
microscopically.  To minimise loss of stain, the dehydration steps 
from 70%-95% were omitted and instead, slides were immersed in 
100% ethanol (x2).  The slides were then cleared in xylene, mounted 
and images were obtained as described in Chapter 2.4.4.  Only 10 
minutes of exposure to van Gieson stain revealed a detectable 
staining of fibres.   
   
4.3.4.2. Periodic acid-methenamine (Jones) silver s tain  
 Periodic acid-methenamine (Jones) silver stain (PAMS) oxidises 
polysaccharides in BM to aldehyde groups.  Aldehyde groups reduce 
silver ion to a black-coloured silver precipitate on the BM revealing its 
location in the tissue.  As for the van Gieson stain, this protocol was 
first tested on wild-type P0 kidney and P2 Bouins and PFA fixed 
ovary.  
 Prior to each experiment all glass and plastic-ware to be used 
was washed in specialised cleaning detergent (Sigma) to prevent 
precipitation of the silver ions elsewhere than on the tissue.  The 
methenamine silver nitrate solution was prepared in advance (5ml of 
5% silver nitrate plus 100ml of 3% methenamine), if stored in an 
amber bottle in the fridge it would last for up to one month.  Slides 
were dewaxed and rehydrated to MilliQ ddH2O (see Chapter 2.4.4).  
The sections were oxidised in freshly made 0.5% periodic acid at 
room temperature for 20 minutes.  During this time the working 
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silver solution was prepared and heated to 62oC in a waterbath: 25ml 
of methenamine silver nitrate solution, 2 ml of 5% borax and 23 ml of 
MilliQ ddH2O.  The slides were removed from the periodic acid, 
washed in running tap H2O before being rinsed in MilliQ ddH2O.  The 
slides were then immersed in the 62oC working silver nitrate solution.  
The speed of the reaction varied greatly (10-40 minutes), thus slides 
were regularly checked for desired staining levels microscopically and 
were agitated to promote the reaction.  Once staining was complete, 
the slides were washed in MilliQ ddH2O (x4) before being toned (to 
emphasise stain) in 0.2% gold chloride for 30 seconds.  The slides 
were washed twice more in MilliQ ddH2O before being dehydrated, 
cleared in xylene, mounted and photographed as described in 
Chapter 2.4.4.                     
 
4.3.5. Histological assessment by antibody detectio n of laminin- α1  
 To improve the detection of ovarian BM, immunohistochemistry 
was carried out for a specific isoform of laminin (α1) known to be 
detectable in the neonatal ovary (Uda et al., 2004; Berkholtz et al., 
2006).   
 
4.3.5.1. Immunohistochemistry  
Laminin-α1 was detected in ovary, testis, kidney and brain by 
DAB as described in Chapter 2.7.1-2.7.3.  The primary antibody used 
was a rabbit anti-rat polyclonal (Abcam) at a 1:100 dilution.  The 
secondary used was a biotinylated goat anti-rabbit antibody (Dako) at 
a 1:200 dilution.  Non-immunised goat serum was used to make 
antibody solutions.    
 
4.3.5.2. Immunofluorescence 
Laminin-α1 was detected in ovary, testis, kidney and brain by 
immunofluorescence as described in Chapter 2.7.1, 2.7.2 and 2.7.4.  
The same primary antibody was used as for DAB detection except at 
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a dilution of 1:300.  The secondary used was a HRP-conjugated 
chicken anti-rabbit antibody (Santa Cruz) at a 1:200 dilution.  Non-
































4.4.1. Basement membrane – general stains  
Initially, I planned to use a general ECM stain which would 
allow assessment of Control and TrkBFL KO ovary ECM, particularly 
that of the follicular BM.  However, it became clear for different 
reasons that the protocols would not be suitable. 
 
4.4.1.1. Van Gieson stain  
The van Gieson stain was tested on P0 kidney and P2 non-
experimental ovary, both of which demonstrated normal morphology 
as shown by H&E in Figure 4.2 A and B.  In the kidney, collagen 
fibrils between tubules were distinctly picked up by the stain, and 
more lightly, the BM of the glomeruli and renal tubules (Figure 4.2 
D).  In the ovary the stain appeared to work better in the collagen 
fibrils of the bursa than in the ovary itself (Figure 4.2 C).  Crucially, 
in the ovary proper, it was not feasible to distinguish between stain at 
cell membranes and stain around follicles, thus, the protocol was not 
used on TrkB material.   
 
4.4.1.2. PAMS stain  
Sections from the same kidney and ovary were used to refine 
the PAMS protocol, although after numerous attempts this method 
also failed to stain the ovarian BM in the desired manner.  Figure 4.2 
E-H demonstrate examples that were either too light to clearly 
visualise BM or too heavy.  It was possible to achieve a level of stain 
between these extremes, but it was not possible to do so consistently.  






































4.4.2. Immunohistochemical analysis of BM 
Due to the varying success of the general stains it was decided 
that immunohistochemistry (including immunofluorescence) could be 
more reliably carried out on the limited tissue available.  It would also 
allow the examination of a specific ECM component whereas the 
general stains could not do that.   
 
4.4.2.1. Laminin- α1 protein expression in the ovary  
Laminin-α1 was selected as it is located in the BM of the 
murine follicles from the primordial stage onwards (Berkholtz et al., 
2006).  Initial trials with the antibody using DAB detection had 
proved problematic, thus, it was tested with fluorescent antibody 
detection as well as DAB (see Figure 4.3).  Ultimately both protocols 
revealed intense staining located in: the BM of follicles; ECM of 
stroma; vasculature (ovary proper and bursa); and ECM immediately 
below the OSE.  Low levels were also apparent in the granulosa layer 
of follicles (see Figure 4.4 C).  Primary antibody titration with the TSA 
fluorescent detection system demonstrated that it could be used at a 
greatly reduced dilution.  A lower concentration of primary antibody 
reduces problems associated with background signal, thus it became 
the protocol of choice to analyse the Control and TrkBFL KO ovaries.   
An initial trial of laminin-α1 protein detection on Control and 
TrkBFL KO ovary indicated two aspects of laminin-α1 deposition that 
appeared to be affected in the TrkBFL KO.  Notably, there was an 
overall reduction in signal present and secondly, the laminin-α1 in 
the BM surrounding the follicles was not continuous (see Figure 4.4).  
It was decided to focus the study on the overall reduction of laminin-
α1 signal, as breaks in continuity of signal around a follicle do not 
necessarily represent areas of abnormal BM (personal 
correspondence with Professor Ray Rodgers, Adelaide, Australia).  
This was confirmed by observations of discontinuous laminin-α1 




































































4.4.2.2. Semi-quantification of laminin- α1 protein  
Limited availability of tissue ruled out quantifying the 
reduction in laminin-α1 by established means such as Western blot.  
Thus, it was decided to use the immunofluorescent protocol to semi-
quantify the signal.  This is based on the principle that the amount of 
fluorescent signal generated reflects the amount of available antigen 
for primary antibody to bind to, indicating protein levels.  This would 
allow an attempt at addressing the question of whether or not 
laminin-α1 is reduced in the TrkBFL KO ovary.  Although not ideal, 
this principle has been used in several other studies to quantify a 
protein of interest (Costes et al., 2000; Seino et al., 2002; Szeszel et 
al., 2005; Wang et al., 2005).  Given that no exact protocol existed, 
and that this is not the standard way of quantifying protein in tissue, 
how the images were obtained and the method of analysis had to be 
carefully considered to ensure that it would give meaningful results.  
Accordingly, suitability of differing protocols was investigated but the 
one considered best practice is described herein.     
To limit variability, paired Control and TrkBFL KO tissue were 
always included in the same run of laminin-α1 immunohistochemical 
detection.  The pair was also always imaged on the confocal in the 
same session.  The Control section was imaged first to set the gain 
which best demonstrated signal in follicular BM (gain is the level of 
excitation used by the laser to generate fluorescence).  The TrkBFL KO 
sibling was then imaged at the same gain, thus fluorescence detected 
would be comparable to that of the Control.  The confocal laser point 
scans across the section in one plane of focus, it then moves a set 
distance to another plane in the section before repeating the scan.  
The resulting image is called a “z” stack as it is made up of several 
layers.  Importantly, point scanning means that each layer of the 
stack is in focus, no blurred light from out of focus layers is collected 
which would affect true signal.   
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Each image is made up of pixels which record the intensity on 
a scale from 0 (no signal) to 255 (maximum signal, it is possible to 
elicit signal greater than this value but it will only record it as 255).  
Initially, the mean pixel intensity (MPI) of confocal stacks was 
measured using the software, ImageJ.  MPI indicates the average level 
of fluorescence in all of the pixels in the image.  The basic 
interpretation of this is: a reduction in MPI represents a reduction in 
available antigen.   
The MPI value was obtained by the following steps in ImageJ.  
Initially a variance filter was applied to the stack of confocal slices 
(laminin-α1 signal only), this allows analysis of the follicular BM as it 
detects areas of high contrast (such as the edge of a follicle).  The 
mask is then applied to the original stack so that the MPI of the 
image can be obtained with reference to these areas of high contrast 
only.  However, this could only be done to the entire image which 
introduced two problems.  Firstly, some of the images obtained 
included bursa, which, as shown in Figure 4.3 B and C, exhibits very 
strong laminin-α1 signal.  So it follows that signal from the bursa 
could affect the MPI, thus preventing a true measure of the signal 
from the ovary proper only.  Secondly, for some other ovaries the area 
of the section was smaller than its sibling.  This results in a greater 
number of pixels at 0, reducing the MPI of the ovary proper.  This 
second problem was partially overcome by thresholding both Control 
and TrkBFL KO images.  Thresholding allows selection of intensity 
values you wish to measure (0-255) and by applying the threshold to 
just above 0, the pixels without signal are not included in the MPI 
value.  The resulting MPI is of pixels with signal only.  However, the 
area issue could not be rectified, which meant that non-ovarian 
signal could not be excluded, thereby preventing a comparison of 
signal from the ovary proper only.   
Image-Pro Analyzer software (COIL facility, Edinburgh 
University) allows selection of areas for analysis and so it was used to 
 129 
compare the Control and TrkBFL KO ovaries.  With Image-Pro 
Analyzer, instead of obtaining an MPI for the image, the area of signal 
was measured.  In the same way that the MPI reflects amount of 
antigen binding, the area of signal present can also be considered to 
represent the amount of laminin-α1 deposition.  With Image-Pro 
Analyzer, an area of interest (AOI) is selected and assessed.  The AOI 
is then thresholded so that low level signal from stroma is excluded 
and the strongest signal from the BM is measured.  The area of the 
objects in the AOI that exceed the threshold are calculated and 
totalled.  This process is carried out on the Control ovary before the 
same AOI and threshold is applied to the sibling TrkBFL KO.  The area 
of signal from the Control is considered to be the basal level of signal 
and is normalised to 1.  The area of signal obtained from the sibling 
TrkBFL KO is divided by the Control area to represent the value as a 
fold change.  The results for each pair can then be compared to other 
pairs.   
There were some TrkBFL KO tissues which elicited no signal at 
the threshold set by the Control; however that is not to say there was 
no signal at all.  In these instances, the 0 value obtained for the 
TrkBFL KO area of laminin-α1 signal would prevent representation of 
the area of signal in the TrkBFL KO as a fold change of the Control.  
Thus, for these samples (marked as * in the figures) it was considered 
an acceptable alternative to set the threshold according to the signal 
in the TrkBFL KO, this threshold was then applied to the Control and 








4.4.3. Semi-quantitative laminin- α1 expression in the P0-P7 sibling pairs 
of Control and TrkBFL KO ovary 
 Ovaries were available for analysis at P0, P3, P4, P6 and P7.  At 
P0, TrkBFL KO ovaries (n=3) exhibited a reduced area of thresholded 
fluorescent signal when presented as a fold change relative to the 
Controls (see Figure 4.5 A).   
 From P3 through to P7 the trend of laminin-α1 expression is 
less clear.  Figure 4.5 B shows that at P3 one TrkBFL KO had virtually 
no signal compared to its Control while the other had the same.  
Similarly, both P4 and P6 ovaries exhibited a TrkBFL KO with virtually 
no signal compared to its Control, but the other showed an increase 
in signal (Figures 4.5 C and D), while the P7 TrkBFL KO had almost 
four times as much thresholded signal as its Control (Figure 4.5 E).   
In spite of the apparent variability, it can be concluded that P0-
P7 Control ovaries always produced measurable laminin-α1 signal in 
the BM of follicles.  On the other hand, six out of ten TrkBFL KOs had 
reduced signal with five of those giving almost no signal at all. 
As discussed in the introduction to Chapter 3, newborn ovaries 
were obtained from the TrkB T1 KO mouse courtesy of Dr Tessarollo.  
These ovaries did not appear morphologically abnormal and laminin-
α1 detection did not reveal a reduction compared to the Control (not 
shown). 
Due to the low sample sizes for most of the ages assessed, 
statistics were not feasible.  The P0 TrkBFL KOs did have a sample 
size of three; however, the same gain was not used for each pair 
which would have allowed the area of signal generated to be averaged 








































4.4.4. Semi-quantitative laminin- α1 expression in non-ovarian tissue of 
TrkBFL KO mice 
 The indication that loss of TrkB signalling disrupts laminin-α1 
deposition in the ovary prompted the consideration that this could be 
a general mechanism of ECM synthesis in response to TrkB 
activation.  If this were true, then laminin-α1 deposition in the TrkBFL 
KO may also be disrupted in other tissues in which TrkB has a 
known function.  It was possible to test this hypothesis on Control 
and TrkBFL KO testis, kidney and brain by using the same protocol 
used to analyse the ovaries.   
 
 4.4.4.1. Laminin- α1 in the TrkBFL KO testis  
 P0 Control and TrkBFL KO testis were stained for H&E.  This 
did not reveal any obvious morphological defect in the TrkBFL KO 
testis (see Figure 4.6 A and B).  Laminin-α1 signal was detected in 
the BM of seminiferous tubules and blood vessels in the testis.  At 
the same level of excitation (gain) the fluorescent signal was virtually 
absent in the TrkBFL KO (Figure 4.6 C and D).  This was confirmed by 
the reduced area of thresholded fluorescent signal exhibited by the 
TrkBFL KO as a fold change relative to the Control testis (Figure 4.6 
E).  As only one TrkBFL KO testis was collected statistics were not 













































4.4.4.2. Laminin- α1 in the TrkBFL KO kidney  
 P3 and P6 Control and TrkBFL KO kidneys were obtained and 
processed for wax histology.  H&E stained sections did not reveal any 
gross morphological defect in the TrkBFL KO kidneys (see insets 
Figure 4.7 A-D).  Laminin-α1 signal was clearly detected in the BM of 
the proximal renal tubules located in the cortex of the kidney, and 
appeared reduced in the TrkBFL KOs (see Figure 4.7 A-D).  Calculating 
the area of thresholded signal in the TrkBFL KOs and presenting it as 
a fold change relative to the Control kidneys confirmed that the signal 
was reduced (see Figure 4.7 E and F).  As only one pair of kidneys at 
P3 and one pair at P6 were obtained for analysis statistics were not 























































4.4.4.3. Laminin- α1 in the TrkBFL KO brain  
 P0 Control (n=4) and TrkBFL KO (n=2) sibling brains were 
processed for immunohistochemistry as were one pair of sibling P6 
Control and TrkBFL KO brains.   
 DAB detection of laminin-α1 in P0 brain confirmed deposition 
in the blood vessels, including those of the choroid plexus in the 
lateral ventricles, and in the developing meninges, including the pia 
mater and the arachnoid membrane (see Figures 4.8 A and B).  
Difficulties were encountered in trying to ensure that equivalent 
coronal sections were compared between genotypes at P0.  To reveal if 
a difference was present, it was decided to compare the signal in a 
region of the brain that did not significantly change in morphology 
throughout the tissue, thus ensuring the signal was measured 
reliably.  The area of signal was, therefore, calculated for the 
meninges (see Figures 4.8 C and D) as described for the ovaries, but 
as the same gain was used for each sample the area of signal 
obtained could be averaged and then compared between genotypes 
(see Figure 4.8 E; as only two TrkBFL KOs were collected it was not 
possible to compare statistically).  It was found, though, that the level 
of signal was reduced in the meninges of the P0 TrkBFL KO brains.   
Comparable coronal sections were obtained for the P6 brains 
allowing assessment of the different laminin-α1 expressing structures 
as confirmed initially by DAB (see Figures 4.9 A and B).  Signal was 
measured in choroid plexus of the third ventricle, meninges and 
lateral ventricles (Figures 4.9 C-H).  The area of signal was then 
calculated for the three different regions of P6 brain and compared 
between genotypes (see Figure 4.10).  Across the three areas of P6 
brain, the TrkBFL KO presented a reduced area of thresholded signal 
compared to its Control, although statistics were prohibited due to 







































































































4.4.4.4. Summary of laminin- α1 expression in TrkBFL KO tissue  
It can be summarised that although only limited samples were 
able to be collected from P0-P7, laminin-α1 signal was measured in 
13 different TrkBFL KO pups (see Figure 4.11).  Out of these 13 
assessed it was found that nine exhibited a reduction in laminin-α1 
signal (in the ovary, testis, kidney or brain).  Two TrkBFL KOs did not 
exhibit a consistent trend across tissues: one did not exhibit a 
difference in the ovary but showed a reduction in the kidney, another 
exhibited an increase in laminin-α1 in the ovary but a decrease in the 
kidney and brain.  The remaining two TrkBFL KOs examined exhibited 
an increase in the ovary but no other tissue was assessed from these 
animals.    


















































4.5. Discussion  
Chapter 3 outlined that H&E sections of TrkBFL KO ovaries 
often exhibited a hazy ultrastructure, and demonstrated that TrkBFL 
KO ovaries measurably contain follicles of poorer health than their 
Controls.  To assess this phenotype further, laminin-α1 protein 
expression was assessed as its known deposition in the BM of 
primordial follicles onwards would allow assessment of the follicular 
BM in the P0-P7 ovaries collected.   
Analysis of immunofluorescent histochemistry demonstrated 
that the TrkBFL KO pup exhibits a reduction in laminin-α1 in the 
ovary, the testis, the kidney and the brain as compared to Control 
siblings.  General conclusions that can be drawn from this 
experiment are considered before the significance of these findings in 
relation to the phenotype of the TrkBFL KO ovary shall be discussed.   
 
4.5.4. Detection and analysis of laminin- α1 expression in the ovary 
The pattern of ovarian laminin found in the ovary here, 
matches that in the literature for the most part (Frojdman et al., 
1995; Pan and Auersperg, 1998; Gomes et al., 1999; Berkholtz et al., 
2006).  It was, though, additionally found in the granulosa layer of 
follicles from the primordial stage onwards.  For the purposes of this 
investigation, the detection of laminin-α1 in follicular BM was 
considered reliable and accurate.  In Chapter 3 it was shown at P0 
that for both TrkBFL KO and Control ovaries, the majority of oocytes 
are either found in clusters or enclosed in non-growing primordial 
follicles.  TrkBFL KO ovaries, however, exhibit a significantly higher 
percentage of poor primordial follicles than Control ovaries.  From 
these observations, and in conjunction with the finding that P0 
TrkBFL KO ovaries exhibit a reduction in laminin-α1, I propose that 
the poor health observed in the TrkBFL KOs is partially evidenced by 
the reduction in expression of laminin-α1.  The physiological 
relevance of this in terms of oocyte survival or follicle formation in the 
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TrkBFL KO is not clear as no difference was detected in the 
distribution of follicle development or follicle number at P0 (see 
Chapter 3).   
As shown in Chapter 3, the phenotype of the P4-P7 TrkBFL KO 
ovary is one of retarded follicle growth, with significantly less primary 
follicles and no primary-secondary follicles observed when compared 
to Control ovaries.  The hypothesis put forward here is that a 
reduction in deposition of laminin-α1 from the time of primordial 
follicle formation contributes towards a reduction in follicle growth.  
However, this cannot be categorically stated, as from P3-P6 ovaries 
displayed variable levels in laminin-α1 (three exhibited a reduction, 
one no difference, and three an increase).  There are, though, possible 
explanations for this discrepancy.  Firstly, it may be that another 
source of laminin-α1 signal in the P3-P7 ovaries is responsible for the 
increase.  The threshold was set by signal observed in the follicular 
BM but it was not possible to exclude non follicular BM laminin-α1 
signal if it was above the threshold, such as the signal from ovarian 
















































Secondly, it has been shown that the absence of primary 
follicles is apparent from P4 in the TrkBFL KO (see Chapter 3).  
Therefore, it seems likely that, although the ovaries do contain 
comparable proportions of total growing follicles, the distribution of 
follicles (primary/primary-secondary) is different, making it difficult 
to obtain an area absolutely comparable between pairs in terms of 
the follicle stages found in that section.  This may prevent a fair 
comparison of laminin-α1.  This suggestion is reinforced by the 
finding that two of the pups examined, which did not exhibit a 
reduction in ovarian laminin-α1 did exhibit a reduction in other 
organs assessed (kidney and/or brain) which show less variability in 
their architecture.   
Assessment of only the follicular BM would need to be carried 
out to prove that there really is a reduction in laminin-α1 in the 
follicles of the older ovaries.  One potential way of doing this would be 
to assess the BM of individual follicles using a variation of the 
analysis used here to assess the whole ovary.  From each Control and 
TrkBFL KO ovary, several sections throughout the ovary would be 
used for immunofluorescent laminin-α1 detection.  By using multiple 
sections from the same ovary, the sample size of each follicle type 
(primordial, primordial-primary and primary) may be large enough for 
statistical analysis.  Following thresholding of the images it is 
possible, using the software described in Section 4.4.2.2, to draw a 
line across a follicle (bisecting it) which can then display the intensity 
of the signal along that line as a histogram.  The histogram of the 
follicle intensity has two peaks representing where the line crosses 
the BM on each side of the follicle.  The intensity of the peaks 
represent the strength of signal (and effectively are a measure of the 
amount of laminin-α1) in the BM.  If this were carried out for several 
follicles in each category from several ovaries it seems likely that if a 
difference does exist in the BM between the genotypes then it could 
be revealed in this way.  This assessment would require a continuous 
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ring of laminin-α1 staining around the follicles.  This has been found 
by some groups (Brown et al., 2006; Gomes et al., 1999) and its 
disruption in continuity is claimed to be indicative of disrupted BM 
integrity.  However, as discussed in Section 4.4.2.1 it is not 
considered by all to indicate this.  Another possibility would be to 
trial other antibodies for laminin to establish if there is one that 
specifically localises only to the follicular BM.  The same analysis 
used in this study could then be repeated without other sources of 
laminin skewing the results.  
A final caveat from the experiments carried out here is that it is 
not possible to distinguish if the reduced detection of laminin-α1 is 
from a reduction in synthesis or an increase in degradation.  
Collection of Control and TrkBFL KO ovaries for analysis of mRNA 
and/or protein levels of laminin-α1 or MMP could to be used to reveal 
if it is increased synthesis or increased degradation that is 
responsible.  However, using this technique with the antibody used in 
this study here, would not have allowed discrimination between the 
sources of laminin-α1 (follicular BM or stromal/vasculature).  Thus, 
considering the resources available (tissue and antibody) the protocol 
used here to assess laminin-α1 in the Control and TrkBFL KO ovaries 
was the most appropriate. 
 
4.5.5. Laminin- α1 expression in non-ovarian tissue  
Given that laminin 1 (α1β1γ1) is produced by many cell types 
including epithelial, muscle (smooth, skeletal and cardiac) and 
endothelial (Bosman and Stamenkovic, 2003 review; Tanzer review, 
2006) it would be expected that if laminin-α1 were affected in the 
TrkBFL KO that it would not just be limited to the ovary or indeed just 
the female TrkBFL KO.  
Laminin-α1 is located in the basement membranes of 
seminiferous tubules in mouse testis (Sasaki et al., 2002), thus, the 
pattern of expression shown for the testis is accurate.  It was 
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demonstrated in this Chapter that laminin-α1 is reduced in the 
TrkBFL KO.  The morphology of the neonatal TrkBFL KO testis does not 
appear to be different from that of its Control, thus, as with the P0 
TrkBFL KO ovary, the reduction in laminin-α1 does not appear to have 
deleterious effects on the tissue.  However, unlike the P0 ovary, the 
P0 testis is undergoing a period of relative quiescence, thus it may be 
the case that the effect of reduced laminin-α1 does not have any 
effect during this period.  It may be, that upon resumption of testis 
development at puberty there is an effect, but due to the neonatal 
lethality of the TrkBFL KO this can only be conjectured.     
 The kidney filters blood of waste products; this process occurs 
by blood flowing through a tuft of capillaries found at the end of the 
renal tubule of the nephron.  This tuft of capillaries is the glomerulus 
located inside the Bowman’s capsule; held in place by a membrane of 
ECM called the mesangium.  Plasma and waste products cross the 
glomerular BM and enter the renal tubules where fluid can be 
reabsorbed into the blood stream or end up along with the waste 
products as urine.  The renal glomerular BM is derived from 
endothelial and epithelial cells, but laminin-α1 is found only in the 
epithelial layers including the proximal tubules and the mesangium 
of the glomerulus, but not in the BM of the glomerulus itself 
(Aumailley and Smyth, 1998).  Thus, despite the P15 TrkBFL KO 
exhibiting a reduced glomerular area (Garcia-Suarez et al., 2006) it is 
unlikely that this is causing the reduction in signal as laminin-α1 is 
simply not expressed in the areas affected in the TrkBFL KO.  The 
physiological relevance of a reduced expression of laminin-α1 is 
unclear.   
Thus, laminin-α1 is reduced in the epithelium of the 
genitourinary tract.  Given that these structures originate from the 
same tissue primordia, it may not be that surprising that they are 
affected in the same way.  Demonstration of reduced laminin-α1 in 
TrkBFL KO brain is, however, strong evidence that the role of TrkB 
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signalling is a general mechanism of BM deposition.  Laminin-α1 was 
detected in the meninges, the choroid plexus and the vasculature of 
the mouse brain.  This is in agreement with the literature for mouse 
(Letourneau et al., 1988; Sasaki et al., 2002) and rat (Krum et al., 
1991).  The choroid plexus is a highly vascular structure, which 
extends frond-like processes into the ventricles of the brain.  A 
network of capillaries is surrounded by a layer of epithelium that is 
continuous with a layer of specialised ependymal cells, which line the 
ventricles.  Fluid leaks out of the capillaries and enters the ventricles 
as cerebrospinal fluid (CSF).  Tight junctions in the epithelium of the 
choroid plexus act as a CSF-blood barrier and intraventricular 
pressure is regulated by CSF secretion and/or absorption.  The CSF 
flows throughout the ventricles of the brain and into the 
subarachnoid space, bathing the brain.  Thus, a reduction in 
laminin-α1 in the structures lining the ventricles may contribute to 
abnormal CSF secretion and/or absorption, although this would 
require further investigation.    
Thus, the tissues assessed in TrkBFL KO mice (ovary, testis, 
kidney and brain) all exhibit a reduction in laminin-α1.  However, it 
is clear that ablation of full-length TrkB signalling is not sufficient to 
prevent deposition entirely.  If that were the case, it would most likely 
cause embryo lethality as found in laminin 1 deficient mice (Alpy et 
al., 2005).  The effect in the ovary is difficult to interpret as the 
reduction was not found to be consistent in the ovaries of TrkBFL KOs 
that were older than P0.  The possible reasons for this, however, have 
been addressed.  I believe that the evidence of reduced laminin-α1 in 
other organs is convincing of a general mechanism for full-length 






4.5.6. What has the TrkBFL KO revealed about laminin- α1 in the ovary? 
I proposed previously that the TrkBFL KO ovary exhibits 
reduced laminin-α1 deposition and that this may contribute to the 
phenotype of reduced follicle growth observed in Chapter 3.  In this 
section I will discuss the evidence that supports this hypothesis. 
There are stages in the initiation of follicle growth that can be 
identified by morphological changes and by molecular markers of 
differentiation, as discussed in Chapter 1.3.2.  The classic 
morphological marker of growth activation is differentiation of 
flattened pregranulosa cells in primordial follicles into cuboidal cells.  
This requires remodelling and polarising of actin filaments in the cells 
(Zhang et al., 2005).  The cue(s) inducing this differentiation in the 
ovarian follicle are unknown but growth factors which can stimulate 
proliferation of epithelial cells and/or ECM deposition are implicated.  
The mammaries of ovariectomised prepubertal heifers exhibit: 
reduced expression of insulin-like growth factor-1 (IGF-1); its 
receptor; epithelial cell proliferation; and laminin (Akers et al., 2005).  
In addition, the cytokines, interleukin-1β and tumour necrosis factor-
α (IL-1β and TNF-α, respectively) have also been implicated in 
regulating ECM deposition as they induce transforming growth 
factor-β (TGF-β) signalling in rat alveolar epithelial cells (Furuyama et 
al., 2008).  TGF-β is so called because of its role in wound healing; it 
regulates the deposition of almost all components of ECM, and in rat 
alveolar epithelial cells it increases laminin, nidogen and collagen IV 
deposition (Furuyama et al., 2008).   
The potential regulation of follicle activation by ECM 
components is not completely clear.  The eggs of Drosophila ovaries 
are supported by epithelial nurse cells which, amongst other roles, 
regulate polarisation of different RNAs in the oocyte.  Certain 
polarisation events are executed by remodelling of actin filaments in 
the posterior follicle cells (Frydman and Spradling, 2001).  Mutation 
of a receptor-like transmembrane tyrosine phosphatase (Lar) results 
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in failure to polarise the cells and revealed that its ligand (laminin) 
may regulate normal polarisation through transient expression in the 
ECM (Frydman and Spradling, 2001).  The expression of laminin in 
the mammalian ovary (pig and rabbit; Lee et al., 1996) prior to follicle 
formation suggests that it is not responsible for epithelial 
differentiation, although it may still be possible that once follicles 
activate growth they then require contact with laminin to support 
continued growth.   
Integrins are cell surface receptors signalling contact between 
ECM and the cell, inducing intracellular signalling in response to 
ECM exposure.  Laminin 1 (α1β1γ1) binds to integrins and in 
particular, to integrin α6β1, which is considered to be integral for cell 
anchorage (Colognato and Yuchenco, 2000).  Integrin α6 mRNA is 
highly expressed in oocytes and granulosa cells of primordial to 
secondary follicles in the mouse, integrin β1 is expressed in the 
oocyte from the primordial follicle stage onwards (Burns et al., 2002).  
Thus, the integrin (α6β1) found to be highly expressed in the early 
stages of follicle growth is commonly associated with laminin-α1.  It 
is, therefore, feasible that reduction of laminin-α1 in the TrkBFL KO 
ovary may contribute to reduced integrin-ECM binding, which as well 
as disrupting follicle structure by reducing cell anchorage, may also 
reduce the intracellular signalling which would otherwise occur in 
response to ECM exposure.  However, Burns et al. (2002) also 
assessed the levels of integrins in the Gdf-9 null mouse and found 
that integrin α6 mRNA was increased three-fold in the mutant 
ovaries.  This is in keeping with the expression pattern of integrin α6 
and the phenotype of Gdf-9 null mouse ovaries (follicles block at the 
primary stage of growth; Dong et al., 1996).  Thus, integrin 
expression is not sufficient to rescue the follicles from blocked 
growth, implying that BM-cell interactions are complementary to the 
actions of growth factors but not compensatory.  
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The evidence supporting a molecular pathway for TrkB 
regulating BM deposition actually stems from work carried out with 
another tyrosine kinase signalling growth factor (fibroblast growth 
factor; FGF).  Prevention of FGF signalling in embryoid bodies results 
in the downregulation of laminin and collagen synthesis.  When this 
research was extended to disrupting the signalling pathway 
components (Akt/PKB), the same outcome was achieved (Douma et 
al., 2004; Yu et al., 2008).  In addition, constitutively activating 
Akt/PKB in embryoid bodies specifically upregulated laminin-α1 
mRNA and protein levels 57 and 55 fold, respectively, compared to 
controls (Li et al., 2001).  The Akt/PKB pathway is also activated by 
downstream signalling induced by activation of the TrkB receptor, 
thus, it is proposed that full-length TrkB signalling may contribute to 
BM deposition through the Akt/PKB pathway.   
The follicles in TrkBFL KOs exhibiting poor follicle health (as 
revealed in Chapter 3) also present disorganisation of granulosa cell 
arrangement in relation to the oocyte.  Whether this contributes to 
the reduction in laminin-α1 deposition or is secondary to it (caused 
by a lack of support from the follicular BM) is unclear.  It is apparent, 
however, that in addition to the BM-cell connections, cell-cell 
contacts are also required for formation of a normal epithelium, thus 
it may be possible to conjecture that the disruption of the granulosa 
cell compartment of the follicle contributes to the reduced follicle 
growth observed in the TrkBFL KOs.  
Within the follicle, structural integrity and cell adhesiveness is 
also important to maintain the follicle.  As discussed in Chapters 
1.3.2 and 3.5.2, gap junctions act to couple the oocyte to somatic 
cells and between the somatic cells themselves.  Mutation of the 
genes encoding the subunits that comprise the gap junctions 
(connexins) results in blockade of follicle growth (Carabatsos et al., 
2000; Ackert et al., 2001).  If follicle structure is abnormal, as in the 
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TrkBFL KO, it could be that gap junctions do not form normally, thus 
contributing to the ovarian phenotype of reduced follicle growth. 
Another family of junctions responsible for cell-cell connections 
are the cadherins.  These transmembrane molecules consist of E- 
(epithelial), N- (neural) and P- (placental) cadherins.  Protein 
expression levels of N- and E-cadherins peaks at P7 in the rat ovary 
with expression found in both oocytes and granulosa cells, although 
E-cadherin is not expressed from the primary stage onwards 
indicating a possible role in regulating entry to follicle growth 
(Machell et al., 2000).  In particular, they may be responsible for 
propagating the cuboidalisation of adjacent epithelial cells seen in the 
transition to the growth phase.     
It appears that the truncated TrkB receptor does not play a role 
in ECM deposition.  This conclusion has been drawn from the 
following.  The TrkB T1 KO did not demonstrate abnormal or reduced 
laminin-α1 detection.  The TrkBFL KO assessed here demonstrates BM 
defects as does the TrkBFLTr KO (Paredes et al., 2004), thus, losing 
potential signalling from truncated receptors does not seem to 
increase the defect but losing full-length signalling is sufficient to 
induce it.  In addition, it is full-length TrkB receptor isoforms that are 
upregulated in cancer cells which have survived anoikis (Yu et al., 
2008).  This again, suggests that it is the full-length receptor which is 
important, not only in deposition but in the survival signalling 
pathways that are normally conferred by contact with ECM.    
Thus, it may be possible that the processes of follicle activation 
and growth depend on factors concomitantly inducing cellular 
differentiation, proliferation and BM deposition.  With the evidence 
presented here, and the known signalling pathways that can be 
activated through full-length Trk signalling (see Figure 1.5), TrkB 
could contribute to the regulation of each of these processes required 
















TrkBFL KO mouse ovary development 
beyond the first postnatal week: 
















As demonstrated in Chapter 3, in vivo TrkBFL KO ovaries are 
capable of generating primary follicles.  Subsequent follicle growth 
and oocyte survival in vivo cannot be assessed, as the TrkBFL KOs do 
not survive past their first postnatal week.  Thus, to ascertain further 
postnatal development of the TrkBFL KO ovary, transplantation was 
undertaken.     
Transplantation of tissues that cannot be regenerated after 
being lost to disease or injury may be an ancient procedure (skin 
grafts actually date back several centuries) but it is still an essential 
tool for surgeons and basic science researchers alike.  Over the last 
four decades the technique has been pioneered in major feats of 
surgery with successful transplants in humans including heart, 
kidney, limbs and even partial face transplants.   
Like all techniques it has continually been refined through 
follow-up research and this has contributed to recognising that 
rejection of grafts can be minimised by matching the immune type of 
the donor and recipient in the first instance and later through 
suppression of the recipient’s immune response.  Tissue storage and 
graft site are also important.  Initially, survival of the grafted tissue is 
dependant on its ability to use the blood supply of the recipient, 
either through the ability of the grafted tissue to create a new 
vasculature (neoangiogenesis) and/or by surgical attachment to the 
recipient’s blood supply (reanastomosis).    
In a clinical setting, transplantation of reproductive tissues is 
certainly not novel and has recently been reviewed (Gosden, 2008).  
Women who suffer from loss of fertility early in their reproductive 
lives, for example through premature ovarian failure or some cancer 
treatments, may be able to recover their fecundity through auto-
transplantation of ovarian tissue collected prior to treatment (Donnez 
et al., 2004).  The major drawback is the possibility that potentially 
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cancerous cells could be transplanted back into a patient, thus, it 
may not be the first choice for some women.   
Transplantation in basic science research is a standard 
technique carried out mainly using rodents as recipients.  This is 
due, not only to the less complicated nature of small animal surgery, 
but also the available sites where grafts can be carried 
(subcutaneously or under the kidney capsule for example), and the 
graft success rate.  This is especially high when carrying out intra-
strain transplants or using immunodeficient nude or SCID mice as 
recipients (Pelleitier and Montplaisir, 1975; Bosma et al., 1983).   
Another benefit of using immunodeficient mice is that tissues 
from different species can be xenografted without rejection.  This has 
been demonstrated particularly well with human ovarian tissue, 
allowing investigations into the effects of tissue preservation (or 
storage prior to transplantation) on the development of the graft 
(Weissman et al., 1999).  This research benefits clinical ovarian 
transplantation techniques by refining the procedure to maximise 
survival of the oocytes and follicles in the tissue transplanted.       
Ovarian grafts have also been utilised when genetic 
manipulation results in fetal or neonatal death of experimental mice, 
as described in Chapter 1.3.2 (the mouse null for connexin43, Gja1 
KO; Ackert et al., 2001).  In fact, this technique has been used in this 
field of research: Paredes et al. (2004) assessed ovarian follicular 
development in the mouse null for full-length and truncated TrkB 
(TrkBFLTr KO; which displays neonatal lethality) using this technique.  
P4/5 ovaries were transplanted under the kidney capsule of 
ovariectomised mice and retrieved two weeks later.  In the Controls, 
follicles had reached the antral stage of growth while the KO grafts 
contained almost no follicles.  The follicles that were present in the 
KO contained degenerating oocytes and the BM was not intact, 
although it was visible that the follicles had progressed beyond the 
secondary stage of growth.  They therefore concluded that, full-length 
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and truncated TrkB signalling is required for the long term survival of 
oocytes.   
 
5.2. Aim 
 As demonstrated in Chapter 3, TrkBFL KO ovaries are capable of 
generating primary follicles in vivo, however further follicle growth 
cannot be assessed due to the lethality of the TrkBFL KO.  Thus, the 
aim was to determine the long-term survival of TrkBFL KO oocytes and 
any potential follicle growth.  This was achieved by transplanting 
ovaries under the kidney capsules of recipient mice before any 
morphological phenotype became apparent in the TrkBFL KO ovary.  It 
was important to carry out the transplants at this early stage to 
ensure that should any deviations from normal development be 
observed following transplantation, it can be interpreted to have 
resulted as a consequence of a direct requirement for TrkB signalling 
in the ovary.  If ovaries were transplanted with a phenotype already 
in effect, it cannot then be determined if subsequent development 















5.3. Materials and Methods 
 
5.3.1. Animals  
Heterozygous matings were set up to generate neonatal 
homozygous TrkBFL null mutants.  TrkBFL heterozygous and wild-type 
siblings were used as Controls.  Over a set period, females were 
checked for seminal plugs to confirm mating had taken place and 
allow accurate prediction of when potential offspring would be at the 
correct stage for transplantation.  Due to technical constraints 
(surgical procedure room was not always available), surgery was 
carried out using E17.5, E18.5 and P0 ovaries (which were actually 
18.5 days post coitum).     
 
5.3.2. Genotyping  
Tail tips were collected from neonates at the point of ovary 
collection prior to transplantation.  Genotyping was carried out after 
surgery, as described in Chapter 2.2.     
 
5.3.3. Transplantation protocol  
In addition to utilising aseptic technique it was also protocol to 
collect the ovaries from the neonates in one room, while the 
recipients were prepared and the surgery carried out in a separate 
procedure room. CO2 incubators in both rooms ensured that the 
ovaries were kept at 37oC.           
 
5.3.3.1. Media 
The dissecting medium consisted of Liebovitz L-15 
supplemented with BSA at 3mg/ml.  It was filter-sterilised using a 
10ml syringe and a 0.22µm cellulose acetate filter into a sterile flask, 
and kept at 4oC.  Prior to use it was pre-heated to 37oC.  The holding 
medium comprised of α-Minimum Essential Medium (α-MEM) 
supplemented with 1% penicillin/streptomycin antibiotics to reduce 
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possible infection.  It was filter-sterilised, stored and pre-heated as 
for the dissection medium.     
 
5.3.3.2. Preparation of ovaries for transplantation  
As stated in Section 5.2.1, ovaries were collected from E17.5, 
E18.5 embryos and P0 pups.  To collect embryos, pregnant females 
were killed by cervical dislocation and a ventral incision allowed 
access to the uterus.  Embryos were dissected free from the uterus 
and placenta in a laminar airflow hood in a sterile glass petri dish 
with dissection medium, before decapitation.  Embryos were then 
pinned to a cork board before a ventral incision was made to allow 
access to the gonads.  If female, ovaries were collected and placed in 
a watch-glass of fresh dissection medium.  If P0 pups were available, 
female offspring were removed from the litter, decapitated and ovaries 
collected in the same way as for the embryos.  Ovaries were freed 
from fat or oviduct using insulin needles.  This ensured minimal non-
ovarian tissue would be transplanted.  Depending on the number of 
females collected on the day either one ovary per animal was 
transplanted and the other fixed in Bouins or frozen, or both ovaries 
were transplanted.  Ovaries to be transplanted were moved from the 
dissecting medium to the holding medium in six-well trays, one ovary 
per well. The holding medium was pre-heated in a CO2 incubator. 
 
5.3.3.3. Recipients 
 6-8 week old, 18-25 gram C57BL/6 females were used as 
recipients; mice were purchased from an external supplier (Harlan) 
and allowed to acclimatise in the animal unit for one week before 
surgery.  Mice of the same background as the TrkB colony were used 





5.3.3.4. Anaesthetic  
 The anaesthetic Avertin was selected as it is suitable for short 
surgical procedures.  It is batch tested on site and quantities were 
purchased as required from the animal unit.  To anaesthetise an 18 
gram mouse, 0.27ml of Avertin was injected intraperitoneally (0.1-
0.2ml of additional Avertin was used for each one gram increase in 
weight).  The mice were then placed in a clean cage until 
unconscious, confirmed by absence of response to foot pad 
compression.   
 
5.3.3.5. Surgical technique 
Hair was removed from the surgical site by clippers and the 
unconscious animal was placed on a heated pad (37oC) for the 
duration of the procedure.  A midline incision allowed visualisation of 
the fat pad attached to the recipient’s ovary through the body wall 
(used as a guide to locate the kidney).  The body wall was then 
opened and pulling on the fat pad allowed the kidney to be accessed 
and exteriorised.  Under magnification, the kidney capsule 
surrounding the kidney parenchyma was nicked and slightly widened 
at one end using a pair of fine watchmaker’s forceps.  A sterile glass 
Pasteur pipette was then used to place a single ovary under the 
kidney capsule.  The body wall was sutured shut before 9mm 
stainless steel autoclips were used to close the skin.  The recipient 
was then returned to a cage on its own or with other recipients at a 
similar stage of recovery.  The animals had access to Vetergesic, 
analgesic purchased from the animal unit, and were kept in a 
recovery chamber overnight before being returned to their normal 
caging.   
 
5.3.4. Histological assessment of transplanted ovar ies  
The transplanted ovaries were collected either 2 weeks (Control 
n=8, TrkBFL KO n=6) or 3 weeks (Control n=5, TrkBFL KO n=3) after 
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surgery.  Recipients were culled by cervical dislocation and the 
transplanted ovaries were recovered by opening the abdomen of the 
recipient and retrieving the kidney that carried the transplant.  The 
kidney was placed in PBS and the transplanted tissue was removed 
from under the kidney capsule using forceps and irridectomy 
scissors.  2-week grafts were either: fixed, embedded in resin, 
sectioned and stained with H&E as described in Chapter 2.5; or were 
fixed, processed for wax embedding and sectioned as described in 
Chapter 2.4.2-2.4.3 (as were all of the 3 week grafts).  The latter 2 
week and all 3 week grafts embedded in wax could be used for either 
morphometric analysis (H&E stained) or for immunohistochemistry.  
The morphometric analysis carried out included oocyte counts, 
follicle classifications and measurements as detailed in Chapter 2.6.   
 
5.3.5. Laminin- α1 assessment by immunofluorescence 
The immunohistochemistry carried out on 2 and 3 week grafts 
was assessment of laminin-α1 deposition as described in Chapter 
4.4.2.2.  Also described therein is the analysis carried out using 
Imagepro software.  This was slightly amended, as a section from 
each transplant was able to be processed for immunofluorescence at 
the same time.  They were also all exposed to the same level of 
excitation on the confocal, meaning that all were comparable in the 
amount of fluorescence detected.  Subsequently an average Control 
value was obtained and compared to the average TrkBFL KO value.   
 
5.3.6. Statistical analysis  
 Where appropriate (and not limited by sample size) multiple 
comparisons of mean oocyte and follicle measurements were made 
between in vivo and transplanted ovaries.  The data sets were subject 
to ANOVA, and where appropriate, followed by Bonferroni’s post-hoc 
test.  Student’s t-test was also used to compare oocyte and follicle 
measurements of transplanted Control and TrkBFL KO ovaries.   
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5.4. Results  
 
5.4.1. TrkBFL KO follicles progress to the secondary stage after  2-weeks 
transplantation  
 Paredes et al. (2004) found virtually no oocytes in the grafts of 
P4/5 TrkBFLTr KO ovaries after two weeks.  Thus, as a starting point it 
was decided to transplant the TrkBFL KO ovaries for two weeks.  
Ovarian tissue was recovered for both Control and TrkBFL KO 
transplants.  Unexpectedly (given the result of the TrkBFLTr KO 
transplants) TrkBFL KOs were just as capable as Control ovaries of 
producing secondary follicles (see Figure 5.1).  Regrettably, numerical 
analysis of follicle counts was not possible as not all of the 
transplants worked consistently (see Figure 5.2).  Some transplants 
were considered not to have worked due to the absence of ovarian 
tissue and/or the presence of cystic structures (Control n=1, TrkBFL 
KO n=2).  Those deemed to have partially worked contained ovarian 
tissue with some cysts or a relatively small amount of ovarian tissue 
(Control n=1, TrkBFL KO n=2).  Those that had worked well were 
entirely composed of ovary (Control n=6, TrkBFL KO n=2).  All poor 
transplants originated from the first run of surgery carried out, thus 
it may be that improved surgical technique from the first 
experimental run to the second resolved the unknown cause(s) of 
variability.  
Control ovaries transplanted by Paredes et al. (2004) reached 
the antral stage of follicle growth after two weeks.  In contrast, the 
Control ovaries transplanted in this experiment reached only the 
secondary stage.  This may have been due to the fact that the TrkBFLTr 
ovaries were transplanted at P4/5 (almost a week older than the 
TrkBFL ovary transplants), thus it seemed possible that subsequent 
follicle growth could be affected in the TrkBFL KO ovaries.  To 
determine this it was decided to repeat the transplants and leave for 



































































5.4.2. TrkBFL KO ovaries do not exhibit a reduction in healthy o ocyte 
number after 3-weeks transplantation  
Three weeks after transplantation, ovaries were recovered and 
it was determined morphologically that the grafts had been 
successful (Control n=5, TrkBFL KO n=3).  Oocyte counts were 
obtained as described in Chapter 2.6.  Control ovaries exhibited 
oocyte counts ranging from 180-714, and the TrkBFL KO ovaries 


























































5.4.3. Transplanted TrkBFL KO ovaries maintain a dormant pool of 
oocytes and initiate follicle growth 
During counting, follicle type was categorised as described in 
Chapter 2.6.2.  To ascertain the ability of Control and TrkBFL KO 
transplanted ovaries to maintain a dormant pool of oocytes, 
primordial follicles were categorised as dormant and all other follicles 
as growing.  The two groups were then calculated as a percentage of 
the total follicles present in each transplant.  It can be seen in Figure 
5.4 that TrkBFL KO ovary transplants are able to maintain dormant 
























































5.4.4. TrkBFL KO follicles progress to the early antral stage af ter 3-
weeks transplantation  
 To assess growth of activated follicles the categories (as 
described in section 2.6.2) were simplified, by combination, into: 
primary (primordial-primary and primary); secondary (primary-
secondary and secondary); preantral; and early antral follicles.  Each 
category was then calculated as a percentage of the total follicles 
counted in each transplant.  Figure 5.5 reveals that the proportions 
of growing follicles found in the TrkBFL KO ovaries were within the 
























































5.4.5. Control and TrkBFL KO follicles appear morphologically similar 
after 3-weeks transplantation  
Morphological assessment of the follicles in terms of 
appearance of oocyte, zona pellucida, granulosa cell morphology and 
their arrangement in relation to oocyte, and presence of thecal layer 
did not indicate a difference between Control and TrkBFL KO ovary 
transplants (see Figure 5.6 A and B).  In addition, in comparison with 
equivalent-age in vivo ovary, the growth of the follicles appeared 
normal, although the oocytes contained in early growth stage follicles 
(in the transplants) appeared noticeably larger than those in vivo (see 
Figure 5.6 C).   
As measurements were available for primordial through to 
primary-secondary oocytes and follicles (from the Control P0-P7 time-
course assessed in Chapter 3) it was decided to compare these with 
measurements from the transplants.  Oocytes from primary follicles 
in transplanted ovaries (of either genotype) are significantly larger 
than oocytes from in vivo primary follicles (see Figure 5.7 A).  
However, only oocytes from TrkBFL KO transplants are found to be 
significantly larger than in vivo oocytes at the primary-secondary 
follicle stage.  In contrast, it is in vivo oocytes which are significantly 
larger than oocytes from transplanted ovaries at the primordial-
primary follicle stage.  Analysis of follicle measurements between in 
vivo follicles and follicles from transplanted ovaries revealed no 
difference at the primordial or primary-secondary stages (see Figure 
5.7 B).  However, at the primordial-primary follicle stage, in vivo 
follicles were found to be significantly larger than those from 
transplants.  This was again reversed at the primary follicle stage 
with larger follicles in the transplants than found in vivo, Control 







































































Comparison of the mean oocyte and follicle sizes obtained for 
Control and TrkBFL transplants from primordial through to the early 
antral follicle stage was carried out (see Figure 5.8).  Two-tailed 
Student’s t-tests revealed no difference between the Control and 
TrkBFL KOs for either oocyte or follicle from primordial to primary 
stages.  TrkBFL KO mean oocyte size was, however, found to be 
significantly larger than the mean Control oocyte from the primary-
secondary to early antral follicle stages.  The mean follicle sizes for 
the TrkBFL KO secondary and early antral follicles were also 
significantly larger than Control follicles.  Thus, TrkBFL KO ovaries 
appear to grow (only slightly, but significantly) larger oocytes and 























































5.4.6. Semi-quantitative laminin- α1 expression in the 2- and 3-week 
Control and TrkBFL KO ovary transplants  
As demonstrated in Chapter 4, P0 TrkBFL KO ovaries exhibit a 
reduced area of laminin-α1 fluorescence.  After 2 weeks 
transplantation, TrkBFL KO ovaries (n=2) exhibit a reduced area of 
thresholded fluorescent signal when presented as a fold change 
relative to the Controls (n=3, see Figure 5.9 A).  This is also true for 
the 3 weeks transplants, TrkBFL KO ovaries (n=3) Controls (n=5, see 
Figure 5.9 B).  Small sample sizes and large data spreads were 


























































Previous findings had strongly implicated the role of TrkB 
signalling in regulating oocyte survival at the time of follicle 
formation.  Not only are the receptor and its ligands expressed in the 
ovary, but TrkB expression is actually upregulated at birth in the 
rodent, and mice with the null mutation (TrkBFL KO) exhibited 
significant neonatal oocyte loss (Spears et al., 2003).  On the basis of 
these findings, the obvious hypothesis was that there is a direct 
requirement for full-length TrkB signalling in the ovary, to maintain 
oocyte survival and support follicle formation.  Following on from this 
hypothesis, the assumption was made that transplantation of TrkBFL 
KO ovaries would not be able to rescue the phenotype.  The results 
presented in this chapter were therefore, unexpected, nevertheless 
transplants of late fetal/early neonatal TrkBFL KO ovaries are able to 
maintain a dormant pool of oocytes and support follicle growth up to 
the early antral stage of development just as well as Control 
transplants.  The primary interpretation that must be drawn from 
this is that TrkBFL signalling is not directly required within the mouse 
ovarian follicle for survival.  It would then follow that the in vivo loss 
of follicles observed in the TrkBFL KO (Spears et al., 2003) may 
actually be due to an indirect effect of loss of full-length TrkB 
signalling.  However, the stark contrast between the findings of this 
Chapter and those of Paredes et al. (2004) demand explanation.  I 
propose that the differences between the two experiments conducted 
raise sufficient queries that would need to be addressed before it 
could be categorically stated that full-length TrkB signalling is not 
directly required by the ovary to support oocyte survival.  These 
differences are outlined in the first part of this discussion. 
 
5.5.1. Comparison of TrkBFL and TrkBFLTr KO ovary transplants 
 TrkBFL KO ovaries were transplanted at late stages of gestation 
(E17.5/18.5) or on the day of birth under the kidney capsule of intact 
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recipients.  TrkBFLTr KO ovaries were transplanted at P4/5 also under 
the kidney capsule, although the recipients were ovariectomised 
(Paredes et al., 2004).  Thus, the contrast in findings between those 
presented in this thesis and those of Paredes et al. (2004) provide an 
intriguing situation whereby several different factors could potentially 
contribute to the difference in results.  The main possibilities are: 1) 
the difference in TrkB mutation; 2) the difference in recipient and/or; 
3) the difference in age of the transplanted tissue.  
 
5.5.1.1. The difference in TrkB mutation  
The first possibility I shall discuss is that the difference in TrkB 
mutation between the two studies is responsible for the differing 
outcomes.  The KO used by Paredes et al. (2004) lacks all forms of the 
TrkB receptor (TrkBFLTr KO), whereas, the KO studied in this project is 
null only for the full-length receptor (Klein et al., 1993).  The different 
results could indicate that there is in fact a direct requirement for 
truncated TrkB receptor signalling to maintain oocyte and follicle 
survival, evidenced by the loss of oocytes and follicles in the TrkBFLTr 
KO transplants.  As the TrkBFL KO transplants were unaffected it 
could, therefore, be interpreted to demonstrate that removal from the 
environment of the TrkBFL KO rescues oocyte survival (indicating that 
the requirement for full-length TrkB signalling in the ovary is 
indirect).  However, I will outline why I believe that an indirect effect 
is unlikely to have caused the ovarian phenotype.  The TrkC KO 
assessed by Spears et al. (2003) also exhibited retarded growth and 
postnatal lethality but no effect on oocyte survival.  Mutations in both 
TrkB and TrkC result in loss of sensory neurones (see reviews by 
Conover and Yancopoulos, 1997; Tessarollo, 1998).  Double TrkB/C 
null mutation results in even greater loss of sensory neurones 
demonstrating the compensatory effects they exert for each other in 
vivo (Silos-Santiago et al., 1997).  Thus, it seems unlikely that the 
TrkB and TrkC KOs exhibit significantly different enough neurological 
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effects to explain why one has a consequence for oocyte survival 
(TrkB) but not the other (TrkC).   
There is further evidence demonstrating that indirect effects of 
TrkB mutation are unlikely to be solely responsible for the ovarian 
phenotype.  Spears et al. (2003) found that depending on the 
background the mutation was placed on (mixed or congenic) the 
phenotype of the TrkBFL KO would exhibit varying effects on oocyte 
survival, although all exhibited retarded growth and postnatal 
lethality.  To uphold the indirect theory it would require that the 
TrkBFL KOs, which exhibited an ovarian phenotype, exhibited 
different effects on their general development from those that did not 
demonstrate an ovarian phenotype, yet all succumbed to the same 
eventual outcome of retarded growth and death.  It seems more likely 
that other oocyte survival factors were able to compensate to varying 
degrees for the loss of signalling in the ovary depending on the 
background.  Put simply, in some backgrounds, sufficient tyrosine 
kinase signalling may be achieved through other receptors (in 
addition to or instead of TrkB) and so loss of TrkB has no great 
impact.  Other backgrounds may express TrkB more highly, over 
other tyrosine kinase receptors, and so mutation has an effect.   
The possibility of a direct requirement for truncated TrkB 
signalling in the ovary cannot be totally ruled out.  It is currently 
thought that the TrkB locus gives rise to three proteins, one full 
length and two truncated receptors, T1 and T2, which lack the 
catalytic tyrosine kinase domain.  As discussed in Chapter 1.5.2.1 
lacking the catalytic domain was considered to imply a lack of 
downstream signalling capabilities, although, in some cell types 
truncated TrkB T1 receptors have been shown to be capable of 
inducing intracellular calcium release in response to BDNF (Rose et 
al., 2003).  It, therefore, seems plausible that the truncated receptors 
are actually capable of generating a signalling cascade in response to 
the binding of neurotrophins.  However, I consider this reason 
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unlikely to account for the discrepancy discussed here, at least for 
the TrkB T1 receptor, as mice null for TrkB T1 have normal ovaries 
and are fertile as adults (mice supplied by Dr Lino Tessarollo, 
unpublished findings by Spears lab 2008).  This clearly does not 
exclude a possible role for truncated receptor TrkB T2, but it has yet 
to be demonstrated to be translated into a functional protein in the 
mouse (Kumanogoh et al., 2008). 
 
5.5.1.2. The difference in recipient  
The second possibility is that the difference between recipients 
is responsible.  Paredes et al. (2004) ovariectomised their recipients, 
in contrast, for this thesis the females were left intact as it was 
deemed to be an unnecessary added risk in terms of recipient 
recovery from the surgery.  However, in light of the contrast in results 
it is reasonable to propose that the intact recipient ovaries may have 
influenced the survival of oocytes and follicles in the TrkBFL KO 
ovaries transplanted.   
 
5.5.1.2.1. Survival factor  
It may be possible that an unidentified survival factor is 
produced by the intact recipient’s ovaries and is carried, systemically, 
to the transplanted ovaries where it is sufficient to rescue the TrkBFL 
KO oocytes.  To address this would require repeating TrkBFL KO ovary 
transplants using both ovariectomised and intact recipients.  Should 
the oocytes and follicles only be lost in the ovariectomised group it 
would be convincing evidence that the in situ recipient’s ovaries do 
confer protection via some kind of mechanism.  It may even be 
possible that it is due to an intact full-length TrkB signalling pathway 
in the recipient’s ovaries.  It could then be hypothesised that 
although TrkBFL is not required autonomously in the follicle for its 
survival it may still be possible that TrkBFL signalling is required at 
the level of the intact ovary to support follicle survival.  In addition (or 
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alternatively) it may be that another intraovarian signalling pathway 
is responsible for the generation of a signal capable of rescuing the 
transplanted ovaries.  A rescue effect has previously been 
demonstrated in vitro; Spears et al. (2003) used the tyrosine kinase 
blocker (K252a) to prevent Trk signalling in newborn mouse ovary 
cultures (which resulted in significant oocyte loss).  Addition of bFGF, 
a growth factor which signals through a non-Trk tyrosine kinase 
receptor (Wert and Palfrey, 2000), negated the effect of K252a on 
oocyte survival.  
In the same vein, it may be possible that steroid hormones 
produced by the intact recipient’s ovaries (including estrogen) may 
have influenced the different outcomes.  This is stated as hormone 
levels (estrogen and progesterone) are high in the neonatal rodent 
pup but fall over the first few days of life (Kezele and Skinner, 2003).  
These first few days have been shown to be a period during which 
ovary development is susceptible to the actions of steroids, as 
discussed in Chapter 1.3.  Kezele and Skinner (2003) were able to 
repress follicle growth initiation when newborn rat ovaries were 
cultured in the presence of estrogen and progesterone.  Interestingly, 
they were unable to alter the follicle distribution when culturing rat 
ovaries from P4 in the presence of estrogen or progesterone.   
Therefore, although not an absolute requirement for follicle 
development, there is a neonatal period where these factors can 
modulate it.  It may be possible that steroids from the recipient’s 
ovaries protected the follicles from loss of TrkBFL by reducing follicle 
activation, and repressing the growth of those that had activated 
such that compensation could be achieved through other survival 
pathways.  Comparatively, even if the TrkBFLTr KO ovaries had been 
transplanted during the period when ovaries could be influenced by 
these hormones (before P4/5) the ovariectomised recipients used for 
the TrkBFLTr KO ovary transplants (Paredes et al., 2004) meant that 
the ovaries would only have been exposed to low levels of circulating 
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estrogen.  Thus, it seems a strong possibility that compensation may 
have occurred in the TrkBFL KO transplants. 
 
5.5.1.2.2. Gonadotrophins  
Another possibility introduced by the difference in recipient is 
that the endocrine status of the recipient may have affected the 
development of the transplanted ovaries.  Small growing follicles do 
not require gonadotrophins for growth, as demonstrated by lack of 
effect of hypophysectomy on the growth of small follicles.  However, 
as with estrogen there is also evidence for a period during the early 
postnatal period where effects of gonadotrophins on immature rodent 
follicle development can be observed.  The timing of when these 
effects can take place are debatable and seem most likely dependant 
on the species assessed, as mice begin to form follicles prior to birth 
but rats commence follicle formation on the day of birth.  Thus, 
variations in when ovaries will begin to “respond” to treatments will 
no doubt depend on the development of the follicles within the 
ovaries being assessed.    
At birth in the rodent, levels of FSH are high but decrease 
within the first few days of life, which led to speculation upon 
possible developmental roles in primordial follicle formation and the 
activation of the first growing follicles (Halpin et al., 1986).  The 
hypogonadal (hpg) mouse has undetectable levels of circulating FSH 
and reduced early follicle growth (Halpin et al., 1986).  Conversely, 
PMSG (which has mainly FSH activity) increased the population of 
growing follicles in mouse ovaries if treated between P0 and P5 
(Lintern-Moore, 1977b).  It was confirmed that mouse ovaries do 
express various transcripts of gonadotrophin receptor isoforms from 
birth (O'Shaughnessy et al., 1994).  It is not, though, until later 
stages (P5-7) that ovaries in culture are actually gonadotrophin 
responsive as demonstrated by production of steroids (progesterone 
and androstenedione; Mannan and O’Shaughnessy, 1991).  These 
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responses by ovaries in culture (LH from P7 and FSH from P15) are 
attributed to the appearance of primary and secondary follicles and 
subsequent acquisition of a thecal layer (Mannan and 
O'Shaughnessy, 1991).   
  Paredes et al. (2004) assessed FSH serum levels and found 
that they are reduced in the TrkBFLTr KO, although the time point at 
which the samples were collected is not stated.  It is possible that the 
P4/5 transplanted TrkBFLTr KO ovaries may have exhibited reduced 
early follicle growth prior to transplantation as they did at P7 
(Paredes et al., 2004).  However, reduced growth was not thought to 
be the result of reduced serum levels of FSH as the TrkBFLTr 
heterozygous females also exhibited reduced FSH but no effect on 
follicle development.   
The removal of in situ ovaries from the recipient results in the 
ablation of the negative feedback loop controlling the release of the 
gonadotrophins (FSH and LH) from the anterior pituitary.  In the 
absence of in situ ovaries, serum FSH levels increase significantly 
compared to the levels found circulating in intact mice (Cox et al., 
2000).  The transplanted P4/5 Control and TrkBFLTr KO ovaries were 
effectively returned to an environment much more akin to that of the 
newborn mouse.  As Control ovary development was normal the 
elevated levels do not disrupt normal follicle growth.  The TrkBFLTr KO 
ovaries, on the other hand, contained only a few atretic follicles, if 
any (Paredes et al., 2004).  The follicles that were present were multi-
laminar and had clearly progressed beyond the secondary stage of 
growth.  This led Paredes et al. (2004) to hypothesise that, in keeping 
with their result of reduced Fshr mRNA expression in the P7 TrkBFLTr 
KO ovary, follicles ultimately fail to become gonadotrophin dependent 
(as discussed in Chapter 3.1).  They conjecture, though, that the fact 
the follicles grew at all was due to the elevated gonadotrophin levels.  
It is, therefore, possible to speculate that the elevated gonadotrophin 
levels were able to override, to some degree, the block in growth that 
 184 
the TrkBFLTr KOs exhibit in vivo.  The fact that the follicles died at the 
preantral stage meant that, unlike the Control ovaries, the TrkBFLTr 
KOs were unable to produce follicles capable of suppressing the 
activation of dormant primordial follicles (as discussed in Chapter 1.3 
and depicted in Figure 1.3).  Therefore, it may be possible that the 
elevated gonadotrophin levels enhanced the phenotype of the TrkBFLTr 
KO ovary by accelerating the rate of follicle growth, their demise and 
the resulting depletion of the pool of primordial follicles.  It is not 
clear how the gonadotrophin levels of the intact recipients used in 
this investigation may have affected the TrkBFL KO ovaries 
transplanted.  It does seem reasonable, though, to speculate that 
they may have influenced the result given that elevated levels may 
have influenced the outcome of the TrkBFLTr KO transplants.  Thus, it 
is possible that the endocrine status of the recipients may have 
affected the outcome of the transplants.  
 
5.5.1.3. The difference in stage of transplantation  relative to 
appearance of phenotype  
A third possibility (and the one I consider to be most likely) is 
that the age of the ovary transplanted influenced the results.  It was 
demonstrated in Chapter 3 that in vivo TrkBFL KO ovaries exhibit 
follicles with poorer health than Control ovaries.  The TrkBFL KO 
ovary transplants were accordingly carried out prior to the presence 
of a morphologically obvious phenotype which may influence 
subsequent development of the ovaries.  Another factor known to 
affect the outcome of a transplant is distribution of follicles in the 
ovary at the time of transplantation.  Growing follicles are lost after 
transplantation but primordial follicles less so (see review by Gosden, 
2008).  By transplanting late fetal and early neonatal TrkBFL KO 
ovaries it is known that they were unaffected in terms of follicle 
distribution and oocyte number (see Chapter 3).  If a difference in the 
number of oocytes in the recovered transplants had been found, it 
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would have been possible to exclude that it was caused by an affect 
on the follicle population prior to transplantation, thus, making it 
possible to attribute any effect found to the mutation and not 
transplantation.   
In complete contrast, Paredes et al. (2004) did not demonstrate 
that the TrkBFLTr KO ovaries they transplanted at P4/5 were 
unaffected either in terms of follicle health, numbers of oocytes or the 
distribution of follicle growth.  Indeed, we know that they were 
affected at P7.  Paredes et al. (2004) observed that the follicles 
present in the TrkBFLTr KO ovaries, after transplantation, exhibit a 
disrupted BM.  Thus, it is possible that the TrkBFLTr KO ovaries 
exhibited reduced follicular health at the time of transplantation.  In 
addition, it also seems likely that by the time they were transplanted 
the ovaries were affected in terms of follicle development.  
Assessment of P7 in vivo ovaries of the TrkBFLTr KO revealed a 
reduction in secondary follicle formation attributed to a reduction in 
granulosa cell proliferation (Paredes et al., 2004).  It may be that at 
the point of transplantation the TrkBFLTr KO ovaries were already 
irreversibly affected by the mutation, at least in terms of follicle 
development if not health, whereas, transplantation prior to any 
obvious defect allows the survival and growth of the follicles in the 
TrkBFL KO. 
 
5.5.2. Comparison of Control and TrkBFL KO ovary transplants   
The main finding of interest from the Control and TrkBFL KO 
ovary transplants was the demonstration that loss of full-length TrkB 
signalling has no effect on long-term oocyte survival.  There were 
differences observed between the Control and TrkBFL KO ovary 
transplants which may be directly attributable to the mutation and 




5.5.2.1. Oocyte growth   
It was observed that oocytes from early growth stage follicles in 
transplanted Control and TrkBFL KO ovaries exhibited an intriguing 
increase in oocyte size.  It was confirmed that oocytes in transplanted 
Control and TrkBFL KO ovaries were significantly larger at the primary 
stage than in vivo primary follicle oocytes.  As this was found for both 
genotypes it appears that this is attributable to the actual process of 
transplantation rather than genotype itself.  This observation could 
be interpreted as precocious responsiveness to the new endocrine 
environment of the recipient.  By the primary-secondary follicle stage 
of growth it became apparent that this was not just a difference 
between in vivo and transplanted ovaries but between Control and 
TrkBFL KO oocytes in the transplants.  TrkBFL KO oocytes were 
significantly larger at this stage of growth than either in vivo oocytes 
or Control transplanted oocytes of the same stage.  Comparing the 
Control and TrkBFL KO oocyte and follicle measurements from later 
stages of follicle growth revealed that the TrkBFL KO has significantly 
larger sized oocytes from the primary-secondary stage through to the 
early antral stage.  This was also found for the secondary and early 
antral stage follicles.  Thus, it appears that loss of full-length TrkB 
signalling has an effect on oocyte growth at these stages.  It may be 
possible that this is attributable to a factor produced by the intact 
ovaries of the recipient, promoting oocyte growth before granulosa 
cell proliferation initiates.  It may also be due to intraovarian 
signalling pathways affected in the TrkBFL KO.  A similar effect was 
found in the ovaries of Gdf-9 null mice.  The growth of follicles is 
blocked at the primary stage as granulosa cells do not proliferate, 
though the oocyte continues to grow (Dong et al., 1996).  This effect 
was attributed to continued production of the cytokine kit ligand (KL) 
by granulosa cells acting on the oocyte expressed receptor (KIT) to 
promote its growth (Elvin et al., 1999).  The fact that this increase in 
size was also observed in the secondary and early antral follicles of 
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the TrkBFL KO indicates that this increase in growth is not just 
limited to the oocyte but is also evidenced by increased growth in the 
granulosa cell compartment of TrkBFL KO transplants. 
 
5.5.2.2. Laminin- α1 deposition   
Assessment of the TrkBFL KO transplants indicated that the 
decrease in deposition of laminin-α1 is maintained, thus the role for 
regulating BM deposition through TrkB signalling appears to be a 
direct one.  However, given that the follicles were able to survive and 
grow normally it also appears that the reduced BM is not on its own 
sufficient to cause loss of oocytes.  It may, though, be possible that 
the endogenous hormones from the intact recipient ovaries rescue the 
effect of the disrupted BM to some extent either by overcoming the 
defect or by partially repairing it.  This can be postulated as estradiol 
and FSH have both been found to increase expression of N-cadherin 
and gap junction components by cultured granulosa cells 
(Amsterdam et al., 1999).  Thus, it could be that upregulated 
expression of other components involved in regulating follicle 
structure, induced by endogenous hormones from the intact recipient 
ovaries, may be able to compensate for the reduction in laminin-α1. 
 
5.5.3. Summary  
In spite of the caveats discussed in the previous sections it 
cannot be disputed that the results of the TrkBFL KO transplants 
reveal the lack of direct requirement within the follicle for full-length 
TrkB signalling.  This entirely unexpected result requires a complete 
shift in our understanding of the role of TrkB signalling in ovarian 

















Chapter 6   
 
Novel description of an immune response 

















The immune system is a form of self-defence evolved to protect 
against disease-transmitting pathogens such as viruses, bacteria, 
parasites and fungi.  It is a fine-tuned system which acts on two 
distinct but co-operative levels: the innate immune response (primary 
reaction to eliminate pathogens mainly by phagocytosis) and the 
adaptive immune response (secondary reaction to infection which 
results in life-long pathogen-specific antibody production).  In 
addition to this powerful defence mechanism, cells of the immune 
system are also functionally involved in normal tissue development 
and homeostasis.  Incorrect regulation of the immune system can 
result in different pathologies including cancer and autoimmune 
disease.   
The cells responsible for the actions of the innate and adaptive 
immune systems are the white blood cells (or leukocytes; see Figure 
6.1).  These cells descend from haematopoietic stem cells (found in 
the bone marrow) along with red blood cells (erythrocytes) and 
platelets.  Haematopoietic stem cells initially differentiate into two 
types of specialised progenitor cell which are subsequently 
responsible for the generation of other immune cells: the myeloid 
progenitor (innate) and the lymphoid progenitor (adaptive).  Myeloid 
progenitor cells can differentiate into cells including granulocytes, 
monocytes, macrophages, erythrocytes, megakaryocytes and mast 
cells.  Granulocytes (identified by granules in the cytoplasm) include 
the polymorphonuclear leukocytes (PMLs), eosinophils and basophils.  
PMLs are so-called because of their distinctive multilobulated nuclei, 
but in literature they are also often referred to as neutrophils.  
Lymphoid progenitor cells are responsible for production of T- and B-
lymphocytes, and natural killer cells.  In contrast, lymphocytes, 



































In response to inflammation or infection, the innate immune 
response is quickly triggered and can be exerting its effects within a 
matter of minutes.  Using the vasculature, and by responding to 
chemokines and cytokines, leukocytes travel to sites in the body 
where they are required.  The most common leukocyte to do this is 
the PML.  Near-mature PMLs are stored in bone marrow ready for 
quick release, after which they are replenished by increased bone 
marrow production.  PMLs are also found in blood vessel walls ready 
to migrate, in the circulation and in tissue.  Infection-causing agents 
are ingested by PMLs before they self-destruct by undergoing an 
apoptotic event.  The apoptotic debris is then subsequently cleared by 
macrophages.  Macrophages are present as monocytes in the 
bloodstream, once recruited they enter the tissue and differentiate 
into phagocytic macrophages responsible for the removal of 
pathogens and debris (Janeway et al., 2001). 
The acquired immune system is much more specific but slower 
in its response.  Lymphocytes are produced by progenitor cells in the 
bone marrow and other lymphoid organs such as the spleen and 
thymus gland.  It is in these organs that they importantly acquire the 
ability to recognize self from non-self.  This ensures that only foreign 
antigens are recognized and removed accordingly, protecting the 
organism from developing autoimmune diseases.  This occurs when 
lymphocytes recognise self-antigens, effectively becoming auto-
antibodies.  B-lymphocytes are bone marrow-derived cells which 
deactivate any antigen they encounter by engulfment.  The cells then 
present the antigen which is recognized by specific thymus-derived T-
lymphocytes.  This results in production of antibodies by derivatives 
of B-cells.  The binding of T-cells to the antigen-presenting cells leads 
to their subsequent destruction (Janeway et al., 2001). 
Although the primary function of leukocytes has been 
simplified here to that of phagocytosis and degradation of foreign 
bodies, leukocytes are also responsible for the propagation and 
 192 
maintenance or dissolution of an immune response.  This is mainly 
achieved through the actions of cytokines and chemokines.  
Cytokines are proteins secreted by activated immune cells which act 
on other immediate immune cells or the tissue they are in.  These 
include members of the interleukin (IL) family 1, 6, 10 and 12, 
granulocyte macrophage-colony stimulating factor (GM-CSF) and 
TNF-α.  Chemokines (chemotactic cytokines which recruit other 
immune cells in the vicinity) include IL-8 and monocyte 
chemoattractant proteins (MCP) 1 and 3.  Leukocytes can also release 
growth factors such as TGF-α and -β, IGF, epidermal growth factor 
(EGF) and vascular endothelial growth factor (VEGF).  These growth 
factors influence the tissue the leukocytes have infiltrated and can 
regulate normal tissue function, or function in response to immune 
stimulus.      
The role of the immune system in ovarian function has been 
well documented for later stages of ovary development, namely follicle 
atresia, ovulation and regression of corpus luteum.  The role of 
macrophages in particular is well studied and is reviewed by Wu et al. 
(2004).  Ovulation of a species-specific number of oocytes relies on 
the appropriate loss of a proportion of growing follicles.  This occurs 
through atresia, the mechanism of which is considered to be 
apoptosis.  In human ovary, more than double the density of PMLs is 
found in the thecal layer of atretic follicles compared to healthy 
follicles (although it should be noted that even healthy follicles have 
four times the density of PMLs in the thecal layer compared to the 
interstitium; Chang et al., 1998).  Thus, it is normal to observe 
immune cells in apparently healthy follicles, but their increased 
presence is associated with follicle atresia.   
Atresia of preantral and antral follicles in prepubertal mouse 
ovaries can be induced by γ-radiation (Lee and Yoon, 2005).  PMLs 
and macrophages were observed within atretic follicles (identified by 
granulosa cell and oocyte apoptosis).  In addition, there were 
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phagocytic granulosa cells and macrophages consuming apoptotic 
debris and PMLs within the follicles.  Thus, it is conjectured that after 
certain insults or during unnatural levels of apoptosis it is possible 
for apoptosis to induce an ovarian immune response (Lee and Yoon, 
2005).    
The role of the immune system in ovulation is the destruction 
and remodelling of ovarian tissue required to enable ovulation to 
occur.  Macrophages assist in this process by secreting degradative 
matrix metalloproteinases (MMPs) which can break down collagen 
surrounding the follicle (Wu et al., 2004).  Macrophages are strongly 
localised to thecal layers of preantral and antral mouse follicles (Wu 
et al., 2004).  It was also found that the presence of macrophages and 
PMLs actually enhances ovulation rates, whereas depletion of these 
cell types results in reduced ovulation rates (Russell and Robker, 
2007). 
Regarding early ovary development, the role of the immune 
system has been less studied.  As discussed in Chapter 1.4, a 
common feature of neonatal rodent ovary development is loss of 
oocytes.  This occurs through different mechanisms, although large 
proportions are considered to be lost by apoptosis.  Given that 
apoptosis is a regulated mechanism for the intentional removal of 
specific cells, it would not be to the benefit of the organism if it 
induced an inflammatory response each time it occurred.  Thus, it 
has been considered dogma that apoptosis is anti-inflammatory and 
necrosis (where a cell dies through some kind of trauma) is pro-
inflammatory.  However, as reviewed by Gregory and Devitt (2004), 
predicting a response is not straight forward as it is possible to have 
neutral, pro-, or anti-inflammatory responses depending on the cell 
types interacting and the cytokines released in the tissue.   
In keeping with the notion that apoptosis is anti-inflammatory, 
existing data indicates that the immune system does not exhibit an 
apparent role during neonatal ovary development, in particular in 
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relation to loss of oocytes at follicle formation and growth activation.  
This is partly based on human ovary studies which indicate that 
PMLs simply do not associate with primordial or early growth stage 
follicles (Chang et al., 1998).  In addition, it was observed 12 hours 
after γ-radiation treatment that prepubertal mouse ovaries lost the 
majority of primordial and primary follicles by apoptosis of granulosa 
cells and oocytes, however, no immune response was described (Lee 
et al., 2000).   
  During the neonatal period the acquired immune response is 
established.  If development is disrupted during this time then it can 
result in autoimmune diseases.  Autoimmune ovarian disease (AOD) 
is a well-documented incidence of autoimmune disease whereby 
failure of correct lymphocyte regulation during the neonatal period 
results in adult onset of oophoritis (inflammation of the ovary).  
Ovarian failure subsequently occurs, thus linking the disease to 
premature ovarian failure (POF).  As a model of autoimmune disease 
in the mouse it is very useful to study as it can be induced either 
through immunisation against a peptide of the zona pellucida protein 
(ZP3; O’Leary et al., 2008), or by removal of the thymus (Lintern-
Moore, 1977a; Taguchi et al., 1980) at P3 (Tung et al., 2001).     
  The potential for Trk signalling in the development and 
regulation of the immune system is strongly implicated through the 
expression of all Trk receptors (including p75) in bone marrow, 
lymphoid tissue (thymus, spleen and lymph nodes) and subsets of 
immune cells located within these tissues (see review by Vega et al., 
2003).  TrkA is expressed in human spleen and lymph nodes and 
NGF has proliferative effects on lymphocytes in vitro (Thorpe and 
Perez-Polo, 1987; Otten et al., 1989).  TrkB, in particular, has been 
localised to haematopoietic cells, PMLs and erythroblasts of bone 
marrow as well as macrophages in spleen and thymus (Vega et al., 
2003).  It is also expressed on isolated lymphocytes (Garcia-Suarez et 
al., 2002) and eosinophils (Noga et al., 2002).  In contrast, isolated B-
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lymphocytes from murine thymus express truncated TrkB mRNA but 
not full-length receptor mRNA (Schuhmann et al., 2005).  
Neurotrophin protein detection in immune tissues has been less 
successful, although mRNA for all has been detected (Vega et al., 
2003).  Therefore, exact establishment of expression of receptors, 
their isoforms and the ligands is not yet complete.  However, use of 
transgenic mice has allowed further analysis of the potential role of 
Trk signalling.  TrkBFL KO mice (Klein et al., 1993) assessed by 
Garcia-Suarez et al. (2002) exhibited significant loss of lymphocyte 
precursors (thymocytes) at P15 in the thymus, demonstrating a 
survival role for TrkB signalling in this cell type, although the exact 
nature (auto- versus paracrine) is not yet established.   
  
6.2. Aim 
As discussed in Chapter 3.3.2. some TrkBFL KO ovaries 
exhibited a cellular infiltrate of unknown origin (see Figure 6.2).  
Some of these cells were clearly PMLs.  The other type of unknown 
cell could not be easily identified but was not considered to be 
apoptotic (personal communication with mouse pathologist Dr David 
Brownstein, University of Edinburgh), thus they may well also be part 
of the immune response.  The questions addressed in this chapter 
are:   
1) what is the nature of this immune response;  
2) is there an association between the response and lack of full-
length TrkB; and 
3) what potential role could this response be fulfilling in the 
neonatal ovary?   
Points two and three are based upon the previously described 
phenotype of the TrkBFL KO being one of increased oocyte loss (Spears 
et al., 2003).  Although oocyte attrition is not an unusual process in 
the neonatal ovary, could it be that the extreme phenotype of the 
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mutation has overwhelmed the normal process by which the ovary 
clears apoptotic debris?  This novel observation may provide some 
































































6.3. Materials and Methods  
 
6.3.1. Animals  
 Transgenic animals were generated and genotyped as described 
in Chapter 2.1-2.2.  Control (wild-type and TrkBFL heterozygote) and 
TrkBFL KO pups were collected from P0 through to P7.   
 
6.3.2. Tissue collection  
Control and TrkBFL KO ovaries were collected as described in 
Chapter 2.3.  Spleen was collected from Control pups at P2.   
 
6.3.3. Tissue preparation  
 Ovaries were fixed in Bouins or PFA before embedding in wax 
and cutting at 5µm, as described in Chapter 2.4, or they were 
embedded in resin and cut at 5µm (see Chapter 2.5).  Spleen was 
fixed in PFA for 1 hour, wax embedded and sectioned as described in 
Chapter 2.4, with the exception that sections were cut at 3µm.   
 
6.3.4. Morphological assessment of immune response  
Only ovaries that had been left attached to the bursa were used 
for assessment of the immune response in the ovary proper, hilar 
region and bursa.  One middling section per ovary (where the three 
areas were visible) was stained with H&E (as described in Chapter 
2.4.4 for wax sections and Chapter 2.5.3 for resin sections).  Each 
area of the section assessed was scored for the presence of immune 
cells, either: no response (0 cells counted); weak (1-9 cells counted); 
medium (10-29 cells counted); or strong (30+ cells counted).   
 
6.3.4. Transmission Electron Microscopy.  
A pair of P5 sibling Control and TrkBFL KO ovaries were 
collected and processed for transmission electron microscopy (TEM).  
See Appendix B for TEM solutions.  Ovaries were fixed using 3% 
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glutaraldehyde in a working buffer of 0.1M sodium cacodylate buffer 
(NaCo) for 2 hours at room temperature with agitation.  Ovaries were 
then washed in 0.1M NaCo (3 x 15 minutes) before post-fixation in 
1% osmium tetroxide in 0.1M NaCo for 45 minutes at room 
temperature with agitation.  Ovaries were washed again in 0.1M 
NaCo (3 x 15 minutes) before dehydration and embedding in resin as 
described in Chapter 2.5.1.2.  Sections were prepared for TEM by 
Stephen Mitchell (EM suite, Edinburgh University) and viewed on a 
Phillips CM120 Transmission electron microscope (FEI UK Ltd).  
Images were taken using a Gatan Orius CCD camera (Gatan UK).   
 
6.3.5. Immunohistochemistry  
Using DAB, as described in Chapter 2.7.1-2.7.3, lymphocytes, 
PMLs and monocytes/macrophages were identified by the pan 
leukocyte marker, CD45, also referred to as the common leukocyte 
antigen (O'Leary et al., 2008).  The primary antibody used was a rat 
anti-mouse polyclonal (BD Biosciences) at a 1:50 dilution.  The 
secondary used was a biotinylated goat anti-rat antibody (Zymax) at a 
1:200 dilution.  Non-immunised goat serum was used to make 
antibody solutions.  As for assessment of the H&E stained sections, 
CD45 detection was carried out on a middle section from the 
available P0-P7, intact, wax embedded Control and TrkBFL KO 
ovaries.  Spleen was used as the positive control and a section with 
primary antibody omitted was included as the negative control.  
Haematoxylin counterstain was used to allow clear identification of 
the ovarian structures assessed.   
 
6.3.6. Assessment of neonatal ovaries from mice nul l for Dazl 
Control and Dazl KO sibling mouse ovaries (fixed, processed 
and embedded in wax) were obtained from Professor A. McNeilly 
(MRC Human Reproductive Sciences Unit, Edinburgh).  They were 
sectioned and stained for H&E as described in Chapter 2.4.4. 
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6.4. Results  
To address the first aim of characterising the immune response 
it was necessary to identify the cells present by morphological and 
histological methods.   
 
6.4.1. The nature of the immune response 
Once it had been recognised that these cells were part of an 
immune response, and due to their distinctive morphologies, it was 
relatively easy to identify the cells even if the infiltrate was not strong.  
It was quickly resolved through assessing the Control and TrkBFL KO 
ovary P0-P7 time-course that the immune response is not limited to 
the TrkBFL KO ovary.  Therefore, the ensuing description will be based 
on the responses observed in both Control and TrkBFL KO ovaries. 
 
6.4.1.1. The unidentified cells 
These cells were originally assumed to be apoptotic due to their 
small, round, very intense haematoxylin stain and lack of cytoplasm.  
It was observed that these cells were often adjacent to oocytes within 
follicles (see Figure 6.3), strongly suggesting that they may be 
apoptotic granulosa cells.  However, a very strong response in a P4 
Control ovary (see Figure 6.4) allowed the identification of true 
apoptotic cells alongside these unidentified cells.  Apoptotic cells 
often exhibit a halo around the remaining cell body and this is not 
apparent around the unidentified cells.  These cells are in fact, 
quiescent cells, demonstrated by the pattern of chromatin and high 
ratio of nucleus to cytoplasm.  It was actually found that the Control 
P5 ovary, used for TEM, exhibited the same strong infiltrate of cells, 
allowing high power examination of these cells (see Figures 6.5 and 
6.6).  Comparisons of the cell morphology against histological 
reference (Berman, 2003) revealed that they have very similar 






































































































































In terms of the distribution of these cells in the ovarian tissue 
assessed, it was apparent that they are only ever found in the ovary 
proper.  They were observed either in discrete pockets or throughout 
the ovary proper, sometimes extending to the hilar region, but never 
in the bursa.  The pockets appear to be surrounded by a BM 
separating them from the stroma, but the cells are also able to access 
the granulosa layer of the follicles (see Figure 6.5).  Interestingly, they 
were never observed without the presence of PMLs and they tended to 
be present when PML presence was very strong.  
Immunohistochemical detection of these cells was initially 
demonstrated with the pan leukocyte marker CD45 (see Figure 6.7).  
However, this was deemed to be unreliable as it did not consistently 























































































6.4.1.2. Identified leukocytes 
During the initial morphological analysis of the neonatal TrkBFL 
KO in Chapter 3, several cell types were counted including apoptotic 
cells.  In some TrkBFL KO ovaries it was observed that there were 
other cells present at the hilar region which were not apoptotic and 
not recognisable as belonging to the ovary, these cells are PMLs.  
Easily identified in H&E sections by their characteristic multi-lobed 
nuclei, PMLs are most commonly and strongly observed in the bursa 
and hilar regions (see Figures 6.4 and 6.9).  Occasional infiltrations 
into the ovary proper of varying intensity can also be seen (see 
Figures 6.2 and 6.8).  Large aggregates of PMLs were also sometimes 
observed in the extraovarian space between the ovarian surface 
epithelium (OSE) and the bursa, particularly when the response was 
strong in the ovarian tissue.  Immunohistochemical detection of these 



















































It is unlikely that the response was induced by tissue damage 
incurred at the time of ovary collection as the scale of the response 
was so great in some samples that it must have been occurring for 
some time prior to collection.  In addition, immature forms of PMLs 
were observed in the tissue, indicating that leukocytes are actively 
formed there (myelopoeisis) rather than simply recruited to the 
tissue.  Different stages of formation of leukocytes can be identified in 
H&E sections by their distinctively shaped nuclei (see Figure 6.9).  
For example, metamyelocytes (which go on to form eosinophils, 
basophils or PMLs) have a nucleus larger and more kidney-shaped 
than mature leukocytes.  The subsequent stage of differentiation is 
the band cell stage where the nucleus becomes more curved but is 
not yet lobular.  Mature eosinophils are clearly distinguished by a 
halo of pink stain (hence their name), although it was harder to 
distinguish between mature cells if the nucleus wasn’t completely 
visible (or if stain wasn’t picked up heavily enough).  Thus, it is 
possible that in addition to PMLs and eosinophils, mature basophils 
may also be present. 
Macrophages can be identified in H&E sections where there is a 
cluster of apoptotic debris contained within a halo lacking stain 
(indicating that debris is contained within one body).  This was 
observed in the ovary proper of some H&E sections.  However, the 
ovary proper is very dense with cells and this prohibited absolute 
confirmation of their presence.  TEM sections obtained revealed the 
presence of macrophages and their active involvement in 
phagocytosis of apoptotic debris and cytoplasmic fluid (see Figure 
6.10).  It also appears that oocytes in ovaries undergoing the immune 
response are also capable of phagocytosis (see Figure 6.11).   
Immunohistochemical detection of macrophages and other 
mature leukocytes is likely with the pan leukocyte marker, CD45.  
However, detection of immature leukocytes is not guaranteed as not 




































































6.4.2. Is the immune response influenced by loss of  full-length TrkB? 
The second aim of the chapter was to investigate the possibility 
that the novel immune response observed is associated with the 
mutation in full-length TrkB.  TrkBFL KO ovaries were previously 
found to exhibit substantial levels of cell death and significant oocyte 
loss during the neonatal period (Spears et al., 2003).  Thus, it was 
proposed that the immune response may be induced by incidences of 
mass cell death to remove apoptotic debris.  The immune response 
was observed in both Control and TrkBFL KO ovaries, thus it could 
not to be solely due to the mutation.  This, however, does not exclude 
the possibility that the immune response is a physiological response 
induced by normal levels of cell death in the ovary.  If this were true, 
Control ovaries would accordingly exhibit a basal level that TrkBFL KO 
ovaries may exceed.  It was, thus, decided to score the intensity of 
immune responses in both Control and TrkBFL KO ovaries to 
determine if there is a difference between genotypes.  As it was 
apparent that the CD45 antibody would not label all immune cells 
reliably it was decided to score available H&E sections for intensity of 
immune response. 
 
6.4.2.1. Immune responses can vary between ovaries from the 
same animal  
Where available, both ovaries from the same animal were 
assessed to maximise the number of ovaries graded for the immune 
response.  This revealed that, while a similar response tended to be 
produced in both ovaries (not shown); it was entirely possible to 
observe a strong response in one ovary and a weak response in the 






































6.4.2.2. Immune responses vary in intensity irrespe ctive of tissue 
location or genotype  
Out of 20 TrkBFL KO ovaries examined, all exhibited leukocytes 
(PMLs, eosinophils, lymphocytes) in at least one or more of the 
following areas: the bursa; the hilar region; or the ovary proper.  Of 
20 Control ovaries examined, all but one exhibited immune cells in at 
least one or more of the regions mentioned above.  Therefore, the 
response was observed to occur equally in both Control and TrkBFL 
KO ovaries.  The intensity of the response, though, varied in its 
location and composition.  Figure 6.13 depicts examples of Control 
ovaries exhibiting weak or strong responses in the different areas 
assessed and the same is shown for TrkBFL KO ovaries in Figure 6.14.  
Thus, as both Control and TrkBFL KO ovaries exhibit varying degrees 
of intensity of immune response, no correlation can be drawn 
between genotype and the intensity of the response.   




















































































6.4.2.3. Immune responses vary in intensity from P0 -P7.  
Although the immune response varied in intensity irrespective 
of genotype there appeared to be a trend of intensity across the P0-P7 
time-course for both genotypes.  Figure 6.15 demonstrates that in 
terms of the spread of intensity of the response it can be generalised 
that it is weakest at P0 and at P7, with both Control and TrkBFL KO 
ovaries exhibiting the strongest responses in the ages between (P2-



























































6.4.3. Assessment of Dazl KO ovaries 
As this immune response is proposed to be involved in the 
active clearance of apoptotic debris produced by overwhelming oocyte 
apoptosis, it is postulated that other models of large-scale neonatal 
oocyte death would possibly exhibit the same immune response.  As 
discussed in Chapter 1.2.2 Dazl KO ovaries lose all oocytes 
perinatally (Ruggiu et al., 1997).  It was, therefore, decided that 
ovaries of the Dazl KO mouse would be an ideal model to assess for 
the presence of an immune response.  H&E sections from ovaries 
were assessed at E17.5 and at P1 in comparison with sibling Control 
ovaries.  At E17.5, all ovaries contained many oocytes with no 
apparent signs of oocyte loss in the KO.  At P1, oocytes were already 
lost from the KO ovaries assessed and no overt signs of an immune 
response were visible.  Thus, the window of opportunity to observe 
the active loss of oocytes was missed.  Attempts to obtain ovaries of 
an age between E17.5 and P1 were unsuccessful, therefore, it was 

















6.5. Discussion  
It has been demonstrated here that during establishment of the 
murine primordial follicle reserve and the initial stages of follicle 
activation it is typical to observe immune cells in the perinatal ovary.  
Through morphological and histological assessment, the nature of 
this response has been identified to consist of cells akin to both the 
innate and acquired immune responses (eosinophils, PMLs and 
lymphocytes).  The fact that this response was originally observed in 
neonatal TrkBFL KO ovary, and its severity in that instance, led to the 
original hypothesis that the immune response is observed due to 
increased levels of cell death in the TrkBFL KO overwhelming the 
normal method of apoptotic debris clearance.  However, this genetic 
link was not proven as it was confirmed that the severe response is 
also apparent in Control ovaries.   
Thus, as it has now been shown that immune cells are almost 
always present in neonatal ovaries (at least at low levels in the bursa) 
I propose that this response may be a normal physiological process 
that has not been previously described. 
Normal ovary development entails a significant loss of oocytes 
neonatally, therefore, it may be that immune cells are constantly 
contributing to the clearance of cell debris.  Abnormally elevated 
levels of cell death invoke a larger reaction and additional types of 
immune cells (such as lymphocytes) may be recruited to the ovary.  
Evidence for this has been found in the mouse lung where high levels 
of PML recruitment and subsequent apoptosis actually increase PML 
recruitment to this organ.  The PMLs phagocytose debris until other 
phagocytes, such as macrophages, are able to control the apoptosis 
occurring (Rydell-Tormanen et al., 2006).  The majority of neonatal 
oocyte cell death occurs by P2 in the mouse (Rodrigues et al., 2009).  
Thus, as the strongest reactions were observed in the P2-P6 ovaries 
assessed, but not at P0, instead of assisting with clearance of debris 
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at the time of oocyte death, perhaps it is a response that occurs after 
the peak has occurred.  This could then explain the reduction in 
response by P7.  However, again this may also be too simplistic as the 
responses were so variable not only between animals at the same age 
but even between ovaries of the same animal.         
Alternatively, and as equally novel, is the possibility that the 
immune response observed may be a case of spontaneous 
autoimmune ovarian disease (AOD) arising due to lack of immune 
system stimulation caused by the sterile housing conditions that the 
TrkB colony is kept in.  There is a window in neonatal development 
(P0-P7 in the mouse) during which the acquired immune system 
establishes what is self from non-self.  Should this not be established 
appropriately, then the immune system can cause autoimmune 
disease.  AOD can be induced in the mouse by thymectomy at P3 and 
a strong infiltration of lymphocytes is observed in the ovary some 
weeks later (Taguchi et al., 1980).  Subsequent loss of oocytes links 
AOD to POF, although normal progression of murine AOD takes 5-6 
weeks before it is apparent in the ovary.  Thus, it seems that the 
response observed here would be precocious in its timing.  However, 
AOD can be induced in newborn mice within a few days, when 
splenic T-lymphocytes from mice exhibiting AOD are transferred 
(Sakaguchi et al., 1982).  It is, therefore, not impossible that a more 
rapid onset of oophoritis has been observed here.  
If this novel observation was to reveal that a form of AOD can 
be spontaneously induced by limited immune stimulation during the 
neonatal window then this is a situation that should be considered by 
all those working with animals in ultra-sterile units.  There is already 
anecdotal evidence of affected animal fertility in very sterile units 
demonstrated by a decline in breeding (personal communication with 
Dr N. Spears, Edinburgh University; Mr D. Thomson of Professor R. 
Ribchester’s group, Edinburgh University; and Dr S. Kimber, 
Manchester University).  Thus, it is even not too large a leap to make 
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the hypothesis that POF in women, which is linked to AOD 
(Chernyshov et al., 2001), could be related to a lack of immune 
stimulation during this window, for example premature or newborn 
babies kept in incubators.   
A third option may be that it is a combination of the two.  
Gregory and Devitt (2004) reviewed that it is sometimes (but not 
always) possible for defective clearance of apoptotic debris to result in 
the production of autoantibodies.  Thus, it may be possible that 
overwhelming cell death occurring physiologically in the ovary may 
trigger AOD and subsequent POF.     
Whichever of the above possibilities it could be, the pattern of 
the response has been observed and described in this Chapter.  It 
was found that PMLs are the cell type most commonly seen in the 
ovarian tissue.  They also appear to be the cell type to reach the ovary 
first, given that the lymphocytes were never observed without PMLs 
present, but that the reverse was common.   
The role of PMLs is unclear in this model as they are more 
prevalent in the bursa and hilar region rather than in the ovary 
proper where oocyte cell death would be occurring.  Therefore, 
although PMLs are capable of cell debris phagocytosis, it seems 
unlikely that they would be solely responsible for this in the ovary 
proper.  It may be that they have been recruited to the ovary through 
release of a potent PML recruiter, such as chemokine IL-8, but are 
not able to penetrate the ovary sufficiently unlike lymphocytes or 
macrophages.  The mode of transport of PMLs into tissue is by the 
vasculature (they adhere to endothelial cells lining vasculature and 
migrate between them to enter the tissue).  It is, therefore, not 
surprising that penetration of PMLs into the ovary proper is reduced 
in comparison to the bursa or hilar region as the vasculature is 
relatively reduced in the ovary proper (the nests of oocytes and 
follicles are avascular but there will be vasculature in the interstitial 
regions).   
 224 
Macrophages are present and active in the mouse ovary during 
the process of ovulation (Hume et al., 1984).  They have also been 
detected in the immature (28 day old) rat ovary, along with 
eosinophils, mast cells, PMLs and T-lymphocytes (Brannstrom et al., 
1993).  In this study, macrophages have also been shown to be active 
in the neonatal ovary, ingesting cell debris and cytoplasmic fluid.  In 
addition to this classic phagocyte, granulosa cells of atretic follicles in 
prepubertal mice exhibit phagocytic properties by ingesting dying 
granulosa cells and oocytes (Inoue et al., 2000).  Material assessed in 
this chapter also suggests that oocytes are capable of contributing to 
phagoctyosis of cell debris.  Characteristically non-phagocytic cells 
are capable of phagocytosis of apoptotic cells even before they exhibit 
characteristic signs of apoptosis (Gregory and Devitt, 2004).  Thus, it 
may be that ovarian somatic cells and oocytes are able to 
phagocytose apoptotic cells before they appear apoptotic 
histologically, perhaps explaining why the massive cell death known 
to occur in the neonatal ovary is rarely observed.  The ability of 
oocytes to exhibit phagocytic (or autophagic) properties has also been 
recently demonstrated by Rodrigues et al. (2009). 
 As it is not possible to distinguish between T- and B-
lymphocytes using CD45, the exact type of lymphocyte present in the 
ovary is unknown.  However, from the quiescent morphology of the 
lymphocytes present it appears that they are functionally silent.  The 
reason for their presence is, therefore, unclear.   
The observation in this chapter of lymphocytes and PMLs 
adjacent to oocytes within follicles indicates loss of BM integrity.  It is 
possible to conjecture that this is a secondary effect, caused by the 
release of proteolytic enzymes from the granulocytes, breaking down 
the BM as done by macrophages during ovulation.  Alternatively, it 
may be a consequence of normal follicle loss.  During normal follicle 
atresia the BM of the follicle is compromised, and when atresia is 
artificially induced immune cells can enter the follicle, possibly due to 
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a disrupted BM (Lee and Yoon, 2005).  Therefore, the ability of the 
leukocytes to access intrafollicular compartments in the ovaries here 
could be due to either possibility or a combination of both.   
The immune response observed in the ovaries is characteristic 
of a response to injury or infection, and given that it had not been 
described in the literature, it was considered that it may have been 
caused by infection in the colony.  This, however, has effectively been 
ruled out as I have since found that the ovarian immune response 
has been noted by others (personal communication with Dr J. Visser, 
Utrecht University; and Professor A. Byskov, University of 
Copenhagen).  In addition, I have observed it myself in ovaries from a 
separate mouse colony in a separate unit.   
There is, however, another possible explanation for the ovarian 
immune response observed.  Professor A. Byskov presented a 
hypothesis (at the Society for Reproductive Fertility annual 
conference, 2008, Edinburgh) that stem cells may get trapped in the 
ovary during development.  Thus, it may be that ovaries with a strong 
immune response may have had haematopoietic stem cells lodged in 
the ovary during development which have begun to proliferate and 
differentiate in an uncontrolled manner due to being in the incorrect 
location.  This theory would be supported by the observations of 
immature forms of the PMLs observed in the ovary and could also 
explain the presence of the seemingly inactive lymphocytes (which do 
not comfortably fit in with the presence of innate immune cells).  
Another observation that may tie in with this notion of trapped stem 
cells is the occasional collection of a bloody ovary.  Could it be that 
formation of blood cells is occurring in these ovaries and instead of 
lymphocytes, I have actually observed nucleated erythrocytes, and 
the apoptotic debris is expelled nuclei?  I propose this as one option 
as it was interesting to note that not all lymphocytes, as identified by 
H&E, were labelled by the CD45 pan leukocyte marker.  It may be 
that another subset of immune cells, which do not express CD45, 
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also infiltrate the ovary at the same time.  Alternatively, it could be 
that the cells are at a stage of differentiation where they do not 
express CD45. 
In conclusion, the novel observation of immune cells in the 
neonatal ovary has been characterised and the possible functions of 





































Chapter 7   
 
















7.1. Aim of thesis   
 The aim of this thesis was to investigate the role of TrkB 
signalling in the development of the neonatal mouse ovary, in 
particular to determine its role in oocyte survival at the time of follicle 
formation.  The main tool used to address this was the TrkBFL KO 
mouse and the assessment of its ovarian phenotype.  The merit of 
this investigation lies in its contribution to our general understanding 
of the factors that regulate neonatal ovary development.  This period 
of development in the mouse ovary is a model of the period of 
development important across many species, including humans, as it 
is the point at which the female mammal’s lifetime supply of follicles 
is formed.  Factors correctly regulating this ultimately determine the 
reproductive lifespan of the individual and ensure the production of 
the next generation.  Incorrect regulation (including failure to form a 
pool of follicles) will result in compromised fertility, or even infertility.   
 
7.2. Effects of TrkB on the neonatal ovary   
 The project commenced with deciphering the developmental 
processes occurring in the TrkBFL KO mouse which result in the 
phenotype of severe oocyte loss by P4/5 (Spears et al., 2003).  
However, as discussed in Chapter 3, the colony had been rederived to 
a new animal unit prior to beginning the project, consequences of 
which severely impacted upon my ability to address the aim set out.  
Namely, the problems encountered were 1) a reduced survival rate of 
pups in the colony, which resulted in an even lower collection rate of 
TrkBFL KO pups than anticipated (due to their postnatal lethal 
phenotype) and 2) an apparent alteration in the ovarian phenotype 
from that previously observed (Spears et al., 2003).  It was simply 
unfortunate that point 2 was not determined until some time into the 
project, due to point 1.   
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With the benefit of hindsight (and the incredible complexity of Trk 
signalling, as discussed in Chapter 1.5) it perhaps should not have 
been so unexpected that the role of TrkB signalling in the ovary could 
be so difficult to unravel.  However, in spite of the difficulties and the 
reduced available sample size, I have demonstrated that instead of 
the severe phenotype previously observed there is a more subtle 
phenotype.  The subtle phenotype might, though, have helped reveal 
how TrkB affects ovary development as once the ovary is very 
affected; it is difficult to determine what has occurred.  The 
phenotype found is one of reduced follicle health in terms of 
granulosa cell to oocyte arrangement, BM integrity and follicle 
development.  Disruption of follicular BM was assessed in the TrkBFL 
KO ovary through analysis of laminin-α1 deposition (see Chapter 4) 
and is postulated to be part of the sequence of events which 
contribute to the resulting ovarian phenotype.  The laminin-α1 defect 
was not restricted to the ovary, but demonstrable in the TrkBFL KO 
testis, kidney and brain.  There is evidence that the Akt/PKB pro-
survival pathway, activated downstream of tyrosine kinase signalling, 
can regulate BM deposition in vitro, in particular isoform laminin-α1 
(Li et al., 2001).  I believe the logical interpretation that can be drawn 
from these findings is that tyrosine kinase signalling through the full-
length TrkB receptor contributes to in vivo regulation of laminin-α1 
deposition in the mouse.  This reduction is detectable before the 
reduced rate of primary follicle formation is apparent.  This finding, 
alongside the requirement for epithelial cell-BM contact to direct 
normal morphogenesis, allows one to conjecture that this effect may 
have direct consequences on the pregranulosa cells’ ability to 
differentiate into cuboidal granulosa cells before commencing the 
proliferation required for follicle growth.  However, it must also be 
considered that this sequence of events can also be influenced by 
other signalling pathways including other Trk receptors.  It was 
discussed in Chapter 1.5.2 that the downstream signalling targets of 
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the Trk receptors can overlap as the specificity for these receptors lies 
in the ligand binding domain.  It is also possible that the many 
factors discussed in Chapter 1.3.2 which have been shown to be 
important in the activation of primordial follicles and their initial 
stages of growth may compensate for the loss of signalling in the 
TrkBFL  KO.   
Since I showed that TrkBFL KO oocytes can survive, form 
follicles and initiate growth in vivo, I decided to ascertain their long-
term survival prospects. This was done by transplanting the ovaries, 
as in vivo assessment is not possible due to the postnatal lethal 
phenotype.  Considering the previous phenotype of in vivo oocyte loss 
(Spears et al., 2003) and the finding that transplantation of TrkBFLTr 
KO ovaries results in mass oocyte loss (Paredes et al., 2004), it was 
anticipated that oocytes/follicles would also be lost in the TrkBFL KO 
transplants.  Instead it was found that TrkBFL KO oocytes and follicles 
can survive and grow as well as in transplanted Control ovaries (see 
Chapter 5).  This has intriguingly revealed that expression of full-
length TrkB cannot be autonomously required within ovarian follicles 
for survival (by granulosa cells or oocytes), otherwise they would have 
degenerated.  How these follicles survive in the first place is 
unknown, though it is possible to speculate that it could be a survival 
factor generated by the intact ovaries of the recipient.  These ovaries 
will be producing multiple factors required by the ovary as well as 
having an intact full-length TrkB receptor signalling pathway.  
However these follicles in the transplants survive, their subsequent 
growth may then produce additional survival factors sufficient to 
rescue the remaining cohort of follicles.  The fact that transplanted 
TrkBFL KO ovaries continue to exhibit reduced laminin-α1 compared 
to Control ovaries, as they did in vivo, indicates that this effect is a 
direct result of loss of full-length TrkB signalling but it is not 
sufficient to prevent follicle growth or cause atresia.  This, however, 
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does not rule out that laminin-α1 deposition may influence the very 
initial stages of follicle growth in the ovary.  
The previously proposed mechanism of Trk action within the 
ovary was that it acted at the level of the follicle: ligand produced by 
somatic cells and/or oocyte binds to receptors present on the somatic 
cells and/or oocyte.  If it could be proved to be the case that the 
TrkBFL KO ovaries have been rescued by an aspect of the 
transplantation procedure then it may still be possible to speculate 
that full-length TrkB signalling is required for normal in situ ovary 
development, albeit not directly within the follicle.  This would 
demonstrate an unanticipated mode of TrkB action within the ovary.  
 
7.3. Variability in inbred mouse strains   
The ability to quantitatively measure change in a phenotypic 
trait in response to a genetic or environmental factor requires that a 
baseline be determined for the innate variability of that trait within a 
population.  Determining this innate variability then allows a 
measure of importance to be placed on factors which, when altered, 
result in a substantial change to the trait in question.  As discussed 
in a commentary by the late Professor Anne McLaren (1999) there is 
evidence that in attempting to obtain a normal baseline, by using 
genetically similar organisms such as inbred strains of mice, it may 
actually only produce greater variability in response to stressors 
(changes in genetics/environment).  This effectively renders the 
objective of using inbred strains null and void; the basis for this 
argument is described herein. 
McLaren and Michie (1956) observed that first generation mice 
(F1) resulting from crossing two inbred strains present a more 
uniform response to a drug treatment than the original inbred strains 
do.  F1 mice are considered to be more genetically variable than the 
original inbred strains and this increased heterozygosity seems to 
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provide them with greater fitness.  Fitness here is considered to be 
the organism’s ability (when faced with a stressor) to maintain 
optimal consistency in development and homeostasis (Waddington, 
1942).  The problem faced at this time was explaining how adaptive 
traits (developed in the face of a stressor) become heritable.  This was 
clearly a topic of interest several decades ago but it was only recently 
that a molecular mechanism was proposed to account for this.   
The molecular evidence for the ability to buffer against slight 
changes in genotype or environment came in the form of the signal 
transduction chaperone, heat shock protein (Hsp90).  Prevention of 
its normal action in Drosophila (either by mutation or 
pharmacological means) result in presentation of morphological 
variants which can become heritable when selected for (Rutherford 
and Lindquist, 1998).  This led to the hypothesis that signal 
transduction chaperones may act as buffers to changes in genetics or 
environment (stressors) to allow the normal development of the 
organism.  If alteration (genetic or otherwise) affects a chaperone it 
may prevent its ability to buffer against many other traits which then 
become apparent, thus instead of affecting only one character many 
could be affected.  The result is a reduction in uniformity within the 
population.  In normal populations, faced with natural selection, the 
process of stressors inducing small variations in phenotype allows 
the heritable acquisition of traits that are beneficial.  However, for the 
research scientist this is not so good, as inbreeding (a form of stress 
as McLaren (1999) puts forth), causes the mouse strains to lose 
heterozygosity, increasing variability in responses to stress within the 
population.  This effectively means that inbred strains could be 
unreliable for measuring the significance of some genetic or 
environmental factors (McLaren, 1999).    
The use of inbred strains to generate transgenic mice is, 
therefore, questionable although commonplace.  Many have 
attempted to circumnavigate the problem of variation between 
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individuals by increasing the homozygosity of the colony through 
moving mutations onto inbred congenic backgrounds.  Congenic mice 
differ by only a small genetic sequence and are generated by crossing 
two strains of inbred mice (one of which expresses a gene, or 
transgene, of interest).  The gene is selected for in each generation 
and the animal is backcrossed with the other strain for 5-10 
generations.  This results in the mutation being the only difference 
between siblings.  However, the degree to which a phenotype will be 
presented can still be variable between congenic strains.  This issue 
has begun to be addressed (Rivera and Tessarollo, 2008) but in 
general, when this type of problem has arisen in the scientific 
community it has often been ignored, as the use of congenic strains 
of mice is considered to be the best practice when assessing the effect 
of a transgenic mutation.    
In terms of mouse ovary development it may not, therefore, be 
surprising to learn that different inbred strains can exhibit 
significantly different numbers of follicles shortly after birth (Canning 
at al., 2003).  There is also large variation in oocyte number between 
individual mice within an inbred strain (Rodrigues et al., 2009).  
Consequently, when animal availability is limited, as for the TrkBFL 
KOs, the innate variability of the ovary magnifies an already existing 
problem.   
 
7.4. Use of animals in research   
Aside from the TrkB colony, it is possible to take the point one 
step further to the controversial debate that has dogged science for 
several decades and quite probably always will: the use of animals in 
research.  Rivera and Tessarollo (2008) recently discussed in a 
commentary that the benefit of using mice as a research tool is their 
closeness to humans, allowing normal and pathological development 
to be studied, with or without manipulation.  However, disparities in 
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results, caused by the variation discussed in the previous section, 
cast a shadow over this logic and question the ability to draw 
meaningful conclusions from mouse studies.  It was proposed that “to 
minimize inter-animal variations…..experiments might need to be 
done in a pathogen-free purebred genetic background, in animals of 
the same age, and only in males; reliable results might even be 
obtained only when phenotypes are recorded at the same time of day” 
(Lathe, 1996).  Having controlled for these aspects in this study 
(except, obviously, for only using males) and finding that variability is 
still apparent in the TrkBFL KO phenotype it seems that the challenge 
faced (if we are to continue using transgenic animals in research in a 
meaningful way) is to develop a reliable robust in vivo model.  A 
possible compromise to this has been proposed by Matthaei (2007).  
The ideal method proposed would be to have a transgene that is 
under total control of the researcher, in terms of where it is expressed 
and when it is expressed.  The ability to reverse the effects would also 
allow each animal to act as its own Control (Matthaei, 2007).  It has 
also been proposed by Rivera and Tessarollo (2008) that meaningful 
interpretations from using transgenic mice can still be obtained if 
careful consideration is made in relation to what is being investigated 
and the known idiosyncrasies of individual backgrounds.  
Additionally, several backgrounds could be studied for effects of the 
same mutation to achieve a broader spectrum of the potential 
phenotypes.  This would potentially allow differentiation of a true 
effect from a background effect (Rivera and Tessarollo, 2008).  That is 
not to say that when an effect is observed it is not real but in a 
situation whereby an effect may appear variable in its presentation it 
may be useful to build a bigger picture of the nature of the phenotype 
across several backgrounds.  This may be ideal, although it would be 
very expensive due to the number of animals that would be required.   
In spite of the problems that were faced in the project regarding 
animals, it demonstrated that the whole animal model is yet to be 
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superseded by new technologies.  In vitro methods are constantly 
being refined and their success places them in a position of 
usefulness that on paper would seem to surpass the mouse.  Cell and 
tissue in vitro culture protocols allow almost total manipulation and 
control of the experiment, however, they cannot truly replicate the 
complexity of the whole animal model, or reveal possibly wider 
reaching consequences.  This project demonstrated how true this can 
be with the novel observation of the neonatal immune response.  It 
was ascertained in Chapter 6 that the neonatal ovary is capable of 
exhibiting severe infiltrations of different types of immune cell 
including the innate (PMLs, eosinophils and macrophages) and 
acquired immune responses (lymphocytes).  The granulocytes, at 
least, could be observed in most ovaries from P0-P7 at low levels 
leading to speculation of potential physiological roles for their 
presence in the neonatal ovary.  In addition the severity of the 
response was characterised to occur during the developmental period 
when neonates are susceptible to aberrant immune system 
formation.  This, I believe is an example of the far wider reaching 
consequences that may come about from mutation or manipulation 
of the environment.  They can occasionally allow scientists to 
speculate on subjects seemingly at a tangent from their original aim 
or interest, but it is clear that it would never have been observed had 
it been cells in a culture dish getting analysed. 
     
7.5. Further research. 
During the course of this thesis, although working with limited 
material, I have been successful in investigating how full-length TrkB 
affects ovary development.  However, I do not believe that further 
work researching the role of full-length TrkB signalling only in 
relation to the ovary would be beneficial to the field due to the lack of 
molecular tools available and (from this study) the lack of 
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autonomous requirement for TrkB signalling within the follicle.  It 
did, however, become apparent that a very useful attribute for a 
researcher to have is an open mind when considering unexpected 
results.  I would say that out of all the results obtained during the 
course of this PhD it is in fact the unexpected results that have ended 
up being the most thought-provoking and possibly revealing.  Two 
aspects that I consider would be interesting to take further are 
discussed here. 
Firstly, it was not anticipated that the results of the TrkBFL KO 
ovary transplants (carried out in Chapter 5) would give such 
staggeringly different results from those of Paredes et al. (2004).  As 
covered in the discussion of that Chapter, the results raised several 
possible factors that could account for the different outcomes, 
although it is apparent that the previously proposed mechanism of 
TrkB action (autonomously within the follicle) is now redundant as 
TrkBFL KO mice examined for this project are able to survive without 
it.  In spite of the lack of requirement for TrkB expression within the 
follicle, it would still be particularly interesting to determine if the 
variables between the two protocols described influence the outcome 
of the transplants.  This would contribute to our understanding of 
the optimal way in which this protocol can be used in the future, 
whether that is to support optimal survival of the transplanted 
ovaries or it is to decipher autonomous from non-autonomous effects 
as this experiment was originally intended to do.   
To determine the effect of the intact recipient’s ovaries on the 
transplanted ovary would require transplantation of TrkBFL KO 
ovaries into ovariectomised recipients.  It would also be proper to 
transplant the TrkBFL KO ovaries at an older age to see if the 
mutation has a “tipping point” after which it cannot be rescued.  The 
reverse experiments would require TrkBFLTr KO ovaries to be 
transplanted into intact recipients as well as transplanting them at 
P0, to see if they can be rescued.  These steps would be best practice 
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to try to rule out variables causing the difference in transplant 
results, however, it would require a sample size of TrkBFL KO ovaries 
large enough to statistically compare each combination.  This fact, as 
well as needing access to TrkBFLTr KO ovaries, unfortunately makes it 
an unrealistic option. 
 The second aspect of this project that I believe would merit 
further investigation is the observation of the neonatal immune 
response described in Chapter 6.  It was originally hypothesised that 
the response was due to elevated rates of oocyte cell death occurring 
in the TrkBFL KO ovary.  The observation of the same response in the 
Control ovaries negated this possibility.  However, it was not proven 
that the response is not associated with cell death occurring in 
ovaries; therefore, it would still be worth obtaining Dazl KO ovaries at 
the point of their dramatic loss of oocytes to see if the immune cells 
are present.   
 I personally consider that the hypothesis of a link between the 
immune response observed in the colony and the cleanliness of the 
unit is one worthy of further investigation.  The induction, duration 
and intensity of the immune response may exert effects on the fitness 
of the animals, in particular, their fertility.  To address this would be 
a major undertaking but if it were possible to access the ovaries from 
animals on the same background in different units with different 
degrees of sterility it may be feasible.  It would, though, require that 
improvements be made to the techniques utilised in Chapter 6.  The 
material used to characterise the response in Chapter 6 was a 
reasonable compromise of some tissue that was good for morphology 
and some that was good for immunohistochemistry.  The pan 
leukocyte marker, CD45, at least confirmed the immune nature of the 
cells present.  However, as the majority of the antibodies investigated 
for this chapter are known to work best on frozen sections it would be 
best to obtain frozen sections and attempt to differentiate between 
the immune cell types with specific antibodies.  It may also be useful 
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to characterise the chemokine signals present in the neonatal ovary, 
however this would not necessarily give a physiological explanation. 
 
7.6. Concluding remarks   
As set out in Chapter 1, the specific aims that I intended to 
address during the course of this PhD were to: 
 
1.  Decipher and investigate the chain of events occurring in 
the TrkBFL KO mouse that leads to the phenotype of severe oocyte 
loss seen shortly after birth. 
2. Extrapolate to determine how TrkB signalling contributes to 
the normal loss of oocytes that occurs at the time of ovarian follicle 
formation. 
 
In examining the phenotype of the TrkBFL KO ovary during this 
PhD it was established that the severe phenotype was no longer 
apparent.  Instead a subtle effect on follicle health, early follicle 
growth and deposition of laminin was found.  Each of these factors 
contributes to normal development of the ovary but intriguingly the 
long-term survival prospects of the oocytes in the TrkBFL KO ovaries 
is not compromised when they are transplanted.  It must be 
concluded, therefore, that full-length TrkB signalling does not directly 
regulate oocyte survival.  It was possible, though, to speculate that 
the reduction in follicle health and deposition of laminin may 
contribute to the reduced follicle growth observed in the in vivo TrkBFL 
KO.  Thus TrkB signalling, in the context of normal ovary 
development, may contribute to follicle growth by regulating the 
extracellular environment of the follicle.  This thesis has also 
highlighted the existence of immune type cells in the neonatal mouse 
ovary, further investigation of which would be interesting.  The 
difficulties faced during this PhD in addressing these aims allowed 
 239 
the scope of this thesis to expand to discuss the importance of 
aspects such as the use of transgenic studies and how animal 
colonies are maintained.  Therefore, although the aims were not able 
to be fully addressed I believe this thesis has contributed to our 
understanding of neonatal ovary development and, in the bigger 
picture, has highlighted areas of working in research that require 
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Appendix A. PCR protocols 
 
DNA extraction by HotSHOT  
 
Combination of the lysis and neutralising reagents produces a 20mM Tris-
HCl, pH 8.1, 0.1M EDTA buffer which DNA can be stored in. 
 
Alkaline Lysis Reagent – pH 12 Neutralising Reagent  – pH 5 
25mM NaOH 40mM Tris-HCl 
0.2mM EDTA  
Dissolve in H2O – no pH adjustment Dissolve in H2O – no pH adjustment 
 
PCR screening for wild-type and mutant TrkB genes  
 
Successful PCR genotyping results were obtained mainly through running 
the reaction for the wild-type gene separately from the mutant gene, although 
it was also possible to obtain results using primers in combination.  
 
Combined reaction 
PCR Reaction Mixture Volume per sample (µl) 
ddH2O (MilliQ-autoclaved) 8.8 
10x PCR Buffer 2.0 
25mM MgCl2 0.6 
10mM dNTPs (1:1:1:1) 0.4 
Taq 0.2 
10mM Primers (1:1:1) 3.0 
DNA 5.0 
 Final volume = 20µl 
 
Separate reactions for wild-type or mutant gene 
PCR Reaction Mixture Volume per sample (µl) 
ddH2O (MilliQ-autoclaved) 9.8 
10x PCR Buffer 2.0 
25mM MgCl2 0.6 
10mM dNTPs (1:1:1:1) 0.4 
Taq 0.2 
10mM Forward Primer 1.0 
10mM Reverse Primer 1.0 
DNA 5.0 
 Final volume = 20µl 
 
All reagents (excluding water) were stored at -20oC, prior to use they were 





Primer sequences  
 
5’ AAGGACGCCAGCGACAAT  Common wild-type forward 
5’ GTCCCCGTGCTTCATGTACTC Wild-type reverse 
5’ GATGTGGAATGTGTGCGAGGCC  Mutant reverse 
 
PCR Parameters  
 
1.  Preheat @ 96oC  2 minutes 
2.  Melt @ 96oC  30 seconds 
3.  Anneal @ 60oC  30 seconds 
4.  Extend @ 72oC  30 seconds 
5.  Steps 2-4 for 34 cycles 
6.  Extend @ 72oC  5 minutes 
7.  End  
 




10µl loading buffer 
 
Agarose gel  
 
TBE Buffer pH 8.3 
Tris 10.9g 




The PCR products were run on a 1% agarose gel, either in a standard gel 
tank or, to allow better separation when using the combined primer PCR 
















Appendix B. TEM solutions 
 
Stock buffer: 0.2M NaCo. 
 
Sodium cacodylate buffer (NaCo) was made as a 0.2M stock in MilliQ ddH2O 
which could be used over 2-3 weeks if stored at 4oC. 
 
Working buffer: 0.1M NaCo. 
 
Prior to a 1:1 dilution in MilliQ ddH2O, the pH of 0.2M NaCo was adjusted to 




25% glutaraldehyde in 0.1M NaCo (TAAB) was diluted to a 3% solution using 
the working buffer. 
 
1% Osmium tetroxide. 
 
4% osmium tetroxide in H2O (TAAB) was diluted to a 1% solution using the 
working buffer. 
 
 
 
